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ABSTRACT 
 
Diabetes mellitus is a chronical condition that features either the lack of insulin or 
increased insulin resistance. It is a disorder in the human metabolic system. To combat 
insufficiency of insulin released by pancreas, a closed-loop control system, also known as 
artificial pancreas (AP) in this application, have been created to mimic the functionality of a 
human pancreas. An AP is used to regulate blood glucose concentration (BGC) by managing the 
release of insulin. Therefore, an algorithm, which can administer insulin to reduce the variation 
of BGC and minimize the occurrences of hyper-/ hypoglycemia episodes, is the key component 
of an AP. The objective of the dissertation is to develop an optimal algorithm to better control 
BGC for people with diabetes. 
For people with Type 2 diabetes, prevention or treatment of diabetes mellitus can 
typically be done via a change of lifestyle and weight management. A virtual sensing system that 
does not require many manual inputs from patients can ease the burden for people with Type 2 
diabetes. This dissertation covers the development of a monitoring system for Type 2 diabetes.  
To achieve the goal of tighter control of BGC for people with Type 1 diabetes, dynamic 
modeling methodology for capturing the cause-and-effect relationship between manipulated 
variable (i.e. insulin) and controlled variable (i.e. BGC) has been developed. Theoretically, this 
dissertation has established that physiologically based nonlinear parameterized wiener models 
being superior to nonlinear autoregressive moving average with exogenous inputs (NARMAX) 
models in capturing dynamic relationships in processes with correlated inputs. Based on these 
results, wiener models have been applied in the modeling of BGC for real subjects with Type 1 
diabetes under free-living conditions. With promising results shown in wiener models, an 
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extended physiologically based model (i.e. semi-coupled model) has been developed from 
wiener structure, which enables the development of a phenomenologically sound feedforward 
control law. The feedforward control law based on wiener models has been tested in simulated 
continuous-stirred-tank reactor (CSTR) that demonstrates tight control of controlled variables. 
Further simulation runs with a CSTR also shows feedforward predictive control (FFPC) can 
provide tighter control over model predictive control (MPC). Lastly, for the special application 
of BGC control for people with Type 1 diabetes, FFPC demonstrates tighter control than MPC 
under simulation environment. To account for unmeasured disturbances and inaccurate models 
for manipulated variable in real life scenarios, feedback predictive control (FBPC) is developed 
and proven to be a more effective control algorithm under both CSTR and diabetes simulation 
environment, which can establish the foundation for tightening BGC in real subject clinical 
studies. 
Key Words: Artificial pancreas, feedforward control, model predictive control, dynamic 
modeling, virtual sensors, diabetes mellitus 
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CHAPTER 1: INTRODUCTION                                                                         
Diabetes, a dysfunction in human metabolic system, has become one of the most 
prevalent health problems around the world. According to the report by Centers for Disease 
Control and Prevention (CDC) in 2014, there is a record that 9.3% of the people among 
population in United States are plagued by diabetes, while 9% of the world population are 
affected by various types of diabetes [1].  The risk of death is 50% higher for people with 
diabetes than people without diabetes. In addition, more than 80% of deaths related to diabetes 
occur in low- or middle-income countries with insufficient healthcare provided [2]. In China, up 
until 2015, 11.6% of population in has diabetes or pre-diabetes [3,4]. 
Diabetes, as a disorder in human metabolic/regulatory system, features deficiency in 
insulin, and is commonly divided into two major categories: Type 1 Diabetes (T1D) features the 
reduced or total loss of the ability to produce insulin from beta cells in pancreas, and it is usually 
caused by beta cells targeted and eliminated by immune system; Type 2 Diabetes (T2D) usually 
features cell resistance of insulin or reduced efficiency of insulin. Both major types of diabetes 
could result in dysfunctional behavior in insulin/blood glucose regulatory. For T1D, their blood 
insulin level is often less than that of a healthy person, while for T2D, the blood insulin level can 
be less than, equal to or more than that of a healthy person. But both types feature inability to 
lower blood glucose concentration (BGC) properly due to either the lack of insulin (T1D) or 
ineffectiveness of insulin (T2D). Consequently, for people with either T1D or T2D, their BGCs 
will often be higher than nominal level. The focus of this dissertation is on T1D or sometimes 
called insulin dependent diabetes (IDD) since the dynamic relationship between insulin and 
glucose is well studied and there are advanced technologies that can administer insulin (i.e. 
insulin pumps), while the mechanism behind T2D is more complex and the treatments for T2D 
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varies greatly from person to person. This dissertation will also cover monitoring systems for 
T2D based on input-only models. 
Hyperglycemia (i.e. high BGCs) poses the major concern for people with diabetes. If 
insulin concentration in the human body is too low, the body will fail to provide sufficient 
energy via blood glucose and blood glucose could remain under-utilized. As a result, high level 
of blood glucose occurs. High concentration of blood glucose accumulating in blood stream will 
cause irreversible damage to body organs as glucose crystals can damage blood capillaries. 
Severe complications can follow diabetes, and the risk of death for population with diabetes is 
higher [1,2].  
To combat deficiency of blood insulin in people with diabetes insulin injection/infusion 
are traditional treatments. Different insulin injection/infusion methods have been developed. 
Traditionally, 3 to 4 injections before meals per day is usually used to prevent BGC from rising 
due to meals. With the advancement of modern technology, equipment such as insulin pumps 
(devices that can release insulin, via a catheter inserted under the skin, at pre-programmed time 
with precise dosage), continuous glucose monitors (devices outputting BGC readings at a 
frequency up to 1 reading per min) can improve the glucose management in diabetes patients. 
However, the fundamental issue with glucose management for T1D, the dosage and timing of 
insulin release, remains a problem.  
One aspect of that problem is the timing of insulin administration. In self-management of 
glucose, when a person with diabetes eats, it usually takes at least 15-30 mins before a rise in 
blood glucose occurs [5]. If that person injects rapid acting insulin after the glucose rise has been 
detected by a monitor, it will take at least 15 mins before insulin reaches the blood stream, and 
another 60mins before insulin action (i.e. lowering BGC) reaches its peak effect [6]. Summing 
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up all the time delays described above, it will take a long time (e.g. over 1 hour) before injected 
insulin can bring down the blood glucose after that meal for a person with diabetes. Thus, there 
will be extended period of hyperglycemia for T1D patients.  
The other aspect of blood glucose management problem is the dosage used in insulin 
administration. When the insulin level in the blood stream is too low, the BGCs will be high and 
hyperglycemia ensues. But if the insulin level is too high, the BGCs will be too low (i.e. 
hypoglycemia) so that the brain will have to gradually shut off first peripheral organs then its 
own functions as BGC goes down and eventually people will die from low BGC [7]. 
To summarize the problem of blood glucose management, with the time delays 
associated with insulin administration and meals, the goal is to develop an algorithm to compute 
insulin dosage needed and time of the insulin injection/infusion to prevent large deviation of 
BGC from desired level. This can help T1D patients to achieve tight control over BGCs and 
improve their quality of life. For people with T2D, the key challenge is to develop an input-only 
monitoring system that can provide BGC information to help people improve BGC control. 
Abstracted from the context of human metabolic/regulatory system, tighter blood glucose 
control/blood glucose management problems essentially could be viewed as a typical process 
control problem as seen in industry. But the complication is that the human metabolic system is 
far more complex than many industrial mass balance systems, as a lot of disturbances are 
unmeasurable or unmeasurable online (e.g. blood insulin), and each person has a unique set of 
dynamic glucose/insulin system that differs dynamically from one another.   
There are other treatments to T1D or T2D. Most notably, various diabetes medicine can 
provide effective treatments for people with diabetes in certain cases according to the 
prescription of physicians. For example, metformin is an oral medicine can help improve BGC 
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control with T2D, exenatide is a glucogan-like peptide-1-agonist medication that works with 
T2D, and insulin glargine is a version of man-made long acting insulin substitute that can be 
used to treat both T1D and T2D. These treatments are not within the coverage of this dissertation 
since the goal of this article is to achieve tighter BGC control from the aspect of controlling 
devices not medication treatments. 
Motivation 
In order to help people with T1D to improve their blood glucose management, the 
concept of the artificial pancreas (AP) was introduced. It usually consists of an insulin pump, a 
control algorithm, and a continuous glucose monitor (CGM). The artificial pancreas shall be able 
to utilize frequent glucose measurements (up to 1 reading per min) from CGM to calculate the 
amount of insulin needed based on the control algorithm. Since the AP aims at glucose 
management without human intervention, it is also being called closed-loop control in process 
control terminology. 
The core part of the AP is the control approach adopted, and the performance of AP 
depends on the control algorithm. There are two basic categories of control algorithms: feedback 
control (FBC) and feedforward control (FFC). FBC is a type of “reactive” control. There has to 
be a deviation from the set point before the control action takes place [8]. In the context of 
diabetes, the BGC has to deviate from its desired value before the algorithm determines the 
amount of insulin needed. The disadvantage of FBC is obvious- it is difficult to achieve tight 
glucose control and large swings of BGC after meal is inevitable. The advantage of FBC is that 
it’s usually easy and simple to implement the algorithm and does not require too much tuning for 
parameters. 
The most popular type of control approach currently in this application is model 
predictive control (MPC). MPC is a sub-genre of FBC. It is still a “reactive” type of control 
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concept; however, the deviation required for control action is not based on what has happened 
but what is going to happen. Hence, MPC can be thought of as futuristic feedback control. The 
disadvantage of MPC usually lies in the models used: autoregressive moving average (ARMA) 
or autoregressive moving average with exogenous inputs (ARMAX) that is usually used for 
control algorithm [9-11]. The model structure benefits from its identifiability and easy 
implementation. However, the prediction horizon is limited by the models since they cannot 
properly represent the true mechanism behind the dynamic behaviors of blood glucose and 
insulin. When past the limited prediction horizon, the prediction will become neither accurate 
nor precise. This issue can often be alleviated by adaptive control [8]. Since diabetes patients 
require a certain amount of time in advance to determine the amount of insulin infusion, MPC 
with output dependent models (e.g. ARMAX) can be less reliable when time delays are high and 
the correlation structure changed. 
Feedforward control (FFC) is a control approach that features “proactive” control actions. 
In principle, FFC that seeks to nullify the measured input effects before there is a deviation for 
set point or the target for the controlled variable. In the context of diabetes, FFC can determine 
the amount of insulin required to cancel the inputs measured such as meal contents, physical 
activities, and emotional stress. This is the control approach of this research. The FFC model 
does not depend on output measurements such as BGCs [12]. With an effective input only model 
implemented into the algorithm, there is a potential to greatly reduce the variation of blood 
glucose in T1D patients and to achieve tighter blood glucose control. 
Moreover, to achieve tight glucose control, the FFC system must capture a significant 
amount of cause-effect relationships associated with major disturbances, must accurately achieve 
subject-specific modeling, and must represent a critical degree of physiological soundness, in 
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order to manage the timing and size of insulin administration. Feedforward predictive control 
(FFPC), a new type of control idea, in this dissertation has the potential of achieving this goal. 
However, in real life scenario, or free-living condition where there is no restriction on the 
life style of patients, it is often difficult to come up with an accurate, yet simple  input only 
model to be used in FFPC. It could be due to the inaccuracy of disturbance sensors that 
quantitatively measure disturbances related to physical activities, or emotional stresses. To 
compensate for the lack of accurate input only models for FFPC, a new type of feedback 
predictive control (FBPC) method is developed. It combines feedforward features from FFPC 
and feedback tuning features from FBC. All it requires is an accurate model that does not drift 
over a long period of time. This requirements on models can be satisfied via the combination of 
input only models and output correction terms. As a result, FBPC could see great potential in the 
application of BGC management in both simulation studies and clinical trials. 
To evaluate different control schemes for comparison, the most effective way is to run a 
simulation study. With a simulation study, the robustness of the control strategy against 
interindividual variability can also be easily evaluated in a large-scale simulation.  Also, for the 
safety of test subjects, simulation tests on virtual patients are required before proceeding to 
clinical trials for people with T1D. In this dissertation, simulation results will be given to 
demonstrate the superiority of FFPC and FBPC methods. Additionally, a framework of BGC 
monitoring system will be shown for people with T2D. 
Dissertation organization 
This dissertation covers modeling and control to improve blood glucose concentration for 
people with diabetes, and will be divided into the following sections:  
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Chapter 2 will cover the literature review on the origin, mechanism, and typical 
treatments on different diabetes mellitus, as well as the current progress of artificial pancreas 
(AP) projects, especially with the focus on results from other simulation studies.  
Chapter 3 will demonstrate the feasibility of low order semi-empirical wiener structure in 
accurately monitoring BGC in a continuous fashion with 22 subjects with type 2 diabetes over 
the length of 4 weeks under free-living conditions. (Modeling and Co-authoring) 
Chapter 4 will showcase the superiority of nonlinear parameterized wiener structure in 
dealing with correlated inputs over nonlinear autoregressive moving average with exogenous 
inputs (NARMAX) models in a distillation column setting. (Co-authoring) 
Chapter 5 will explore the application of wiener structure in the modeling of BGC under 
outpatient free-living settings for people with type 1 diabetes. (Data collection and Co-authoring) 
Chapter 6 will propose a novel semi-coupled structure to better represent the 
physiological insulin BGC metabolic structure within human bodies, and demonstrate the 
advantages of semi-coupled structure over wiener structure. (Data collection and Co-authoring) 
Chapter 7 will introduce a powerful feedforward control law that potentially could greatly 
reduce the variation of BGC around its desired levels. Its effectiveness has been tested in a 
simulated continuous-stirred-tank reactor (CSTR). (Co-authoring) 
Chapter 8 demonstrates significant reduction in standard deviation around mean for 
controlled variable with the implementation of feedforward predictive control (FFPC) law with 
the presence of significant time delays associated with manipulated variables (i.e. time delays 
greater than other measured disturbances) and unmeasured disturbances. (Co-authoring) 
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Chapter 9 demonstrates the feedback predictive control (FBPC) algorithm applied in 
simulated CSTR can effectively tighten control of controlled variables compared against MPC. 
(Co-authoring) 
Chapter 10 indicates the applications of feedforward predictive control in BGC control 
for people with type 1 diabetes, could provide as tight as, or tighter control of BGC than the 
typical model predictive control methods. (Modeling, simulated control runs and Co-authoring) 
Chapter 11 demonstrates the proposed feedback predictive control method can provide 
significantly tighter control than feedforward predictive control and model predictive control 
methods. (Modeling, simulated control runs and Co-authoring) 
Chapter 12 discusses future works that could be done on the modeling and control to 
improve BGC for people with diabetes. 
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CHAPTER 2: LITERATURE REVIEW                                                                                       
Introduction 
Diabetes mellitus is a chronical metabolic disorder that features the lack of insulin in 
regulating blood glucose concentration (BGC) within human bodies. Therefore, to understand 
diabetes mellitus, one must first understand the metabolic systems that have been disturbed by 
diabetes. 
Blood glucose is a form of sugar that exists in bloodstream and can be carried into cells 
within human bodies to provide energy [1,2]. A major source for blood glucose is carbohydrate 
from meal ingestion. Through meal ingestion, carbohydrate after digestion will transform into 
glucose, galactose or fructose, all of which will be absorbed into the portal vein in gastro-
intestinal tract. From there, glucose enters glucose metabolic system and becomes blood glucose 
[2,3]. Glucose metabolic system is composed of two major pathways: in one pathway, blood 
glucose works as energy fuels. While in the other pathway, it works as the storage unit. When 
providing energy, blood glucose can be used by most muscle and adipose tissues as energy fuel 
through biochemical reactions, and the uptake of blood glucose by those tissues is facilitated by a 
hormone named insulin. When working as a storage unit, blood glucose could be stored in liver 
in the form of glycogen which is an alternate version of glucose that can help the liver to regulate 
BGC when there is too much glucose circulating in bloodstream. The uptake and storage of 
blood glucose in the liver is also facilitated by insulin. Fig. 1 illustrates this blood glucose 
pathways.  
In addition to the major glucose pathway introduced above, there are some minor yet still 
important pathways for blood glucose. For example, blood glucose could emerge from other 
sources as well: it could be formed from glycogen stored in liver through glycogenesis, which is 
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a process facilitated by hormones such as epinephrine and glucagon. Another source of blood 
glucose is through gluconeogenesis from various precursors of glucose. Those glucose 
precursors can be generated via various glucose metabolic pathways: lactic acid oxidized from 
glucose can be reform into glucose in the liver, and glycerol from adipose tissues can be 
delivered to the liver to revert into glucose via gluconeogenesis as well. Moreover, besides 
providing energy to muscle and adipose tissues, blood glucose can also fuel the nervous system, 
specifically, the brain. However, the mechanism for fueling brain is quite different from others. 
As the brain makes use of blood glucose via diffusion of glucose from high concentration to low 
concentration and insulin does not facilitate this process. As a result, the level of blood glucose 
directly impacts the functionalities of the brain. If BGC drops below a certain threshold, the 
brain would be unable to utilize blood glucose as fuels. Therefore, brain functions could be 
reduced or shut off, and this situation could be life-threatening.
 
Figure 1. Blood glucose major metabolic pathway 
Several key metabolic pathways in human bodies are made possible by a hormone called 
insulin. Insulin is secreted within human bodies. It was first discovered in 1922 [4]. Then it was 
revealed that insulin is produced by beta cells in pancreas and released into metabolic system. 
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Insulin plays a very important role in glucose metabolic pathways. High BGC stimulates the 
secretion of insulin. In turn, insulin facilitates the uptake and storage of blood glucose in liver 
and kidney to remove blood glucose from blood stream. As a result, euglycemia (i.e. normal 
concentration of blood glucose) can be achieved within human bodies [5]. The following Fig. 2 
illustrates major insulin metabolic pathways. Insulin delivery represents exogeneous insulin 
intake for people requiring insulin to be infused/injected due to insufficient insulin produced by 
pancreas. For a healthy person, insulin is produced by beta cells in the pancreas, and decomposed 
primarily in liver and kidney via insulin degradation enzyme. When plasma insulin level is high, 
insulin will inhibit the secretion of insulin from pancreatic beta cells, when the insulin level is 
low, the inhibition effect will be lifted.  
 
Figure 2. Plasma major insulin metabolic pathways 
Other hormones involved in glucose and insulin metabolic systems such as glucagon and 
epinephrine usually work in conjugation with insulin in the regulation of BGC. Glucagon, 
secreted by alpha cells in pancreas, can regulate the process of converting glycogen into glucose, 
and thus increase BGC in blood stream. Epinephrine, also known as adrenalin, is another type of 
hormone that is released by adrenal glands and has the effect of increasing BGC among other 
13 
 
effects. Those hormones work together with insulin to regulate the level of blood glucose and 
maintain it within euglycemia. 
Diabetes mellitus can be usually diagnosed through various tests. Fasting glucose test 
involves taking measurements of BGC for people under fasting conditions. When fasting glucose 
is greater than 126 mg/dl, that person can be at the risk of diabetes mellitus. A more formal 
method is the measurement of hemoglobin A1c (HA1c) [6], which indicates the average BGC 
for the past several months. The criteria for diabetes usually can be treated as HA1c values being 
greater than 6.5%.  
With the knowledge of physiological background for the metabolic pathways for blood 
glucose and insulin, greater insight can be gained towards diabetes mellitus. The rest of this 
chapter will be divided into following sections: different types of diabetes mellitus, their risk 
factors, and general treatments. Then, the latest development of closed-loop control system for 
Type 1 diabetes (i.e. artificial pancreas) will be covered, especially the development of in silico 
studies.  
Type 1 diabetes 
Though symptoms may be similar, there are different categories of diabetes based on the 
mechanism behind them. Two major categories of diabetes mellitus plague the vast majority of 
those with diabetes.  
Type 1 diabetes (T1D), having its root in the inability of beta cells in the pancreas to 
generate insulin, affects about 5% to 10% of all people with diabetes. T1D is also known as 
juvenile diabetes since its onset is usually diagnosed in adolescence. Its typical symptom starts 
with increased thirst, frequent urination, fatigue, weight loss, acetone smell in breath, etc. In 
addition, diabetic ketoacidosis (DKA) can often be diagnosed along with the onset of T1D. DKA 
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is a life-threatening complication with diabetes mellitus. Severe DKA can cause confusion and 
sometimes coma [7]. Besides the typical symptoms and complications, T1D causes other long-
term effect such as permanent damage to organs, loss of eye sight, limb loss, etc. [8]  
   Risk factors 
There are various studies on the risk factors of T1D. According to those researches, 
several factors contributed to the onset of T1D.  
        Genetics 
Genetic factors play an important role in the development of T1D.  T1D involves more 
than 50 genes. The heritability of T1D is estimated at around 80% to 86% [9]. Although genes 
involved in T1D can be dominant, recessive or status fall somewhere in between, there is still 
great risks of T1D from the aspect of genetics. For example, if a father has T1D, the child has 
5% chance having it. And if one identical twin has T1D, the chance of the other one has it is 
around 50% [10]. 
        Environmental 
Evidence shows environmental factors influence the onset of T1D. The same example of 
identical twins can demonstrate that even with the same genes, the second twin does not have 
100% chance of T1D [11]. There are other specific environmental factors that could cause T1D. 
Certain virus in human bodies can trigger an autoimmune reaction, where the immune system 
will destroy virus-infected cells along with beta cells that produce insulin. Plus, being in contact 
with some chemicals or drugs can induce the onset and development of T1D. Research also 
shows gluten could be a factor in the development of T1D. However, the mechanism is unclear 
yet [12]. 
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   Treatment 
        Insulin pump therapy 
Currently the most popular and feasible treatment for people with T1D is insulin pump 
therapy. The traditional treatment features insulin bolus injection, which requires patients to 
inject bolus insulin based on their diet schedule and needs to bring down BGC. With the rapid 
development of continuous subcutaneous insulin infusion (CSII), insulin pumps have been 
widely adopted in insulin administering. In insulin pump therapy, patients will have long-acting 
basal insulin infused into body to balance BGC around their fasting glucose level, and rapid-
acting insulin, also known as bolus insulin, will be used to counter act the rise in BGC due to 
meal ingestion. The amount of basal insulin is calculated based on personal attributes of the 
patients. And the amount of bolus insulin, in insulin pump therapy, is calculated by the 
carbohydrate/insulin ratio, whose value indicates the amount of carbohydrate countered by one 
unit of insulin. 
        Pancreas transplant 
A pancreas transplant is usually performed along with a renal transplant. The recipients 
of pancreas will typically have their newly transplanted organ attached to a different location 
while the original organ untouched since removing the original organ could increase mortality 
rate. Around 90% of people with transplanted pancreas are insulin-independent at the one-year 
mark, while at the five-year mark, the percentage drops to as low as 65% [10,13]. 
Type 2 diabetes 
Type 2 diabetes (T2D) is the most prevalent form of diabetes that affects around 90% of 
people with diabetes [14]. People with T2D usually can still generate insulin from their beta cells 
in pancreas. However, insulin resistance in organs prevent the body from utilizing insulin 
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effectively. The symptoms of T2D also includes thirst, frequent urination, and weight loss. The 
long-term effects include blindness, kidney failure and limb loss, etc. People with T2D can have 
10 years shorter life expectancy [15]. However, unlike T1D, T2D is preventable and treatable in 
some cases by proper weight management and regular exercise. 
   Risk factors 
        Lifestyle 
T2D often comes along with obesity and lack of exercise. As a result, lifestyle becomes 
an important factor in the onset and development of T2D. Overweight, defined by body mass 
index (BMI) greater than 25, is a major factor associated with T2D. For instance, obesity 
accounts for around 30% of cases of T2D in people with Chinese ancestry [16]. The lack of 
regular exercise can account for 7% of T2D population. In addition, diet composition (in terms 
of glycemic index) can also impact the risks for T2D.  
        Genetics 
Over 30 genes are involved in the onset and development of T2D. Overall, heritability of 
T2D is less than that of T1D. Genetics factors only account for 10% of T2D. However, if one 
identical twin has T2D, the risk increased for the other twin is 90% [11]. 
   Treatment 
        Change of lifestyle 
The most simple and readily available treatment for most people with T2D is to change 
the lifestyle including losing weight, regular exercise, proper diet management, etc. Sufficient 
exercise and healthy eating habits can help to improve insulin resistance [17]. Exercise, 
especially aerobic exercise can reduce HbA1c and lead to tighter BGC control. A diet with a low 
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glycemic index or low carbohydrate can also improve BGC control. Typically, a healthy lifestyle 
can help people with T2D to improve their BGC control within weeks.   
         Medication 
Medication is also an effective treatment for people with T2D. Oral medicine such as 
metformin can help people with T2D to better control BGC. Injection of insulin is usually not 
required during the early phases of T2D. However, if lifestyle change and medication do not 
work as intended, long-acting insulin or insulin substitute may become a choice to better control 
BGC for some cases. 
Artificial pancreas (AP) 
Recently, development has been made to show the AP/automatic closed-loop control can 
improve the percentage of time that BGC stays within desired glycemic range (70-180 mg/dl) 
[18].  Various strategies were applied in glucose management in order to maintain euglycemia 
(i.e. normal level of BGC). 
While clinical trials are an essential step toward final products for patients, there are a lot 
of groups working on simulation studies. With the highly dynamic, highly nonlinear nature of 
human metabolic system, and the between subject variation of the system, computer simulation 
with complex compartment models, such as University of Padova/University of Virginia models 
[19] and a simulator based on Cambridge model [20], can provide insight into the dynamic 
relationship between glucose and insulin, but they cannot provide much useful information 
towards real-life scenarios or free living conditions (i.e. people live their life without any 
constraints ) since there are a lot of unknown disturbances to account for. However, simulation 
studies can provide researchers with a safe environment to test different BGC control algorithms 
without putting any patients in potential risks for experiencing hypo- or hyperglycemic episodes. 
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In addition, simulation studies can facilitate the comparison of different control schemes on the 
same group of patients, and since simulation studies are easy to expand in scale, it becomes an 
effective way to evaluate the robustness of tested control algorithms against the interindividual 
variability before in vivo clinical trials. As a result, this review will focus on human subject 
studies as well as simulation studies. 
Currently, clinical trials from different research groups range from inpatient to outpatient 
studies. These clinical studies can last from only night hours to a few full days or even weeks. As 
a practice, all their results are reported in terms of percentage of time within certain glucose 
range. Most of these studies are called hybrid closed-loop studies since they require meal 
announcements from the patients and bolus insulin is usually manually administered. The studies 
that are completely devoid of human intervention are called fully closed-loop. Some of studies 
have physical activities such as trend mill test, and some do not (or as free-living studies that do 
not restrict life style of patients). In contrast, simulation studies mostly feature control runs that 
last from a few hours around meals to a few days with meal announcements, and without any 
involvement of other disturbances such as physical activities. 
By control strategy, there are mainly four categories in AP:  
   PID Controller 
PID controller is a traditional feedback controller that has been used in many applications 
across industry. Its general controller is shown in Eq.1 below. 
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where e(t) represents the deviation of measured blood glucose from its set point (in unit of 
mg/dl), and u(t) represents the signal for insulin action required to bring down the elevated blood 
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glucose. Eq. 1 is for fully feedback control. It only reacts to deviation from the set point of blood 
glucose level. The PID controller is often compared with Sensor-Augmented Pump (SAP) 
therapy (SAP mainly consists of CGM and Insulin pump). The control scheme in SAP is a 
simple insulin suspension system. That is, the insulin pump will shut off as soon as it detects 
patient’s blood glucose level below a certain threshold. 
In clinical trials, research on PID control for diabetes patients shows this type of control 
algorithm does not appear to improve glucose control over SAP therapy significantly [21].  
   MPC Controller 
The MPC controller is the most popular controller in AP community, since MPC can 
potentially adjust for future blood glucose changes to minimize the delay in insulin action. 
According to the model types used in MPC, there are two major subgroups. The most popular 
one is the physiological based compartment model. Usually can be viewed as an extension of 
Bergman’s Minimal model [22] using insulin and glucose dynamics only as demonstrated in Eqs. 
2 and 3, 
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−=                                                           (3) 
where G represents plasma glucose concentration (mg/dl), I represents plasma insulin (unit/dl), 
X(t) denotes remote insulin actions (i.e. the insulin effect is organs that are not in quick 
equilibrium with blood stream) in unit of (1/min), SG denotes glucose effectiveness (1/min), p2 
represents fractional appearance rate of insulin in interstitial fluids, and p3 represents fractional 
clearance rate of insulin in interstitial fluids. Although Bergman’s model only considered the 
dynamics of glucose after an injection of glucose into blood, Equations 2 and 3 forms the basis 
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of modern physiological based compartment models. Those compartment models predict BGC 
excursion based on carbohydrate contents in food (that is reason why hybrid closed-loop 
experiments require meal announcements), and rapid-acting insulin [23-26]. While these control 
schemes can demonstrate their improvement over SAP therapy, night time during sleep without 
many unmeasured disturbances is easier to achieve tight control [27]. 
There are also research projects that make use of glucagon in maintaining BGC control 
(dual-hormone models) [28, 29]. However, on one hand, the usage of glucagon will increase the 
burden on patients, and on the other hand, glucagon infusion/glucagon online measurement 
device is not commercially available right now.  
For insulin and glucose models discussed above, there are exercise components included 
in some models but most models do not have exercise as inputs. Also, most of them have not 
applied fully subject-specific modelling methods, and only certain individual information is 
collected (e.g. subject body weight, BMI, daily insulin dosage).  
Another subgroup within the MPC controller includes empirical based models. A typical 
empirical models used is autoregressive moving average with exogenous inputs (ARMAX) 
model where output BGC data is used in predicting BGC [30-32]. These algorithms use 
prediction models that depend on output (i.e. measured BGC). In this case, the contribution to 
insulin infusion calculation could be mostly due to output measurements, which indicates the 
cause and effect relationship may not be well captured in the models. The results tend to show 
these MPC algorithms had improved control during night time and did not achieve significant 
better control during daytime due to disturbances from daily activities.   
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Exercise data in autoregressive moving average (ARMA) or ARMAX models is often 
used for constraints. Linear or low order models are used in modeling, where those linear or low 
order terms cannot provide proper physiological structure for BGC dynamics.  
Since models used in MPC fail to or can only partially capture dynamic behavior of BGC 
and blood insulin, in order to adapt to BGC/blood insulin dynamics, MPC controllers often use 
receding horizon strategy in which parameters are updated whenever new measurements are 
available. 
   Fuzzy Logic/MD-Logic Controller 
This type controller is to mimic the thinking process of the physicians. It does not use 
dynamic BGC structure to calculate insulin infusion. This type of controller had some success in 
improving BGC control during night time [33,34]. 
As mentioned before, all the results in AP research being reported in terms of percentage 
of time within certain range (e.g. 70-180 mg/dl) of BGC makes it difficult to tell if the insulin 
infusion rate calculation is based more on dynamic BGC structure or more on previous BGC 
measurements. If the previous BGC measurements are contributing more to insulin infusion rate, 
then the change of correlation structure under life pattern change could damage the predictability 
of the controller. 
   Feedforward Controller 
Feedforward control is a relatively less touched category of control approach in diabetes 
literature. Marchetti et al. proposed a Feedforward-feedback control algorithm [35,36]. It used 
meal based glucose contents as measured disturbance. In terms of transfer function, first order 
transfer function was used for the approximation of the process from Laplace transformations of 
the disturbance, D(s) to BGC denoted by Y(s) as shown in Eq. 4. A second order transfer 
22 
 
function is to approximate the process from Laplace transformations of insulin infusion rate U(s) 
to Y(s) as in Eq.5. 
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The feedforward control law is dictated by Eqs. 6 and 7. However, the problem with this 
controller is that it is unrealizable (i.e. the controller will depend on future values of 
disturbances). A typical way to solve this issue is to approximate the exponential term with a 
lead-lag term [49]. Hence, Eq. 7 becomes Eq. 8, where
K
K
K df = , and θτττ ++= 213 , and
dττ =4 .  
The tuning approach is to minimize the discrete cost function, as in Eq. 9. 
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where 
spG  is the BGC set point and Gˆ is an estimator of BGC. 
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This research was conducted in silico. The patient model used was Cambridge model 
[20]. The simulation study shows that Feedforward control can successfully reduce post-meal 
glucose by set point reduction. 
Alternatively, Abu-Rmileh and Garcia-Gabin evaluated Feedforward control with 
scheduled gain approach in simulation [37]. State space models were used in the control scheme. 
This study showed decent controller performance in a fasting condition with meal challenges. 
In silico studies for feedforward controller can provide initial evaluations on the 
performance. But these studies failed to recognize that free living environment cannot be realized 
by current simulation methods, and also traditional approximation in unrealizable controller 
could negatively affect the precision of the controller. This type of approximation does not 
prevent large swings of BGC from happening.   
   In silico studies 
The history of AP can date back to 1977 when the first commercialized AP Biostator was 
used for inpatients [38]. However, its development was not a smooth sail. Even up until the end 
of 2016, the first commercialized AP has just been approved by FDA for people over 14 years of 
age with insulin-dependent diabetes [39]. It can automatically correct basal insulin infusion rate, 
but people still need to manually determine the values of the bolus insulin. The most important 
consideration in clinical trials is the safety of patients, which adds additional constraints to 
clinical trials and the development of the AP. With the consideration of patient safety, extreme 
conditions cannot be tested in clinical trials. Also with the cost of large scale inpatient studies, 
the pace of AP development has been slow. Therefore, simulation studies become an effective 
substitute to preclinical trials, animal trials and clinical trials to a certain degree. Although the 
simulation environment is not as realistic as environment in clinical trials, in silico studies 
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expedite the development of AP projects since it is easy for simulators to work under extreme 
conditions that cannot be done for in vivo studies, as well as to scale up studies to extract 
information on interindividual variability in test sample. 
The objective of diabetes simulation studies is to demonstrate the proposed control 
algorithm can maintain BGC within desired region and reduce the occurrence of hypoglycemic 
episodes [40]. Diabetes simulators have aided in the demonstration that closed-loop control can 
help people tighten their BGC than open-loop control [41], can help maintain BGC overnight 
[42], and should be a valuable replacement for animal trials that precede clinical trials [20]. 
Recent simulation studies show that meal announcement is an essential part in tighter control of 
BGC during meal challenges [43]. If meal announcement or record is missing, meal detection 
and meal size estimation algorithms have been developed and can effectively reduce the mean 
BGC when combined with MPC in closed-loop control [44]. Also, MPC can provide robust 
performance under different physiological conditions with a low order state space model [45], 
and outperform traditional PID control [43,45]. Linear time varying MPC has also been applied 
in BGC control and it shows great potential as well [46]. Other dynamic tuning algorithms are 
also being demonstrated in simulation settings [30]. There are studies that involve investigation 
of the performance of PID control with intravenous pumps [47], and control algorithm that 
makes use of glycemic index (i.e. the composition of food based on categories of carbohydrate) 
[48]. Most simulation studies last less than 3 days, and usually features 3 meals or less per day.  
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Abstract 
Continuous-time glucose monitoring (CGM) effectively improves glucose control, as 
oppose to infrequent glucose measurements (i.e. using Lancet Meters), by providing frequent 
blood glucose concentration (BGC) to better associate this variation with changes in behavior. 
Currently, the most widely used CGM devices rely on a sensor that is inserted invasively under 
the skin. Because of the invasive nature and also the replacement cost of sensors, the primary 
users of current CGM devices are insulin dependent people (type 1 and some type 2 diabetics). 
Most non-insulin dependent diabetics use only lancet glucose measurements. The ultimate goal 
of this research is the development of CGM technology that overcomes these limitations (i.e. 
invasive sensors and their cost) in an effort to increase CGM applications among non-insulin 
dependent people. To meet this objective, this preliminary work has developed a methodology to 
mathematically infer BGC from measurements of non-invasive input variables which can be 
thought of as a “virtual” or “soft” sensor approach. In this work virtual sensors are developed 
and evaluated on 20 subjects using four BGC measurements per day and eight input variables 
representing meals, activity, stress, and clock time. Up to four weeks of data are collected for 
each subject. One evaluation consists of 3 days of training and up to 25 days of testing data. The 
30 
 
second one consists of one week of training, one week of validation, and 2 weeks of testing data. 
The third one consists two weeks of training, one week of validation and one week of testing 
data.  Model acceptability is determined on an individual basis based on the fitted correlation to 
CGM testing data. For 3 day, 1 week, and 2 weeks training studies, 35%, 55% and 65% of the 
subjects, respectively, met the Acceptability Criteria that we established based on the concept of 
usefulness. 
Keywords: Virtual Sensor, Wiener Modeling, Block-Oriented Modeling, Type 2 Diabetes. 
 
Introduction 
Recent research suggests that real-time, frequent, glucose monitoring can improve blood 
glucose control over infrequent monitoring provided through the use of lancet glucose meters for 
both insulin dependent [1]-[6], and non insulin dependent diabetics [7]. Frequent glucose 
measurement capability is referred to as continuous-glucose monitoring (CGM); although not 
really continuous, current devices can deliver on-line glucose measurements as often as every 
one to five minutes [8]. Nonetheless, this is a substantial improvement over lancet monitoring 
that only produces a few values (e.g. four values) per day, at best. CGM therefore improves the 
user’s ability to achieve better glucose control by providing frequent, real-time, glucose 
concentration levels that enables correlation with activity and food consumption. For example, a 
user is able to see with a high frequency display rate the extent to which the size of a meal affects 
glucose changes. Currently, the most widely used and effective CGM devices rely on a sensor 
that is inserted invasively under the skin. Sensors cost from $35 to $60 and last 3 days to a week. 
Thus, two significant drawbacks of these devices are comfort and cost [9].  Given these 
drawbacks, these devices are not widely used except by insulin dependent diabetics that rely 
heavily on a fast sampling rate for better control. For this reason, these devices are less likely to 
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be used by non-insulin dependent people, including non-diabetic, pre-diabetics and diet-
controlled type 2 diabetics.  
Hence, the motivation of this work is the development of a useful, non-invasive, subject-
specific (personalized), continuous monitoring system in an effort to increase CGM among non-
insulin dependent people.   
To achieve this goal we seek to develop a low maintenance, high frequency monitoring 
system with an accuracy that is high enough to be useful for non-insulin dependent people. 
Moreover, this preliminary work proposes an inferential (i.e., virtual) sensor approach for 
predicting blood glucose concentration (BGC) from noninvasive inputs. This virtual sensor 
updates at the same rate as conventional physical sensor CGM devices. The model is developed 
from lancet BGC measurements that are obtained at a rate of four measurements per day. Since 
each sensor is calibrated from user data, the model developed for each person is said to be 
“subject-specific.” While inferential modeling of BGC has been done by a number of researchers 
[19]-[24], [29], [31] particularly in type 1 diabetic applications using frequent glucose 
measurements, this is the first approach that we are aware of that seeks to develop an inferential 
model for non-insulin dependent subjects using infrequent lancet measurements from the 
subject’s personal lancet glucose meter. Our approach to achieve this goal is to use a novel 
Fig.  1. The SenseWear® Armband of BodyMedia, Inc. 
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modeling method to infer glucose concentration using non-invasive input measurements for each 
subject from variables representing food, activity, clock time[10]-[12], and stress[13],[14].  
Methods 
The main physical component of this system is a BodyMedia® armband of the type 
shown in Fig. 1. This device is a multi-sensor monitoring device that provides accurate estimates 
of physical activity data using accelerometers, heat related sensors and galvanic skin response 
(GSR) [15]. GSR is the conductivity of the wearer’s skin that varies due to physical and 
emotional stimuli. For more details see [27], [28]. Given that the armband currently uses 
complex algorithms (e.g., for pattern recognition) it should also be able to incorporate our 
proposed BGC prediction algorithm. However, this research is beyond the scope of this article 
which is focused on the development of the modeling methodology.  
The most critical challenge in this highly complex, non-linear, multiple-input, highly 
underdetermined modeling problem is the estimation of a large set of dynamic and static 
parameters from a very small set of BGC data, with a sampling frequency of only 4 values per 
day. To achieve accuracy under these conditions is a significant advancement over the work of 
Rollins et al. and a unique accomplishment. Other challenges include adequately guarding 
against over-fitting, the lack of initial steady state data, low quality meal information that uses a 
designation of small, medium and large, and frequent and arbitrary removal of the armband 
monitor. Through novel modifications of the Rollins et al. [16] approach, this work demonstrates 
an ability to overcome these challenges, and thus, has promising potential to develop an effective 
inferential continuous-time BGC sensor for the target population of non-insulin dependent 
people. The details of the proposed modeling approach are now described. 
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The Modeling Approach 
The basic objective of this work is the development of a subject-specific “soft sensor” 
or “virtual” sensor methodology that provides “useful” information to help individuals monitor 
and control their glucose more effectively than with lancet glucose meters. The most critical and 
challenging objective  in this highly underdetermined problem is that the model must be 
developed from a BGC sampling rate of only four samples per day. These samples will come 
from the lancet meter of the subject and the idea is to transform these measurements to a CGM 
display frequency during the period of the day that the subject is not sleeping. This virtual sensor 
approach is an inferential model that is developed from measured variables that are termed 
inputs. This virtual sensor idea has seen wide applications in process monitoring and control 
applications in recent years [17], [18] due to advancements in computer hardware, software, and 
measurement technology. Note that to distinguish the type of sensor, i.e., “virtual” versus 
“physical,” we will use the terms “virtual-sensor” and “physical-sensor.” In addition, it should be 
noted that our use of “monitoring” include both the use of a virtual-sensor or physical-sensor 
although virtual sensors do not measure the process variable being monitored directly. This 
major challenge in this work is the frequency of BGC data for model building (in this research, 4 
times per day) is much less than the virtual measurement rate of 5 minutes. This limitation means 
that the information available for model identification, i.e., parameter estimation, is quite limited 
and could thus, severely impact accuracy.  
 The information for the development of a virtual senor comes from two sources -- the 
response data set and the input data set. Since the information content of lancet BGC is quite 
limited, the proposed approach strongly relies on the input data set for information on glucose 
behavior. More specifically, this data set consists of meal size with three levels, six (6) variables 
from the BodyMedia armband, and the time of day (TOD) in minutes on the 24 hour clock. The 
inputs that we selected for this study from the armband are those selected by Rollins et al [16]. 
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We eliminated near body temperature as we determined it was not contributing significantly to 
glucose behavior for any of the subjects. The inputs are shown in Table 1. 
 The ability to map the available input/output information to accurate sensor 
measurements depends on the model structure, the model building procedure, and the inferential 
algorithm that we are calling the “Inferential Engine.” The model structure consists of the 
mathematical functions and the network that tie these functions together. The model building 
(i.e., identification) procedure is the process of using input/output information to estimate the 
values of unknown parameters in the mathematical functions. The Inferential Engine is the 
equation used to obtain the virtual senor measurements at the desired sampling frequency. This 
equation represents input selection, parameter estimates, and the use of lancet glucose 
measurements to enhance reliability. The purpose of this section is to describe these three 
components of the proposed technique in detail.  
Table 1. Input variables: Meal Size (1), Armband (2-7), and TOD (8). 
Input Name 
1. Meal Size Index  
2. Transverse accel – peaks 
3. Heat flux – average 
4. Longitudinal accel – average 
5. Transverse accel – MAD 
6. GSR – average 
7. Energy expenditure  
8. Time of day (TOD) 
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Modeling Structure 
The modeling structure of this application must permit accurate parameter estimation 
under a small number of sampling times (n), effectively handling several inputs with different 
dynamic behavior, and mild extrapolation. The proposed modeling network is what we call the 
Coupled Dynamic Insulin (CDI) network (its structure is given in Fig. 2). As shown, the first 
input, meal size (x1), enters both a linear dynamic food block (G1) and a linear dynamic 
unmeasured insulin block (GI). The output from the unmeasured dynamic insulin block (vI) 
enters a pseudo blood insulin block which is coupled with the food block (G1) which produces 
the dynamic food input (v1) to the pseudo BGC block. Then, the unmeasured output from the 
coupled food block is the dynamic glucose (Gf) input due to food consumption. Each of the other 
inputs (e.g. inputs 2-8) enters a separate linear dynamic block and the outputs from these blocks 
are collected into non-observable variables (vi) and together with Gf are passed through a static 
block which can be any type of function. The CDI model simulates the process where food 
digestion is responsible for the rise of blood glucose after each meal, while the secretion of 
insulin is responsible for the fall of blood glucose level a period of time later after the meal. The 
CDI network is defined by the attributes of allowing separate dynamic behavior for each input 
and the use of variables for unmeasured insulin generation (vI) and unmeasured blood insulin 
concentration (I). To our knowledge, this is first application of unmeasured pseudo insulin in 
modeling blood glucose concentration. This idea is a key reason for the success of our modeling 
approach in this application of infrequent BGC measurements. 
 The dynamic functions for Gi, i = 1, …, p, I (the I is for insulin), follow the modeling 
work of Rollins et al. [16] and are second order differential equations of the form: 
)(
)(
)(
)(
2
)(
2
2
2
tx
dt
tdx
tv
dt
tdv
dt
tvd
i
i
aii
i
ii
i
i +=++ τξττ                                       (1)                                
36 
 
where xi(t) is the ith input, i varies from 1 to p, p is the total number of inputs, τai is the lead 
parameter, τi is the time constant, and ξi is the damping coefficient, with x1 = meal size input 
variable, xi, i = 2, . . ., p-1, are armband input variables, and vp is the TOD input variable. 
Using backward difference finite derivative approximations, Eq. (1) gives (Rollins et al., 
[16])
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 Note that the number of dynamic parameters associated with each input is three. This 
small number is a strength that we exploit to obtain parameter estimates under limited sampling, 
as discussed below. The CDI model for food alone is represented by the following coupled Eqs.  
(5) and (6): 
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where 1v  and Iv  are outputs from dynamic blocks G1 and GI respectively, and 1α  to 4α  are the 
“coupled” model parameters. 
 We also use backward difference finite derivative approximation on Eqs. (5) and (6) to 
give 
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Note there are four additional parameters ( 1α , 2α , 3α  and 4α ) that need to be identified. 
 The function f(V) is called “the static function” and is a function of all of inputs. This 
function can theoretically be of any form. For effectiveness under mild extrapolation and 
minimum parameter estimation (as discussed below) we have chosen a first order linear 
regression model of the form: 
 
 
ttppttfttt vavaGay εεη +++++=+= ,,22,0 K                                            (9)                                     
where tε is the error term and assumed to be independently normally distributed with mean 0 and 
variance σ2 for all t, and sa i ' are static parameters.  
 As stated in Rollins et al. [16], the modeling objective is simply to maximize the true but 
unknown correlation coefficient between measured and fitted BGC. This quantity is represented 
by ρy y, $ and estimated by rfit. Thus, under this criterion, as a minimum, a model is considered 
useful, if, and only if, 
0ˆ, >yyρ                                                              (10) 
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Since the degree of usefulness increases with ρy y, $ , the goal is to obtain the largest (as close to the 
upper limit of 1) value as possible. Due to the highly complex mapping of the parameters into the 
response space of rfit, the following indirect criterion is used in obtaining the parameter estimates 
as described in Rollins et al. [16].  
 
                                                              (11) 
 
Note that only training data are used to compute SSE under Eq. (11).       
Model Identification Procedure 
We use the CDI network with Eqs. (1)-(9) and developed a procedure that can 
accurately estimate the 3(p+1) dynamic parameters, 4 coupled parameters ( 1α , 2α , 3α  and 4α ) 
and the p static parameters even when the number of sampling times (n) is much less than 4p + 7, 
the total number of parameters. This procedure requires each input to have a separate set of 
dynamic parameters as uniquely met by the Wiener network but not by other common networks 
(e.g. such as the Auto Regressive Moving Average with eXogenous (ARMAX) variables 
network) [16].  
 Let Gf,t = 0 and vi,t = 0 for all i in Eq. (9) except for one value of i = j, i.e., vi = vj ≠ 0, for 
one value of i, i = 2, …, p. Thus, with only one input variable vi = vj, Eq. (9) becomes a simple 
linear regression model (SLRM). To distinguish this SLM from Eq. (9), the fitted form is written 
as  
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 where =tiy ,ˆ  the fitted BGC for the one 
input i at t; oiγˆ  and iγˆ  are the estimated 
intercept and slope parameters, 
respectively, for the SLRM for input i; 
and 
tiw ,ˆ  is the SLRM estimate of .,tiv  
Note that for fitting the SLRM, 
only five (5) parameters (the temporary 
static parameters γ0 and γi, and the 
permanent dynamic parameters τi, ζi and τai) are estimated each time which, as necessary, is less 
than n = 12 for three days of data collection, for example. 
 
 In Appendix A, a proof is given to show that for the SLRM, .
,, tit vyfit
rr =  More 
specifically, for the SLRM, rfit is determined by tiw ,ˆ only and not by the static model coefficients, 
oiγˆ  and .ˆ iγ  Thus, for the SLRM, since vi only depends on the dynamic parameters for input i, 
one can find the set of dynamic parameters that results in the best rfit for each input i separately 
(i.e., τi, ζi and τai.). We exploit this result by decomposing the modeling problem into separate 
sub-problems that will be identified in 3 steps: 1. the dynamic parameters for each input i, i = 
2, …, p,  under Eq. (12) (five parameters are estimated for each i); 2. the insulin and food 
dynamic parameters under Eqs. (7),(8), (13) (eleven parameters are estimated; one temporary 
intercept parameter, four coupled parameters for initial values to be used in Step 3, and six 
permanent dynamic parameters); and 3. the permanent static and coupled parameters with all the 
inputs included under Eq. (9) (at most p + four coupled parameters are estimated). 
 
 
Fig. 2. A graphical representation of the Coupled 
Dynamic Insulin (CDI) network. 
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 In Step 1, our current procedure is to manually adjust the dynamic parameters one input 
at a time to find the “best” set of values for each input. Our definition of “best” will be given 
momentarily. In Step 2, the following reduced form of Eq. (9) is applied: 
ttft Gy ελ ++= ,0                                                                (13)                           
where λ0 is a temporary parameter only used in Step 2. This step is the most challenging. With a 
given set of initial values, either some or all the parameters are estimated simultaneously using 
an effective nonlinear regression algorithm. This process is the most iterative and time 
consuming as some parameters are manually set and fixed and the rest are estimated using the 
optimization algorithm. This process is iteratively repeated until no more improvement can be 
made in rfit.  The only input involved in Step 2 is food, i.e., meal size. If an adequate rfit (rfit for 
training should be positive in agreement with Eq (10)) is not found in this step, the modeling 
procedure is terminated, and we conclude that the procedure failed to find an adequate model for 
this subject from the given data sets. Step 3 is completed in one estimation trial when the 
dynamic and couple modeling parameters from Steps 1 and 2 are used since Eq. (9) becomes a 
first order linear regression model. However, if one desires to estimate the couple modeling 
parameters also, Eq. (9) becomes a nonlinear regression model and the estimation process can be 
more challenging. Note that, for example, with n = 12, or three days of data collection and p = 8, 
at most twelve parameters are estimated in Step 3, which is still not exceeding n. At the end of 
all three estimation steps, with p = 8, 4p + 7 or 39 total parameters have been uniquely estimated 
in a highly nonlinear modeling problem from at least n =12 or three days of data collection, for 
example. This ability is a critical novelty and a powerful benefit of this approach.   
 The “best” set of modeling parameters is determined for two given scenarios. The first 
one only uses a Training set of data. In this scenario, the goal is to maximize rfit of the training 
set. Consequently, the procedure is to reach convergence at the global minimum for the least 
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squares objective criterion. This estimation procedure is “unsupervised” training (note this is a 
different definition from that of T. Hastie’s book [25] and A.J. Izenman’s book [30]). The second 
scenario is when there are both Training and Validation sets of data. In this scenario, the goal is 
to determine the largest rfit for the Validation data set with a “close” value of rfit for the Training 
data set. Here, convergence for the Training set may not be reached and the Validation set 
determines when the iterative process terminates. Since the Validation results determine when 
the optimization process terminates, this is a type of “supervised” training. This procedure is 
used to guard against over fitting, (i.e., fitting BGC behavior in the Training set that is not due to 
true variation in BGC). The success of both types of training is evaluated through the use of an 
additional set of data called the “test set” which had no influence on the model identification 
process (i.e., the parameter estimates). The first scenario is used when n is small, say 12, the 
number after 3 days, whereas the second scenario is used otherwise, e.g., when n is 24, the 
number after 6 days. Parameter estimation was done using the Excel® Solver Routine. 
 Successful model identification relies on effective selection of initial conditions and 
starting values for model parameters and the dynamic inputs (i.e., the vi’s). The following 
procedure is given under a protocol where the armband is worn nearly 24 hours a day and 
removed only for showering. The initial steady state is chosen during a period of slow change, 
commonly early in the morning. The set of initial values in our procedure are τi = 1.1 ζi = 0.9, 
2α  = 20, 4α  = 0.1, and all other initial parameter values are equal to zero. The initial values for 
the vi’s have to be determined iteratively. When the dynamic parameters are set to values so are 
the vi’s as shown by Eq. (2). Our procedure is to set the initial values of the vi’s to their average 
values over the training data. These values are to remain fixed during estimation and changed 
after estimation of dynamic parameters. The estimation process for a set of dynamic parameters 
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is completed when the “best” rfit is obtained with initial values of vi’s close to their average 
values for the training data.    
                     For the missing data due to removal of armband[32]: if data missing lasts for a short 
period of time (e.g. no more than one hour of missing data), the missing data were interpolated 
with the average value of the two sides of the missing data interval. If data missing lasts longer 
than one hour, we set the missing data to its initial value. 
Development of the Inferential Engine 
After obtaining a full set of parameter estimates, the proposed model development 
procedure has two more refinements.  The first one is elimination of any armband inputs that 
adversely affect the value of rfit. This is done by setting each, and only one, ai (for i = 2, …, 7) to 
zero at a time, and observing rfit. If rfit increases for the Training set in Scenario 1 or for the 
Validation set for Scenario 2, this input is removed.  After this process is completed for each 
input, all the remaining static parameters are estimated under Step 3 for a final time.  
 The final refinement involves the use of lancet glucose to help to reduce model bias. 
Since these measurements are infrequent and are not measured at a constant rate, it is not 
possible to build a correction model based on the correlation of residuals. The correction 
equation that we use comes from Rollins et al. [16] where only the most recent measurement, at t 
= t*, is used. This equation, which represents the proposed virtual sensor, is given as:  
( ) t
tt
tttt yy
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subject to: t > t* and 0 < λ < 1, where λ is an adjustable constant, yt* is the lancet BGC 
measurement at t = t*, 
tηˆ = the estimated BGC at time t under the Eq. (9) model, *ˆ tη = the 
estimated BGC at time t = t* under the Eq. (9) model, and
tyˆ = the virtual (i.e., soft) sensor value 
for the proposed method at time t. Note that 
tty ηˆ* − represents that amount of correction and this 
correction diminishes as time increases based on the value of λ which is close to 1. Thus, by the 
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time the next lancet measurement is taken, usually .ˆˆ tty η≈  This means that at t = t*, *ˆˆ tty η≈ ; at t = 
t* + Δt, 
*ˆ tt yy ≈ ; and for t = t* + kΔt, with k >> 1 and before the next lancet measurement, tty ηˆˆ ≈ . 
That is, at the time of the lancet measurement, the proposed virtual monitor would display a 
value close to
tηˆ , the next value would be close to the lancet measurement, and as time 
proceeded, the lancet value would have less corrective influence as the predictor would rely 
more on the model to infer BGC. When two sets are used to estimate model parameters, λ can be 
set to give the most accurate values in the validation set. When only a training set is used to 
estimate the model parameters, a default value can be used based on results from modeling 
several subjects. 
Clinical Study for 22 Subjects 
For the proposed method, the development of a virtual-sensor requires 4 lancet 
measurements per day spread as evenly as possible over the time the subject is awake in about a 
14 hour period. We did not have access to data meeting this requirement. However, from a 
previous study, we had physical-sensor CGM data sets which were collected with Institutional 
Review Board (IRB) approval, and the data sets were used to develop and evaluate the 
methodology. Thus, these data sets played two roles. First, for each subject, they played the role 
of a surrogate person, i.e., the true BGC for the purpose of evaluation. Secondly, they played the 
role of the lancet sampled data, i.e.,, the data used to build the virtual-sensors. 
Using 22 test subjects (see Table 2) with 4 weeks of data collection (in most cases and 
slightly under 4 weeks in other cases except for Subject 1 and 8 which had only about 3 weeks of 
data due to loss data), we have obtained results to support the modeling viability. As just stated, 
these data sets were collected for another study (see Beverlin et al. [26], [32]). Modifications had 
to be made to these data sets for use in this study. First, food quantities, which were in grams of 
carbohydrates, fats and proteins, had to be converted to a food index  representing meal sizes 
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with 0 for no meal, 1 (two time stamps) for a small meal, 2 (three time stamps) for a medium 
meal and 3 (four time stamps) for a large meal. In practice the time stamps will be entered by the 
user pressing the time stamp button on the armband at the start of a meal. The conversion we 
used was based on the grams of carbohydrates only with less than 20 grams being a small meal, 
more than 100 grams being a large meal and all other amounts considered a medium size meal. 
Secondly, infrequent BGC measurements were not obtained from a lancet meter but converted 
from a continuous glucose monitoring system (CGMS) at a sampling rate of only four values  per 
day at particular and fixed times (i.e. only 4 values per day out of the continuous readings from 
CGMS were used) to mimic infrequent lancet sampling. CGMS values were taken only at 8 am, 
noon, 4 pm and 8 pm; if data were unavailable, then the nearest value was taken with no more 
than 4 values used per day.  The monitoring period was taken to be from 8 am to 10 pm daily 
which means that this was the only period that virtual BGC were reported. Thus, the period from 
10 pm to 8 am was taken to be a non-monitoring period in order to mimic that monitoring is not 
required during the sleeping period. 
Note that, the original data sets contain meal information in terms of grams of 
carbohydrates, fats and proteins. The amounts were calculated from self reporting logs of the 
type and quantities of food eaten. Hence, the errors of these quantities are likely quite high at 
times and it is likely that a significant number of meals were not recorded or logged at the proper 
times. When we converted the quantities to an index value for meal size for this study (i.e. “1” 
represents small meal size, “2” for medium size, and “3” for large size), we applied the same 
conversion equation to all of the subjects. Thus, the quality of food information that we 
developed our models from in this study is quite poor. Therefore, since these results are obtained 
under poor food information they indicate the robustness of the technique to low quality food 
information.  
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Before evaluating model acceptability, subject 21 and 22 were rejected due to poor food 
information. As a result, subject 21 and 22 were removed from this research from this point on. 
Measures of Performance 
 Model acceptability will be determined on an individual subject basis given that the 
models are subject-specific and each individual will only be concerned about model accuracy as 
it pertains to model developed for them. Thus, this study is evaluated based on the number of 
subject-models that meet a particular Acceptability Criteria. But we state and justify this criteria 
momentarily, after we present the statistics they it uses.  
 The first one is called the averaged error (AE) and is simply the average value of the 
residuals: 
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where m is the number of terms being averaged.   
The second one is called the averaged absolute error and is similar to Eq. (15) except that 
the absolute difference is used for the term in the summation as follows: 
 
m
yy
m
i
ii∑
=
−
=
1
|ˆ|
  AAE                                                             (16) 
A scaled AAE value to adjust for spread is used called the relative AAE (RAAE). This measure 
of performance is determined by dividing Eq. (16) by the standard deviation of the values used to 
calculate AAE as follows: 
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RAAE is a relative AAE statistic that accounts for large spread in the glucose variation of 
subjects. For replicated lancet measurements, the study in Rollins et al. [16] determined RAAE 
to be about 0.60. Thus, we will assume that a value around 0.60 is comparable to the 
performance of a glucose lancet meter. However, lancet accuracy or even repeatability can vary 
widely from individual to individual due to the accuracy of the device, inherent variability in the 
measurement protocol, and human error. Nonetheless, since this is the only result that likely 
exists in this type of study (i.e., four weeks of data collection under the protocol of this study) we 
will use it in our criteria. It is also noted that, given that the models in this study are developed 
from three discrete levels of food size and not from the three types of consumed quantities, and 
from a much lower frequency of glucose data when comparing to  typical CGMS values (i.e., 
four values per day versus 12 values per hour), we expected RAAE to be higher and allow for 
slightly higher values in the Acceptability Criteria.  
The last statistic or performance measure is rfit. Based on the results in Rollins et al. [16] 
for a type 2 diabetic and in Beverlin et al. [26] for the 20 subjects used here, we set a minimum 
acceptable value for rfit of 0.40. Using these three measures of performance, the Model 
Acceptability Criteria (MAC) for this study is given as: 
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As the MAC shows, a model with an rfit of at least 0.6 is considered acceptable based on this 
value alone. However, if this value is between 0.4 and 0.6, the fitted model must meet a certain 
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level of performance on both rfit and AAE or both rfit and RAAE. For example, if AAE and 
RAAE are 18 mg/dL and 0.75, respectively, the AAE sub-criterion is rfit ≥ 0.5 and the RAAE one 
is rfit ≥ 0.55. Thus, for this example, the fitted model will meet the MAC if, and only if, rfit ≥ 0.5. 
As this example illustrate, when rfit is in this range, the MAC is written to require rfit values to be 
higher than 0.4 with this requirement increasing as AAE and RAAE increase. Note that on the 
upper boundary of rfit = 0.6, AAE must be < 20 mg/dL or RAAE must be < 0.8, and on the lower 
boundary of rfit = 0.4, AAE < 16 mg/dL or RAAE < 0.6. The lower boundary was defined based 
on the results in Rollins, et al. [16] and the upper boundary was established from an examination 
of fitted models in this work. See Fig. 3 for plots of three fitted models as they compare with 
CGM measured responses at the limits and middle of the MAC.  
 
Table 2. Characteristic information on the 22 subjects used in this study. 
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Results 
The results of this study are given in Tables 3-5. Each table represents a different training 
period. There are two types of predictions in these tables; ,ˆ *tη the values of the fitted model at the 
time the lancet measurements were taken and ,ˆty fitted model at the sampling rate of the CGMS, 
i.e., every five minutes. The model parameters are estimated using ,ˆ *tη  but the MAC is applied to 
the testing results for 
tyˆ to determine model acceptability on an individual basis which is shown 
in the tables. In addition, summary results for the performance measures are given for all the 
subjects and for the set of subjects meeting the MAC.  
Table 3 gives the modeling results are for three (3) days of training under Eq. (13) (i.e., 
for food only). Since training stop at convergence under the least squares criterion given by Eq. 
(11), the remaining days consisted of the test set.  In addition, for all these subjects, ζ1 = 0.2, τa1 
= 0, ζI = 0.8, and τaI = 0. This was done to increase the degrees of freedom to estimate the more 
critical parameter τ1, τI and the four coupled parameters and to simplify the optimization. The 
best choice for these values is future research work. As Table 3 shows, the results indicate that 
35% of the cases met the MAC. This is really quite promising as a minimum initial calibration 
period given that the number of data points, n, used is only 12. In practice, it appears that a 
significant number of subjects could have successful calibration after three days and as more data 
are collected this number would grow. This conclusion is supported by the results in the next two 
tables.  
Table 4 contains results under Eq. (9) for one week of training, one week of validation 
and two weeks of testing. As shown, 55% of these cases met the MAC. In addition, for this 
group that meets MAC versus all the cases in table 4 as whole, the average values of AAE and 
RAAE dropped considerably from 19.8 mg/dL and 0.76 to 13.5 mg/dL and 0.71, respectively, 
while rfit increased from 0.47 to 0.55.  These values are excellent. Table 5, also under Eq. (9), 
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contains results for two weeks of training, one week of validation and one week of testing. As 
shown, the number meeting the MAC further to 65% (it is a promising result given the strict 
MAC) with very good average results for this group with AAE  = 15.0 mg/dL, RAAE = 0.74 and 
rfit = 0.54.  
We found that using the armband inputs increases rfit for *ˆ tη by 0.1 over using just food 
alone. (These cases are not shown for space considerations). Thus, both food and the armband 
inputs are to obtain the results presented in this section. The robustness to poorer food quality is 
supported by similar rfit values for this study as compared to the ones in Beverlin et al. [26] and 
Beverlin [32] where food quantities were used on these same data sets. 
 
Concluding Remarks 
This article presented preliminary work on the development of a virtual sensor for BGC 
with the objective of developing a noninvasive CGM system that could increase CGM among 
non-insulin dependent people. This device would require users to wear a readily available 
armband monitor and manually entering meal sizes through the use of a button on the armband. 
This device would require four (4) lancet measurements per day as most current invasive 
CGMSs require.  
 The modeling methodology presented in this work is quite powerful. It takes on the 
challenge of modeling BCG in a highly complex, non-linear, multiple-input, highly 
underdetermined problem.  As illustrated in this work, it is able to develop useful multiple-input 
dynamic models for BGC under free living, outpatient, data collection from just four glucose 
measurements per day and from as little as three days of data. In addition, these results are 
achieved with minimal food information of only three discrete levels. This ability stems from a 
number of innovative ideas to overcome several challenges in this complex modeling problem as 
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follows. First, the use of the coupled structure allows for the inclusion of inferential blood insulin 
concentration and leads to insulin and glucose interaction in the blood. This structure is a 
significant advancement over a straight Wiener network and contributes significantly to the 
accuracy and ability to obtain adequate fitting for acceptable model usefulness. Secondly, the 
result in Appendix A provided the knowledge that produced the idea to decompose the modeling 
problem into a dynamic part and a static part. Added to this idea is the inspiration of determining 
the dynamic parameters for each input, one input at a time. Once the dynamic parameters are 
determined for each input, they are fixed. Note that, from the use of a validation set we are able 
to control over-fitting and by controlling rfit to be about the same in the training set and 
validation set for each input separately, we have found that this helps the final rfit in all the data 
sets (Training, Validation, and Testing) to be quite similar. After obtaining the dynamic 
parameters, the low number of static parameters is then obtained separately as a linear regression 
model.  Thirdly, as the results show, the correction provided by Eq. (14) contributes strongly to 
the accuracy of the proposed method in the case of continuous glucose monitoring (CGM). 
While this correction does contribute significantly to the reduction in bias, it also contributes 
majorly in the reduction in AAE. This can only occur if there is a significant positive correlation 
for the fitted response, as the correction brings it close at the times infrequent measurements 
occur, but the correlation determines the direction from these points. If the correlation is not 
positive, the trend will be in the wrong direction and accuracy would suffer tremendously. This 
is why subjects must have a significant positive correlation for acceptability. In practice if this is 
not achieved, the device would simply give a calibration error and not report measurements. 
Lastly, we developed the new Model Acceptability Criteria (MAC) which instead of evaluating 
separate aspects of performance such as correlation or  bias, and  is able to evaluate all of them 
and also can give a summary statistics (MAC Passing Rate) on the sample population. 
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 This work applied and improved the methodology from Rollins et al. [16]. It was not the 
purpose of this work to improve on this approach by investigating the impact of other armband 
variables, or the time variant nature of model parameters, as well as other model improvement 
issues. To develop the best model for a specific subject, these issues could be considered but they 
add to the modeling overhead, which is already very high given the small amount of information. 
The value of this work lies in that the modeling methodology shows great potential in modeling 
BGC, and provided powerful tools for statistical learning in real life scenario. Nonetheless, these 
are issues that can be addressed in future research.  
 Future work will involve running clinical studies under the protocol that subjects will 
follow when wearing the device such as time stamping for meal size and using only their glucose 
meter to collect data. If these studies are successful, we plan to develop a prototype armband and 
evaluate it on several subjects. We envision this device collecting input and output data into the 
armband where the model will reside. After a sufficient number of lancet measurements have 
been collected, the model with be built from these data automatically for calibration of the 
device. After successful calibration, the armband will collect input data, infrequent output data, 
and display BGC continuously over time on a watch type display or smart phone. Transmission 
of data from the armband to the display monitor may utilize Bluetooth technology. 
We have overcome many challenges such as the use of a food index, the lack of initial 
conditions, frequent and long term removal of the armband and multiple inputs, subject-specific, 
modeling under infrequent sampling.  However, as this work is only preliminary, there are still 
several challenges to overcome. This includes finding novel ways to improve the accuracy that 
leads to a higher percent of users meeting the MAC. In addition, the model procedure is quite 
complex as it requires advanced modeling experience and consists of several steps. One way we 
plan to improve accuracy is by gaining a better understanding on the bounds of each parameter. 
To address the model identification issue, we plan to development an estimation algorithm that 
52 
 
identifies parameters automatically. This program will reside in the armband and will be used to 
calibrate the virtual sensor from on-line data. These are areas of future research that we have 
begun and the results are quite promising. 
 
 
 
                
 
Fig. 3. Graphical examples during the testing period for three subjects meeting the MAC: Subject 
2 (strongly meeting the MAC); Subject 6 (weakly meeting the MAC) and; Subject 20 (moderately 
meeting the MAC).    
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AE AAE RAAE rfit AE AAE RAAE rfit AE AAE RAAE rfit
1 0.0 11.6 0.48 0.78 6.1 35.3 1.32 0.03 5.9 39.2 1.38 0.23 No
2 0.0 10.9 0.55 0.64 -10.6 21.7 0.85 0.33 -3.8 16.4 0.79 0.41 No
3 0.0 7.5 0.66 0.47 -11.2 15.9 0.88 0.40 -3.5 12.1 0.69 0.53 Yes
4 0.0 6.8 0.45 0.79 0.7 19.9 1.67 0.19 1.6 17.8 1.36 0.28 No
5 0.0 10.2 0.57 0.63 -3.3 18.6 0.77 0.22 -0.6 16.1 0.77 0.50 Yes
6 0.0 14.7 0.99 0.30 -11.5 19.9 0.97 0.17 -12.9 18.0 1.08 0.24 No
7 0.0 20.2 0.51 0.76 9.7 27.7 1.14 0.20 -2.2 37.3 1.38 0.20 No
8 0.0 6.4 0.51 0.78 -11.8 25.2 0.83 0.23 -7.0 17.2 0.66 0.60 Yes
9 0.0 14.0 0.57 0.68 -24.5 30.6 1.29 0.24 -11.3 25.7 0.90 0.30 No
10 0.0 15.0 0.58 0.51 -32.5 39.4 1.19 0.27 -17.3 33.0 0.91 0.33 No
11 0.0 38.5 0.64 0.46 -15.6 51.7 0.93 0.29 -0.6 51.0 0.93 0.35 No
12 0.0 9.2 0.70 0.54 3.3 11.7 0.86 0.20 -0.2 12.4 0.88 0.27 No
13 0.0 20.5 0.75 0.35 10.7 19.9 0.72 0.27 7.0 15.8 0.69 0.41 Yes
14 0.0 19.3 0.69 0.58 -21.3 27.7 1.21 0.20 -16.5 21.7 1.05 0.39 No
15 0.0 33.3 0.88 0.03 -7.9 27.2 0.90 0.36 -12.6 29.5 0.99 0.33 No
16 0.0 9.0 0.71 0.04 7.1 14.6 0.63 0.22 1.2 12.9 0.51 0.58 Yes
17 0.0 37.5 0.45 0.86 13.4 91.0 1.51 0.39 9.8 85.4 1.37 0.17 No
18 0.0 19.9 0.70 0.33 -13.6 21.4 1.01 0.18 -9.7 15.9 0.84 0.44 Yes
19 0.0 14.8 0.55 0.65 -5.8 16.2 0.74 0.37 2.0 16.6 0.69 0.43 Yes
20 0.0 10.3 0.56 0.78 -3.4 17.1 0.88 0.27 -5.4 17.2 0.96 0.39 No
Mean 0.0 16.5 0.62 0.55 -6.1 27.6 1.01 0.25 -3.8 25.6 0.94 0.37
Stdev 0.0 9.7 0.14 0.24 12.4 17.7 0.27 0.09 7.7 17.5 0.26 0.12
Mean 0.0 12.6 0.64 0.47 -4.0 18.8 0.80 0.27 -1.5 15.2 0.69 0.50
Stdev 0.0 5.8 0.09 0.25 9.5 3.7 0.12 0.08 5.7 1.9 0.10 0.07
Testing
Subject
Training Testing
Table 3. Three days training and up to 25 days of testing data.
Meeting 
Criteria
Criteria 
Passing 
Rate
35%
For cases meeting the criteria
*tˆη tyˆ
Table 3. Modeling results of 3 days training and up to 25 days of testing data 
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AE AAE RAAE r fit AE AAE RAAE r fit AE AAE RAAE r fit AE AAE RAAE r fit
1 -1.0 14.9 0.64 0.60 -5.8 17.3 0.80 0.42 7.9 24.3 0.74 0.40 10.3 23.4 0.77 0.39 No
2 -1.1 12.1 0.62 0.60 -2.0 12.7 0.57 0.63 7.7 17.6 0.65 0.54 1.6 11.9 0.54 0.72 Yes
3 -2.8 8.6 0.59 0.64 -2.5 11.3 0.64 0.57 13.1 15.7 0.94 0.45 2.1 10.7 0.65 0.60 Yes
4 -0.8 9.0 0.69 0.42 0.6 7.8 0.71 0.47 7.2 11.1 0.93 0.32 6.8 9.8 0.73 0.50 Yes
5 2.9 16.1 0.63 0.50 -4.2 18.8 0.71 0.37 1.6 15.6 0.75 0.33 -2.1 13.4 0.72 0.54 Yes
6 -0.5 17.2 0.72 0.45 -10.1 14.7 1.10 0.36 -7.8 15.8 0.81 0.50 -7.3 15.0 0.93 0.31 No
7 0.3 25.2 0.74 0.42 1.9 13.7 0.60 0.52 2.6 15.1 0.71 0.51 0.0 23.0 0.84 0.23 No
8 0.0 13.7 0.67 0.38 6.1 23.6 0.71 0.44 0.0 22.0 0.72 0.40 -3.9 16.5 0.61 0.61 Yes
9 0.2 16.3 0.67 0.63 -2.8 14.4 0.70 0.68 -0.3 18.6 0.70 0.49 7.4 22.9 0.72 0.41 No
10 1.3 15.2 0.40 0.80 -4.8 23.2 0.69 0.49 -7.9 24.1 0.69 0.53 8.4 28.9 0.78 0.43 No
11 0.0 42.3 0.65 0.55 -16.1 37.8 0.97 0.54 -24.3 45.3 0.80 0.43 -3.8 41.2 0.70 0.50 Yes
12 0.0 8.7 0.64 0.38 9.7 15.5 1.01 0.29 3.6 11.2 0.89 0.27 0.4 10.7 0.90 0.47 Yes
13 3.1 19.1 0.91 0.49 14.5 19.8 1.30 0.53 16.9 24.4 0.72 0.52 6.9 21.4 0.80 0.40 No
14 -1.1 14.4 0.54 0.74 -7.6 17.0 0.83 0.43 -7.6 18.0 0.77 0.53 -11.6 20.1 0.94 0.40 No
15 0.3 21.0 0.78 0.40 21.1 24.3 1.01 0.45 0.7 23.3 0.68 0.43 -0.9 20.3 0.66 0.49 Yes
16 -0.2 21.4 0.70 0.39 -26.1 26.1 1.68 0.52 -24.3 25.1 1.56 0.42 0.2 13.0 0.85 0.43 Yes
17 4.4 51.9 0.64 0.62 -4.5 36.1 0.66 0.59 16.6 41.1 0.73 0.59 -5.5 47.6 0.73 0.47 No
18 0.1 13.0 0.55 0.69 8.5 14.8 0.64 0.63 -5.4 18.8 0.95 0.33 -0.6 13.3 0.75 0.51 Yes
19 -9.2 14.9 0.69 0.56 -4.3 16.1 0.65 0.50 -5.7 19.7 0.90 0.14 0.7 17.9 0.74 0.47 No
20 0.0 13.9 0.56 0.64 -3.7 11.0 0.78 0.43 -12.4 16.9 0.98 0.38 -9.6 14.7 0.85 0.49 Yes
Mean -0.2 18.4 0.65 0.55 -1.6 18.8 0.84 0.49 -0.9 21.2 0.83 0.42 0.0 19.8 0.76 0.47
Stdev 2.7 10.8 0.10 0.13 10.4 7.8 0.28 0.10 11.4 8.6 0.20 0.11 6.0 9.9 0.11 0.11
Mean -0.2 12.9 0.64 0.52 3.8 15.5 0.75 0.47 1.8 16.9 0.83 0.38 -0.7 13.5 0.71 0.55
Stdev 1.5 4.0 0.07 0.13 8.4 5.7 0.16 0.12 7.5 4.2 0.13 0.08 4.5 3.3 0.11 0.08
Meeting 
Criteria
For cases meeting the criteria
Criteria 
Passing 
Rate
55%
Testing
Subject
Training Validation Testing
Table 4. Modeling Results for 1 week training, 1 week Valiadation, and 2 weeks testing data
*tˆη tyˆ
Table 4. Modeling results of 1 week training, 1 week validation and 2 weeks testing data 
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Appendix 
The purpose of this appendix is to provide a mathematical proof that rfit, under the simple 
linear regression, i.e., Eq. 27 with one input. Let
tiit vaa ,0 ˆˆˆˆ +=η , in this context, rfit is 
mathematically given by 
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Thus, with iaˆ  > 0, 
tit vyfit
rr
,ˆ,
= and for iaˆ < 0, .
,ˆ, tit vyfit
rr −=  This result means that if the correlation 
of measured blood glucose concentration (BGC) and 
tiv ,ˆ is positive, iaˆ  can be set at any positive 
value and rfit, which will be > 0, will depend only of the behavior of tiv ,ˆ which is independently 
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controlled by the values of the dynamic parameters associated with vi,t. Conversely, if the 
correlation of BGC and 
tiv ,ˆ  is negative, iaˆ can be set at any negative value and rfit will be > 0 and 
independently controlled by the values of the dynamic parameters associated with vi,t. 
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Abstract 
When modeling dynamic processes for several inputs with freely existing data, such as 
data collected with normal process operations, the ability to accurately model the output response 
for a given input change is impeded when inputs are cross- (i.e., pair-wised) correlated as this 
adversely affects accurate estimation of the causative effects of inputs on the response variable. 
The causative effects of the inputs can be evaluated functionally and analytically via the Jacobian 
Matrix which is done in this work for NARMAX and Wiener structures that are linear and 
nonlinear in model parameters. This analysis shows that the Wiener structure with physically-
based nonlinear parameterization is superior. This conclusion is also supported in this work by a 
modeling study on a real distillation column consisting of eight test runs over a period of three 
years.  
Key Words  
Wiener Modeling, NARMAX Modeling, ARMAX Modeling, Modeling Plant Data, Modeling 
Freely Existing Data 
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Introduction 
 In chemical processes, output variables are determined by the values of input variables, 
which may or may not be measured and some input variables may not even be known. 
Mathematical modeling is the process of mapping measured variables to output variables using a 
mathematical formulation. In mathematical modeling a structure must be selected and any 
unknown coefficients (i.e., parameters) must be estimated. For a general model structure, let its 
expectation be represented as ηi = f(Xi;θ), where ηi is the expected value of the response (i.e., 
output) at the ith sampling time, i = 1, . . ., n; Xi is the vector of input values at the ith sampling 
time; and θ is the vector of unknown model parameters with θ =[θ1 . . . θq]T. Therefore, the 
element of its Jacobian Matrix, Jnxq, in the ith row and jth column is ,
j
i
θ
η
∂
∂
that is, .








∂
∂
=
j
i
θ
η
J  
Moreover, the jth column represents θj and its column vector represents the change in the 
response space as θj changes for the set of experimental conditions. If two columns, say j and k, 
are orthogonal, their correlation coefficient is zero, and the information to estimate θj is 
decoupled (i.e., separate or independent) from the information to estimate θk, and vice versa. The 
advantage of this is that causative relationships of inputs on the response can be obtained and 
standard estimation errors of parameters are minimum [1]. Correlated columns in the Jacobian 
Matrix arise from pairwise correlation of inputs. Thus, obtaining orthogonal columns for each 
parameter necessitates setting Xi according to some predetermined statistical experimental 
design. However, running a statistically designed experiment is not always practical or possible. 
Theability to accurately model the output response for given inputs is impeded when inputs are 
cross-correlated [2,3]. Consequently, model identification often involves the use of experimental 
data with correlated inputs that result in columns of J that are not orthogonal (i.e., correlated). 
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Notwithstanding, for a given set of experimental data, with pairwise correlated inputs, the best 
model (in the sense of evaluating causative relationship between inputs and response and 
extracting scientific knowledge from parameters ) will be the one that produces columns of J 
with the smallest pair-wise correlation. Therefore, the goal of this work is to evaluate dynamic 
model structures based on pair-wise correlation of the columns of J when the inputs are pair-
wise correlated. This scope is restricted to transfer function models that are linear in the time-
dependent process variables. More specifically, this work compares structures that are developed 
from transfer functions that are applicable to Nonlinear Autoregressive Moving Average with 
eXogenous variables (NARMAX) and Wiener models.  
 The basic difference of NARMAX and Wiener transfer functions is the characteristic 
equation which is the same for each input for NARMAX but can be different for each input for 
Wiener. With discrete-time modeling, this work will evaluate linear and nonlinear regression 
transfer function models of NARMAX and Wiener networks. The engineering literature typically 
defines linear models based on the form of the time-dependent variables in the differential 
equations of transfer functions. However, this scope is parameter estimation with focus on J 
which is based on the behavior of the parameters. Hence, this article adopts the statistical 
definition of linear and nonlinear models in parameter estimation. More specifically, a linear 
model in this work is one that is linear in parameters and a nonlinear model is one that is 
nonlinear in parameters [1]. All parameters in this work are estimated with the least squares 
criterion. 
 From a search in the process identification literature, we discovered that for NARMAX 
models and its subclasses, linear forms in parameters are widely, if not exclusively, used (see the 
following articles for examples: Baldacchino, Anderson & Kadirkamanathan, 2013 [10]; Chiuso 
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& Picci, 2004 [11]; Ozkan et al., 2001 [12]; Pearson, 2003 [13]; Shardt & Huang, 2011 [14]). It 
also revealed that the common practice of Wiener Modeling is the use of transfer functions that 
are linear in the estimated parameters (see the following articles for examples: Giri & Bai, 2010 
[6]; Hagenblad, Ljung & Wills, 2008 [7]; Norquay, Palazoglu & Romagnoli, 1998 [8]; Pearson & 
Pottmann, 2000 [9]). The only discrete-time Wiener approach that we found to use nonlinear 
transfer functions is the one developed by Rollins et al. [5] The nonlinear parameterized 
NARMAX structure will be developed in this work following this approach.  
 This article is organized as follows. The Method and Theory Section will give the details 
linear and nonlinear parameterized discrete-time NARMAX and Wiener structures to be 
evaluated. This section will also compare and evaluate these structures based on J. The next 
section will evaluate these structures in a study on a pilot distillation column with several 
unmeasured disturbances. Models with nine inputs for both model structures are developed from 
one run of training data and one run of validation data. These models are evaluated on eight test 
cases (i.e., runs of the column) spanning a period of about three years. The last section gives 
concluding remarks and comments on future work. 
 
Methods and Theory 
The main purpose of this section is to give the J analysis for each model.  These models 
will need to be derived first. Since the Wiener Model (WM) is most general, and since the 
NARMAX (NM) can be a subclass, the WM is derived first. After the models are given, a J 
analysis will be given for each one. 
       The Wiener Structures  
Figure 1 is a block diagram with unity gain linear dynamic blocks (i.e., linear differential 
equation in the time dependent variables), Gi, and a static gain block f(V), where xi is the input to 
64 
 
transfer function Gi, vi is its output, vector V = [v1 v2 . . . vp]T, f(V) is an unrestricted function, and 
i = 1, . . ., p. Therefore, Fig. 1 is representative of the Wiener network and as we will show later 
in this section, it is also representative of a NARMAX network with the restrictions that the Gi’s 
have unity gain and the same characteristic equations. This section derives discrete-time linear 
and nonlinear regression transfer function model structures for the Gi’s.  
 
Fig. 1. Block diagram for a general transfer function network with p inputs and one output. Each 
input, xi, is passed through their own unity gain linear dynamic block, Gi, after which these 
unobservable intermediate outputs are collected and passed through a single unrestricted static 
gain function, f(V), to produce the output, y. This is a NARMAX network when the Gi’s have the 
same CEs and a Wiener network when they can have different CEs.  
  
Rollins et al. [5] presented a discrete-time WM structure for Gi with a second-order-plus-
lead-plus-dead time (SOPLPDT) form that estimates the physically-based dynamic parameters of 
the vi’s directly with a highly non-linear structure including physical constraints. The form of this 
differential equation (dead-time is excluded for simplicity) is 
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where i = 1, . . ., p, p is the total number of inputs (xi’s), iτ is the time constant, iζ is the damping 
coefficient, and aiτ is the lead parameter. Note that a zero dead time assumption is not made; dead 
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time is not shown in the Eq. 1 only to simplify the written form. With a parameter for dead time 
included, the inputs in the equations would shift in time by the amount of dead time [5]. Using a 
backward difference approximation 





∆
−
≈
∆−
t
vv
dt
tdv ttitii ,,)( e.g.,  applied to a sampling interval of 
Δt, one will obtained the following approximate discrete-time form of Eq. 1 [5]:  
ttiittiittiittiiti xxvvv ∆∆∆∆ 2,2,,1,2,2,,1,, −−−− +++= ωωδδ                         (2) 
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and 
1,2,1,2, 1 iiii ωδδω −−−=                                                     (6) 
  
to satisfy the constraint of unity gain, and xi,t is the value of the ith input at t. Two additional 
physical constraints are 0>iτ and .,0 ii ∀>ζ  Note that Eq. 2 is linear in the sδ ′ and .sω ′  Thus, 
Eq. 2 represents the linear regression form of the WM with the sδ ′ and sω ′ estimated directly. 
Notwithstanding, the nonlinear regression form of the WM is obtained by the substitution of Eqs. 
3-6 into Eq. 2 and estimating the ,sτ ′ ,sζ ′  and sa 'τ (i.e., the physically-based dynamic 
parameters) directly with
tiv , given as a highly nonlinear function of the estimated parameters. 
Physical constraints also strengthen estimation by adding more true structure. Notably, these are: 
Eq. 6, 0>iτ and ii ∀> ,0ζ . Another advantage from using physically-based dynamic parameters 
is the ability to give sensible starting values for estimates.  
 In general Eq. 2 can be given as 
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tstisittiitrtirittiiti xxvvv ∆∆∆∆ −−−− +++++= ,,,1,,,,1,, ωωδδ KK                   (7) 
From Eq. 7, Gi,t is obtained as follows: 
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where s and r are the orders in the numerator and denominator, respectively, and B denotes the 
backwards shift operator (i.e., Bmxt = xt-m∆t; where ∆t is the sampling time). Note that in Eq. 2, r = 
s = 2. From Eq. 9, 
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The general discrete-time, “white noise,” WM is given as  
tttt fy εηε +=+= )(V                                                    (11) 
where  
( ) ttlyindependenNt ∀2,0~ σε                                              (12) 
the common assumption with least squares estimation and yt is the measured output at time t. 
Note that the expected response at time t is ],[ tt yE=η  since .0][ =tE ε  While f(V) can be any 
function, in the work, for simplicity, it is given as 
tpptt vavaf ,,11)( ++== KVη                                              (13) 
where ai = the steady state gain associated with input xi,t. Substituting Eqs. 2 and 6 into Eq. 13 
gives 
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Eq. 14 will be the form that we will use in the J analysis.  
 The estimator for ,tη  is found using Eq. 11 as follows: 
0=−= ttt y ηε                                                         (15) 
Therefore, the optimal estimator of tη  with “white noise” is given as 
tppttt vavay ,,11 ˆˆˆˆˆˆ ++== Kη                                              (16) 
where the symbol “^” denotes estimator.   
      The NARMAX Structures 
 With “linear” defined as a linear dynamic system, i.e., one of linear differential equations, 
in Eq. 16.6 in this book [4], Nelles defines “the general linear model” as  
)(
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)()( kv
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kyqA +=                                                       (17) 
Eq. 17 is the basic structure containing the transfer function form for the NARMAX family of 
models (i.e., NARMAX and all of its subclasses) as shown in Nelles [4] in Chapter 16 for 
Autoregressive Moving Average with eXogenous variables (ARMAX) models and its subclasses 
and in Chapter 17 for NARMAX in general. Rewriting Eq. 17 in our preferred discrete-time 
notation with Eq. 13 for ,tη  gives, for one input: 
tt xBB )(*)( ωηδ =                                                       (18) 
since ,0)]([][ == kvEE tε where ( )r
r BBB δδδ −−−= K11)(                                              (19) 
and  
       ( ) s
s
s
s BBBBaB **)(* 11 ωωωωω ++=++= KK                       (20) 
 More specifically, Eq. 18 is the expected response for the family of ARMAX models. For p 
inputs, Eq. 18 becomes 
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tpptt xBxBB ,,11 )(*)(*)( ωωηδ ++= K                                    (21) 
where  
       ( ) ssiissiiii BBBBaB **)(* ,1,,1, ωωωωω ++=++= KK                       (22) 
A general NARMAX equation for the expected response is given as 
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where f*(X) is an unrestricted function of all inputs from t - ∆t to t - s∆t. The expected response 
for ARMAX is a special case for NARMAX with Eq. 13 with 
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Note that the denominator in Eq. 24 is the same for each transfer function meaning that 
NARMAX models use the same characteristic equation for each one, which is the primary 
difference from WM. With Eq. 24, at t = n∆t, Eq. 14 becomes 
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Note that, the form of Eq. 25 is consistent with that of Eq. 23. This is the linear parameterized 
NARMAX form that will be used in the J Analysis. The nonlinear form that will be used in the J 
consists in the substitution of Eqs. 26-28, given below, into Eq. 25. 
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      The J Analysis 
 Using the general notation from the Introduction Section, J with t = k∆t to n∆t, is 
represented by Eq. 29 below. 
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Although, technically, we will use the ARMAX expected response function in the analysis in this 
sub section, the analysis applies in general to NARMAX. With r = s = 2, the unconstrained linear 
parameterized ARMAX expected response represented in Eq. 23, from t = 3∆t to n∆t, becomes 
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Thus, J for Eq. 30, from t = 3∆t to n∆t is 
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As Eq. 31 shows, the first two columns representing δ1 and δ2 are clearly highly correlated and 
the correlation of the inputs translate directly into the columns representing the ω*s. Thus, when 
the inputs are significantly correlated, an unconstrained linear parameterized NARMAX model 
(NM) would not likely fit the data acceptably due to the inflation of the standard estimation 
errors of the parameters.  
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 With r = s = 2, the constrained linear parameterized ARMAX expected response is given 
by Eq. 25. From Eq. 25, for this case, the columns of J will come from Eqs. 33-36 below. 
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As shown by Eqs. 33 and 34, the first two columns representing δ1 and δ2, respectively, are 
clearly highly correlated as they only differ by one time step in ηt. As Eqs. 35 and 36 show, the 
correlation of the inputs translates directly into the columns representing the ωi’s and ai’s. Thus, 
when the inputs are significantly correlated, a constrained linear parameterized NM would also 
not likely fit the data acceptably.   
With r = s = 2, the constrained linear parameterized WM expected response is given by 
Eq. 14 and the columns of J will come from Eqs. 37-40 below. 
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As shown by Eqs. 37-39, the columns representing the linear dynamic parameters will be 
strongly correlated for reasons mentioned previously. However, the correlation of columns 
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representing the static parameters, i.e., the ai’s, will depend on the cross correlation of the 
outputs from the transfer function, i.e., the vi’s. While the cross correlation of the xi’s will 
influence the cross correlation of the vi’s, it can be significantly different, depending on the 
dynamic behavior of the transfer functions. Nonetheless, when the inputs are significantly 
correlated, the linear parameterized WM suffers from the limitations as all linear structures in the 
dynamic parameters and would also not likely fit the data acceptably. 
 The nonlinear parameterized NM in this work is based on the Eqs. 26-28 for the dynamic 
parameters. With Eq. 13, the columns of J, would come from Eqs. 41-42 below: 
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For iτ and ,iζ  respectively, Rollins et al. [5] derived the following equations (the equations for τai 
were not given but would be similar to the ones below): 
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(44) 
 
 
With ττ =i and ,ζζ =i for i = 1, …, p, (i.e., the characteristic equation (CE) is the same for each 
transfer function) substituting Eqs. 43-44 into Eq. 41 indicates that the columns of J for the 
dynamic parameters are highly nonlinear and thus, are not likely to be significantly correlated. 
Eq. 42 indicates that the correlation of the columns for the static parameters will depend on the 
cross correlation of the vi’s as in the linear parameterized NM structure with unity gain transfer 
functions. However, since the CEs are the same, the pairwise correlation of the vi’s can be 
greater than that of the xi’s. This is seen mathematically from the similarity for different i in Eqs. 
43 and 44. The only difference is in .aiτ  Consequently, although the nonlinear parameterized 
structure appears to be better than the linear structure for the dynamic parameters, this strength 
could be offset by greater pairwise correlation in the vi’s than in the xi’s, resulting in large 
standard estimation errors for the static parameters. 
 For the nonlinear parameterized WM, the CEs can all be different. Thus, Eq. 41 is  
iaiii
i
tp
p
i
t
i
t
v
a
v
a τζτθ
θθθ
η
or ,,;
,,1
1 =∂
∂
++∂
∂
=∂
∂
L                             (45) 
This is the critical difference that makes the WM structure superior to the NM structure. More 
specifically, this strength results in less pairwise correlation of the vi’s and thus more accurate 
static parameters. In summary, this J analysis supports the nonlinear parameterized Wiener 
structure as the most superior (i.e., less pairwise correlation of the columns of J). In modeling 
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data, this superiority can be evaluated by comparing the pairwise correlation matrix of the vi’s, 
which should be significantly better for the WM when the pairwise correlation of the xi’s is large. 
In the next section, this evaluation is made in modeling data from a distillation column.  
 
Modeling Study 
 In this section the nonlinear parameterized NM and WM structures formulated in the 
previous section will be compared and evaluated. The structure of these models is exactly the 
same except for the CE which is the same for the NM and allowed to be different for the WM. 
The hypothesis is that the correlation matrix of the vi’s will be significantly better (i.e. less 
pairwise correlation) for the WM with correlated input variables and this will result in the best fit 
as supported by the J analysis in the previous section.  
Since this article is focusing on modeling inputs, the models in the study are developed 
using inputs only. Thus, k-steps-ahead-modeling is outside the scope of this work as the use of 
outputs can dominate the fit to the degree that the contribution of the inputs to the model 
accuracy can be hidden or not directly obtainable. Two applications where models must be built 
using inputs only are feedforward control (FFC) and virtual sensor development. In FFC the 
model uses input measurements at the current time to determine the value of the manipulated 
variable needed to compensate for these input changes. This type of model will be developed and 
evaluated in Part 1 of this study. More specifically, in Part 1 the models will be developed from 
data where the output and inputs are available at each sampling instant. In Part 2, models will be 
developed as if for a virtual sensor application. More specifically, these models will be 
developed from limited output data to mimic the situation where the output is sampled 
infrequently and irregularly and the model is built off line and then used to provide frequent, 
constant sampled online virtual measurements.  
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The output in this study is the top tray temperature of a pilot distillation column that 
separates methanol and water. The details of this process will be given first. Next, the models 
will be developed from data that are split into a Training Set and Validation Set. Results are 
collected on eight (8) test sets or runs over a period of three years.  
      The Process 
The distillation process is a pilot-scale methanol/water distillation column consisting of 
12 trays, with an inside diameter of 6 inches.  Feed was introduced at Tray 4 and had a 
concentration of 15% (mole) methanol.  A process instrumentation diagram of the column is 
shown in Fig. 2 (Loveland and Rosa, 2005 [15]).  The column is connected to an industrial type  
distributed control system. The nine (9) input variables were feed flow rate, feed temperature set 
point, reboiler level, reboiler steam pressure, reflux flow rate, column pressure, bottoms product 
flow rate, distillate product flow rate and overhead condensate temperature.  The output response 
of the process was the top tray (Tray 12) temperature. These variables were sampled at a rate, 
=∆t 1/12 minute (m). 
 
      Results – Part 1 
 The Training and Validation Sets consisted of one run of the distillation column that was 
nearly evenly split into the first 121 minutes and the last 122 minutes of the run as Training and 
Validation data, respectively. We did attempt to build a linear parameterized NM using 
MATLAB and Excel. Not surprising, based on the J analysis in the previous section, the fits in 
both cases were very poor and essentially showed no fitted correlation to the test data sets. The 
specific results are not worth reporting and thus, are not included in the tables to conserve space. 
After building the NMs and the WMs they were tested on the eight (8) test sets. All the model 
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results for Part 1 are given in Table 1 for three statistics. The first one, the average error (AE), is 
defined as 
)ˆ(
1
AE
1
i
n
i
i yy
n
∑
=
−=                                                 (46) 
AE is an estimate of systematic model bias. While it is informative to obtain this estimate in Part 
1, model bias is an irrelevant metric in the evaluation of a FFC model since the purpose of a FFC 
model is to estimate the amount of change needed in the manipulated variable to offset changes 
in inputs and not to estimate output response.  The average absolute error (AAE) is defined as 
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i yy
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∑
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−=                                              (47) 
While this statistic gives a measure of closeness to the measured output, it is also affected by 
model bias and thus, is also not relevant to the evaluation of a FFC model. Both AE and AAE 
have units of degrees Celsius (oC). The last statistic in Table 1, the correlation of yi and iyˆ , rfit, is 
the premier measure of performance for a model meant for a FFC application.  
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Fig. 2. Process instrumentation diagram of the distillation process.  
 
 
 
 
77 
 
Table 1. Part 1 results for NM and WM: Training from 100% of the output data**. 
 
**Note: AE and AAE results are in oC. 
 
 Before we discuss the results in Table 1, it is informative to compare the correlation 
matrix of the inputs with the correlation matrix of the vi,t’s that will be called the “dynamic 
inputs” since they are the dynamic counterparts of the xi,t’s. The training data correlation 
matrices for the inputs, the NM dynamic inputs, and the WM dynamic inputs are given in Tables 
2-4, respectively. Results with absolute values of 0.5 or greater are in bold and red text. As 
shown in Table 2, the absolute value of three results are much greater than 0.5. For these three 
pairs, as shown in Tables 3 and 4, both methods have similar significantly smaller results. 
However, both methods have higher and similar correlation for variables 2 and 3, and higher 
(0.79 for NM and 0.63 for WM) but not similar correlation for variables 3 and 8. While this 
difference is notable, the important difference in these results for the two methods is the much 
greater numbers for NM greater than 0.5 in absolute value. More specifically, while the inputs 
(Table 2) and the WM (Table 4) only had the same five pairs, the NM had these same five pairs 
and 10 more pairs (Table 3), which is 3 times higher. Since the only difference between NM and 
A 03/08/08 Training 123 0.00 0.09 0.96 0.00 0.14 0.92
B 03/08/08 Validate 122 -0.01 0.09 0.97 -0.22 0.24 0.92
C 03/22/08 Testing 568 0.11 0.37 0.61 2.96 3.12 0.03
D 04/13/08 Testing 391 0.17 0.24 0.82 2.62 2.62 0.20
E 06/05/08 Testing 230 0.53 0.54 0.83 1.28 1.28 0.51
F 09/10/08 Testing 142 0.54 0.54 0.93 3.51 3.51 0.39
G 09/24/08 Testing 245 0.01 0.11 0.87 -0.03 0.20 0.85
H 05/22/09 Testing 205 0.31 0.32 0.90 2.23 2.24 0.01
I 02/27/11 Testing 130 -0.05 0.18 0.89 5.99 5.99 -0.03
J 03/24/11 Testing 105 -0.14 0.19 0.90 0.69 0.81 0.30
0.23 0.31 0.84 2.41 2.47 0.28
0.21 0.16 0.10 1.86 1.82 0.30
Testing Absolute Mean
Testing Absolute Stdev
Case
WM NMIdentification
Date Type Duration (Min) AE AAE rfit AE AAE r fit
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WM is the same CE for NM and different ones for WM, it appears that use of the same CE is 
causing greater cross-correlation in the dynamic inputs which is consistent with the J analysis. 
We will now examine the modeling results to see how this difference is impacting the fit of the 
models.   
Table 2. Training Set correlation matrix for the input variables 
                
 
 
 
 
 
 
 
Table 3. Training Set correlation matrix for the NM dynamic input variables 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x1 x2 x3 x4 x5 x6 x7 x8 x9
x1 1 0.01 0.14 0.22 -0.14 0.13 -0.03 0.15 -0.11
x2 1 0.65 0.01 -0.09 0.04 0.02 0.36 -0.18
x3 1 0.01 0.07 0.08 0.01 0.56 -0.12
x4 1 -0.16 0.93 0.91 0.11 0.13
x5 1 -0.10 -0.06 0.10 0.16
x6 1 0.88 0.11 0.13
x7 1 0.10 0.05
x8 1 -0.04
x9 1
v1 v2 v3 v4 v5 v6 v7 v8 v9
v1 1 0.52 0.59 0.21 0.51 -0.07 -0.02 0.72 0.41
v2 1 0.80 0.12 0.30 0.02 -0.02 0.85 0.70
v3 1 0.16 0.44 0.05 -0.03 0.79 0.70
v4 1 0.20 0.81 0.85 0.22 0.09
v5 1 -0.04 -0.02 0.60 0.38
v6 1 0.78 0.03 0.08
v7 1 -0.01 -0.02
v8 1 0.81
v9 1
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Table 4. Training Set correlation matrix for the WM dynamic input variables 
 
 
 
 In Table 1, the training and validation results for both methods are excellent with NM (rfit 
equal to 0.92 and 0.92, respectively) being only slightly worse than the WM (rfit equal to 0.96 
and 0.97, respectively). However, the testing results for the NM are considerably worse with an 
average rfit of 0.28 versus 0.84 for the WM. Thus, it appears that using the same CE is causing 
greater pairwise correlation for the dynamic inputs that are translating into an adverse effect on 
causative modeling, resulting in a significantly worse fit. Therefore, with conditions of cross-
correlation of the inputs, the nonlinear parameterized WM should be selected over the nonlinear 
parameterized NM and any linear parameterized model. A representative case (Case H) is given 
in Fig. 3 where measured data and the fits for both models are plotted. As shown, the WM fits 
(i.e., correlates with) the data considerably better than the NM. 
v1 v2 v3 v4 v5 v6 v7 v8 v9
v1 1 0.08 0.09 0.24 0.15 0.11 -0.03 0.08 0.36
v2 1 0.79 -0.02 -0.02 0.03 0.04 0.47 -0.08
v3 1 0.02 0.22 0.03 0.02 0.63 -0.12
v4 1 0.14 -0.86 -0.73 0.23 0.07
v5 1 0.04 -0.01 0.27 0.35
v6 1 0.80 -0.21 0.04
v7 1 -0.33 0.00
v8 1 -0.05
v9 1
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Fig. 3. The response plot for Case H in Table 1 for measured, NM and WM fitted output values. 
 
 
   Results – Part 2  
 Using uniformly distributed random sampling, we took ten percent of the training and 
validation output data, each, and obtained a fit for the WM. This case is made to mimic an 
infrequent sampling situation where the sampling rate is not constant and values for a variable 
are needed at some specified higher sampling rate that can be provided by modeling a set of 
measured variables. These results are given in Table 5 along with the corresponding results from 
Table 1. As shown, AAE is about the same with 0.32 oC and 0.31 oC for 10% and 100% 
sampling, respectively. The average rfit for 10% sampling is slightly lower at 0.79 versus 0.84, 
but still quite high. In some of the specific cases rfit is not lower or only slightly lower (e.g., 
Cases F, G and J). The most rfit dropped was for Case H which is significantly more than for any 
of the other cases. Also note that the training and validation results are only slightly less for 10% 
sampling. 
 With 10% of the sampled values available, the WM can be used to provide good accuracy 
and fit of the data since accuracy is an important performance measure for a virtual sensor. These 
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measured output values are used to reduce model bias by applying feedback correction (FBC) as 
given by Eq. 48 below. 
( )** ˆˆˆˆ tttt yy ηη −+=                                                          (48) 
where t* is the time of the most recently measured output.  
 The WM 10% sampling results with FBC are given in Table 6 along with the 10% 
sampling results from Table 5. As shown, with FBC, AAE dropped from 0.32 to 0.18 or by 44%, 
which is substantial. The average rfit also improved to the level with 100% sampling. However 
for one, Case E, this value actually dropped from 0.79 to 0.74. This can happen when FBC is 
reducing bias but not improving fitted correlation. However, since in this application accuracy is 
more important than correlation, this loss would be acceptable. As a representative case to 
illustrate the improvement from FBC, response plots for Case E are shown in Fig. 4 without FBC 
(Fig.4A) and with FBC (Fig.4B). As shown, FBC greatly improves the agreement of the fitted 
WM model with the measured values. 
Table 5. WM 10% sampling results compared to 100% sampling results from Table 1**.  
 
**Note: AE and AAE results are in oC. 
 
 
A 0.00 0.01 0.09 0.94 0.96
B 0.00 0.01 0.09 0.96 0.97
C 0.09 0.39 0.37 0.54 0.61
D 0.18 0.28 0.24 0.74 0.82
E 0.48 0.50 0.54 0.79 0.83
F 0.44 0.45 0.54 0.91 0.93
G -0.05 0.18 0.11 0.87 0.87
H 0.22 0.28 0.32 0.77 0.90
I -0.10 0.24 0.18 0.84 0.89
J -0.16 0.23 0.19 0.87 0.90
Testing Absolute Mean 0.22 0.32 0.31 0.79 0.84
Testing Absolute Stdev 0.16 0.11 0.16 0.12 0.10
r fit  -- 100% Sampled 
Model
Case AE AAE r fit
AAE -- 100% 
Sampled Model
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Table 6. WM 10% sampling results with FBC compared to results without (w/o) FBC**. 
 
      **Note: AE and AAE results are in oC. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. The response plots for Case E in Table 6 with all the measured outputs, 10% sampled 
outputs, and the WM fit with 10% sampling. The left plot (4A) is the fitted model without FBC 
and the right plot (4B) is with FBC. The reduction in model bias from using FBC is evident. 
 
 
 
 
C 0.36 0.39 0.67 0.54
D 0.15 0.28 0.88 0.74
E 0.21 0.50 0.74 0.79
F 0.10 0.45 0.95 0.91
G 0.14 0.18 0.88 0.87
H 0.12 0.28 0.87 0.77
I 0.18 0.24 0.87 0.84
J 0.15 0.23 0.89 0.87
Average 0.18 0.32 0.84 0.79
Stdev 0.08 0.11 0.09 0.12
Case
r fit 
FBC
AAE 
FBC
AAE -- w/o FBC r fit  -- w/o FBC
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Concluding Remarks 
 
 The objective of this work is the identification and evaluation of an effective 
multiple-input process identification method with significant input crossed-correlation. 
Specifically, this work compared NM structures to WM structures that were linear and nonlinear 
in model parameters. These structures were formulated based on differential equations for the 
transfer functions with a scope of discrete-time modeling. The J analysis of this study showed 
clearly the unacceptability of any structure that is linear in the dynamic model parameters. This 
study also showed why the WM is superior to the NM which is the use of different CEs for the 
transfer functions. This difference results in less pairwise correlation in the outputs from the 
transfer function in WM structures, which results in less pairwise correlation in the column of J 
associated with the static parameters. The ability of the WM to have less pairwise correlation in 
the dynamic variables was demonstrated using data from a distillation study by examining the 
correlation matrix. In this nonlinear model parameterization study, the only difference in the NM 
and WM is the CEs, which is the same for the NM and allowed to be different for the WM. 
Using one fitted model and testing it on eight test sets spanning a period of about three years, the 
WM greatly outperformed the NM and gave excellent fitted correlation coefficients in two types 
of applications – FFC and soft sensor development.    
This work shows the importance of using nonlinear parameterized physically-based 
model structures with unique parameterization for transfer functions when the inputs are 
significantly cross-correlated. Currently, the WM of Rollins et al. [5] is the only one that we 
know with these attributes. Thus, future work could be the expansion of methods that develop, 
improve and extend approaches with these characteristics. 
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Abstract 
The ability to accurately develop subject-specific, input causation models, for blood 
glucose concentration (BGC) for large input sets can have a significant impact on tightening 
control for insulin dependent diabetes. More specifically, for Type 1 diabetics (T1Ds), it can lead 
to an effective artificial pancreas (i. e., an automatic control system that delivers exogenous 
insulin) under extreme changes in critical disturbances. These disturbances include food 
consumption, activity variations, and physiological stress changes. Thus, this article presents a 
free-living, outpatient, multiple-input, modeling method for BGC with strong causation attributes 
that is stable and guards against over-fitting to provide an effective modeling approach for 
feedforward (FF) control.  This approach is a Wiener block-oriented methodology, which has 
unique attributes for meeting critical requirements for effective, long-term, FF control. 
Key words: Type 1 diabetes, artificial pancreas, Wiener modeling, block-oriented modeling, 
predictive modeling, model predictive control. 
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Introduction 
Diabetes is characterized by an inability to synthesize, secrete, and/or, in some cases, 
respond to insulin.  Without this vital hormone, cells and tissues cannot absorb glucose, and the 
patients’ cells can starve to death, despite high levels of glucose in the bloodstream.  Among the 
two major types of diabetes, Type 1 diabetes is characterized by the inability to produce insulin. 
Type 1 diabetics often experience extreme variations in BGC which can have adverse long- and 
short-term effects such as severe hypoglycemia, hyperglycemia and organ destruction. Studies 
have established that there is a need to maintain glucose levels within a normal range (e.g. 80– 
150 mg/dL) to avoid complications caused by diabetes [1-4]. Therefore, Type 1 diabetics require 
daily exogenous insulin infusion for survival. Current injection treatment usually involves an 
insulin pump with manually controlled bolus infusion and pre-programmed basal infusion. 
However, often times the patient is still not able to mimic a normally occurring insulin profile 
using insulin pumps or/and insulin injections, which leads to inadequate regulation of blood 
glucose concentration (BGC) possibly causing hyperglycemia, hypoglycemia or various 
complications [5,6].   
Consequently, what is needed is an automatic insulin delivery system (i.e., artificial 
pancreas) with the ability to determine continuously the amount of insulin required to provide 
optimum closed-loop glucose control (i.e., to minimize the variability around a desired glucose 
level) and to eliminate the individual from the insulin dosage decision making in this control 
loop.  
The development of a closed-loop artificial pancreas has the potential to simultaneously 
reduce the risks of hypoglycemia and hyperglycemia while also enabling individuals with Type 1 
diabetes mellitus to maintain a normal lifestyle [7].  To create a closed-loop artificial pancreas, 
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three crucial components are needed: a continuous glucose sensor, an insulin pump, and a robust 
controller [7-11].  
For effective long-term control of BGC, the control system must be capable of tight 
control under critical disturbances with extreme changes such as food, activity and stress. While 
feedback control (FBC) and model predictive control (MPC) have shown promise under mild 
changes (e.g., overnight) in disturbances [12-15] these approaches have not shown strong 
promise for long-term tight control under extreme changes in disturbances. Due to recent 
technological advancements of body monitoring devices [30,31], activity-, stress-, circadian 
rhythm-related disturbances [16-19] can be monitored in real time, which makes feedforward 
control (FFC) a possibility.  Given that FFC directly models the relationship between 
disturbances and the control variable, BGC in this context, an accurate modeling approach that 
can produce stable causation relationships between critical disturbances and BGC has the 
potential to make a significant advancement in the development of an effective long-term 
artificial pancreas.    
Hence, the focus of this article is strictly model development for effective FFC. The 
maximization of cause-effect relationship between critical disturbances and BGC is the goal of 
this model. Mathematically, a viable and general FFC law based on the model ( )θx ˆ;ˆ txt fy =  is 
given below by Eq. 1: 
( ) ( ) ( )( ) ( ) ( ) 0ˆ;ˆ;ˆ;ˆ;ˆ;
,,,
=−=−−−=−− θ0θxθ0θxθx x
x
tx
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x
set
x
tx
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x
tx ffYfYfBYf
tItItI
      
(1) 
where B is constant systematic model biased such that ( ) ,ˆ; setx YfB −= θ0 setY is the target value 
of the controlled variable (i.e., the set point); tyˆ is the modeled estimate of BCG at current time t; 
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fx is the fitted function; tx is a vector of measured input variables at t; θˆ is the vector of estimated 
parameters; and
tIx , is the insulin infusion rate at t that is required to satisfy Eq. 1 (i.e., the inlet 
flow rate needed so that Eq. 1 is satisfied at t). Eq. 1 gives the estimated insulin infusion rate to 
compensate for the all modeled input changes. Thus, the goal and scope of this work is to obtain 
a model for fx that is able to significantly tighten BGC in an automatic FFC scheme. Note that 
under Eq. 1 large systematic modeling bias does not impede effective FF control since B cancels 
out as shown. Physically, this means that Eq. 1 estimates the amount of insulin infusion at each 
time instant, i.e., 
tIx , , needed to dynamically compensate for deviations of modeled inputs from 
their initial values where the model was at the target BGC level. Modeling errors in estimating
tIx , will exists and will be compensated for under FB control. Note that any modeling approach 
that contains outputs, such as k-steps-ahead prediction models, does not meet the requirement of 
fx in Eq. 1 and are, therefore, not in the scope of this work. Moreover, the only types of models 
that have relevance to our scope are those that depend on inputs only.   
There are a number of studies in the literature involving the development of models in 
BGC for real type 1 diabetic subjects [20-26]. There are models that used measured BGC only 
[20-23], ones that use BGC and food consumption, namely carbohydrates only [24], and ones 
that use BGC, food and activities variables [25,26]. However, we have not found any approach 
that gives modeling results for only inputs and thus, the results reported in these articles are not 
in this scope of this work as they do not meet our criteria under Eq. 1. 
 Therefore, the goal of this work is the development of a FF modeling approach that has 
the characteristics mentioned above under Eq. 1. The outline for this article is as follows. 
Specific mathematical details of the proposed approach are given in the next section. Next, the 
details of the study in this article to evaluate the proposed method are given. Following this 
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section are the results of this study on 15 two-week outpatient data collection cases, which is 
then followed by concluding remarks including future work.  
 
Modeling Methodology  
The proposed modeling approach is a critical advancement over the modeling method 
proposed by Rollins et al. [27] which is an extension of the Wiener method developed by Rollins 
and Bhandari [28].  The Rollins et al. technique was developed in the context of non-insulin 
dependent Type 2 diabetics. For modeling Type 1 diabetics, it becomes necessary to refine this 
approach due to the incorporation of insulin infusion as an input. This refinement or extension 
involves the development of a new parameter estimation procedure that guards better against 
over-fitting and is better able to handle a large input set. Before introducing this new procedure, 
we present the modeling equations under a general Wiener framework that are the foundation to 
this approach. 
     Mathematical Models 
Wiener modeling follows a block-oriented model structure formed by a series and/or 
parallel arrangement of unrestricted static functions and linear dynamic blocks.  A block diagram 
with p inputs and one output is given in Fig. 1. 
The inputs, xi for i = 1,…, p, of the Wiener network are the measured noninvasive 
variables or disturbances (i.e., food, activity, and stress) and the output, y, is BGC.  Each input 
has its own linear dynamic block, Gi, and each dynamic block has an intermediate unobservable, 
output vi, which represents the independent dynamic response of its corresponding input.  All the 
intermediate vi’s are collected and passed through a nonlinear static gain block, f(V), to produce 
the final output, y.  The linear dynamic blocks are essentially linear ordinary differential 
equations; a second-order-plus-lead with dead time (SOPLDT) form as shown in Eq. 2. 
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  (2) 
where i = 1, . . ., p, p is the total number of inputs, τi is the time constant, ζi is the damping 
coefficient, τai is the lead parameter and θi is the dead time.  Using a backward difference 
approximation (e.g.,
()

≈
,	
,	∆	
∆
), applied to a sampling interval of Δt, Rollins et al. [27] 
obtained an approximate discrete-time form of Eq. 2.   
   (3) 
where, to satisfy the unity gain constraint, , = 1 − , − , − , and  
  (4) 
  (5) 
  (6) 
As described in Rollins et al. [27], this discrete form provides several strengths. First, the 
function form does not change as values of the parameters change, unlike the continuous form 
that can change as iζ changes. Secondly, one does not have to be concerned about applying a 
fading memory algorithm that is needed for the continuous form to truncate terms after a certain 
period in the past. Thirdly, Eqs. 4-6 are highly nonlinear in the dynamic parameters 
( )iiai ζττ and,,  and these intelligent complex structures aid in strengthening input-causation 
relationships by restricting parameters estimates to regions that are phenomenologically sound. 
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Lastly, the physical constraints, namely unity gain, 0>iζ  and ,0>iτ  also provide intelligence 
towards physiologically sound structure. 
The engineering community tends to define a linear model based on the time dependent 
variables in the model. For example, Eq. 2 is linear in v(t) and the transfer functions represented 
by this equation are said to be “linear” (but in the variables). However, this article defines a 
nonlinear model based on the statistical definition, which in Bates and Watts [34] is defined as 
“at least one of the derivatives of the expectation function with respect to the parameters depends 
on at least one of the parameters.” Thus, the statistical definition is based on the form of the 
parameters in the model and not the variables. If the proposed approach estimated the parameters 
in Eq. 3 directly, the model would be linear and would fall in the scope of the article by Garnier 
et al. [33] for linear multiple-input, single output (MISO) structures. However, because the 
parameters estimated in this work are the ones given in Eqs. 4-6, i.e., the dynamic parameters, 
the proposed model is nonlinear, and not in the scope of the models in Garnier et al. [33] which is 
deliberate and is a unique strengthen of this approach.     
 
Figure 1. Block diagram for a general Wiener network with p inputs and one output. Each 
input, xi, is passed through their own linear dynamic block, Gi(s), after which these unobservable 
intermediate outputs are collected and passed through a single unrestricted static gain function, 
f(V), to produce the output, y. 
G1
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f (V)
x1
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v2
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After obtaining Eq. 3 for each i, the modeled glucose value is determined by substituting 
these results into the static function, f (V), such as a second order regression form shown below:  
  (7) 
  
where ai, bi, and ci,j, denote the linear, quadratic and interaction parameters for i = 1, . . ., p-1 and 
j = 2,…, p.  The measurement model is given as   
 ttty εη +=                                                              (8) 
where yt is the modeled glucose concentration at time instant t, tε  is the error term under the 
assumptions of independence, normality and constant variance (i.e., ).),,0(~ 2 tNt ∀σε Under 
these assumptions Rollins et al. [27] proposed the following estimator for BGC under this 
measurement model: 
  (9) 
  
Thus, Eq. 9, along with Eqs. 3-6 give the functional form with its supporting equations for the 
proposed FF controller under this work. Later, in the Results Section, this control law is given as 
a differential equation.  
     Modeling Procedure 
The proposed modeling procedure is a novel approach to maximize input-causation, 
guard against over-fitting, and maximize long-term stability. As discussed above, we attempt to 
maximize input-causation throughout the use of highly nonlinear structures and physical 
constraints. Cross-validation, in a novel fitting strategy, is used to guard against over-fitting. We 
do not use a k-fold cross validation procedure with the testing data randomly split into k equal 
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groups as this is not a realistic evaluation since in practice the model can only be applied to data 
collected after the model is built. Thus, our cross-validation procedure uses only Testing data 
obtained after any data (i.e., Training and Validation data) used to influence model building. We 
seek to enhance long-term stability by obtaining consistent performance under significant 
changes in unmeasured disturbances. Our cross-validation procedure aids in this goal by seeking 
to achieve similar fitting results on all data sets. In addition, we evaluate the models using 
Testing data several days after the Training data so that unmeasured disturbances are more likely 
to be correlated differently with measured inputs.  
The proposed modeling methodology is an extension and enhancement of the procedure 
proposed by Rollins et al. [27] due to the larger number of inputs (13 variables) including the 
addition of two exogenous insulin inputs and the additional complexities they bring. For 
simplicity and to provide the best fit for mild extrapolation, this work used a reduced form of Eq. 
9 that is given by Eq. 10, below. As shown, Eq. 10 eliminates all second order and interaction 
terms of Eq. 9 and consists only of the first order, a, terms. 
tttt vavaay ,1313,110 ˆˆˆˆˆˆˆ +++== Lη                                     (10) 
where 
tiv ,ˆ is the estimate of vi,t obtained by substituting the estimated dynamic parameters, i.e., 
,ˆ,ˆ,ˆ iaii ζττ and ,ˆiθ into Eqs. 3-6 for all i. Note that the linear form of Eq. 10 makes this particular 
network structure equivalent to a general class of transfer functions where the gains for each one 
is contained in Eq. 10 by ai, i =1, . . ., 13.  Also, note that a model is completely specified when 
the dynamic parameters in Eqs. 4 to 6 have estimates for obtaining Eq. 3; then for each input 
these equations are incorporated into Eq. 10 along with estimates for the a’s. 
As stated in Rollins et al. [27], the modeling objective is simply to maximize the true but 
unknown correlation coefficient between measured and fitted BGC. This quantity is represented 
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by ρy y, $ and estimated by rfit. Thus, under this criterion, as a minimum, a model is considered 
useful, if, and only if, 
0ˆ, >yyρ                                                        (11) 
Since the degree of usefulness increases with ρy y, $ , the goal is to obtain the largest (as close to the 
upper limit of 1) value as possible. Due to the highly complex mapping of the parameters into the 
response space of rfit, the following criterion is used in obtaining the parameter estimates: 
( )
i,Validation and Training for r maximizingtoSubject
yySSETraining Minimize
fitiii
tn
tt
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∀>>>
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2
θτζ
          (12) 
The objective criterion, Eq. 12, is written to address the effect of unmeasured 
disturbances which is an artifact of real modeling as opposed to hypothetical simulated data 
modeling without unmeasured disturbances. The validation data set helps to guard against fitting 
the training data to unmeasured input variables that are correlated with measured input variables 
during training but differently during validation. This is done by seeking to obtain similar fitted 
correlation for training and validation sets which is a goal of the proposed modeling approach. 
The systematic bias that appears in the validation set is largely due to level changes in 
unmeasured inputs. However, as Eq. 1 shows, the proposed approached is not affected by this 
type of systematic bias and thus, can be effective in the presence of level changes for 
unmeasured disturbances. This is a critical attribute for long-term effective FF control. 
For FF model evaluation, of the statistics commonly used for evaluating model fit, rfit is 
premier as supported by the discussion earlier in regards to Eq. 1. As discussed, a FF model 
needs to be accurate for the change in inputs and rfit is the best statistical measure of this ability. 
Statistics that are affected by model bias are not relevant as measures of performance in this 
context as discussed earlier.  
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The novelty of the proposed modeling procedure lies in a two level decomposition of the 
parameter estimation problem. The first level decomposes the static and dynamic problem. That 
is, the dynamic parameters, i.e., the parameters in Eq. 2, are estimated first and separately from 
the static parameters, i.e., the sai 'ˆ  in Eq. 10. The second level decomposes dynamic parameter 
estimation into p = 13 separate (i.e., sub-) problems, one for each input. For this approach to be 
possible, a modeling structure must allow these decompositions. Under a SOPLDT dynamic 
model structure, the Wiener network is the only one that does as opposed to other common 
networks like the autoregressive moving-average exogenous input (ARMAX) model [27,29].  
For this approach to be effective, with only one input, xi, in each dynamic estimation problem, rfit 
must depend only on the dynamic parameters to obtain the best set. That is, the value of rfit must 
be solely controlled by the values of the dynamic parameters irrespective of the values of static 
parameters. Fortunately, this is the case because with only one input, xi, rfit = ,ˆ, ivyr the correlation 
coefficient for yt and tiv ,ˆ (see the Appendix for the mathematical proof). Thus, for the simple 
linear regression model (SLRM) (i.e., Eq. 10 with one input), since 
tiv ,ˆ depends only on the 
dynamic parameters, rfit depends only on the dynamic parameters. Although a formal proof is 
given in the Appendix, one can prove this in practice quite easily by changing the static 
parameters for a fixed set of dynamic parameters and verifying that the value of rfit does not 
change by observation.  
In the proposed procedure, models are developed from Training and Validation data sets. 
The Training set is used to determine the value of SSE and in adjusting the values of the 
parameters directly to minimize this value. The Validation set calculates rfit for each adjustment 
on the values of the parameters, and is used to stop the minimization process for SSE if rfit for the 
Training set increases significantly and causes a significant drop in rfit for the Validation set. This 
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is the practical way that we feel that cross validation is done in practice as mentioned above. In 
addition, the proposed procedure includes a more stringent condition -- that is, rfit for both sets to 
be close to one another. Thus, for each input, the goal is not just for high values of rfit for 
Training and Validation but also for their values to be close. Moreover, this procedure will lower 
the value of rfit in the training data to bring its value close to the validation data and vice versa. 
We impose this condition because we have found from modeling many cases that when this 
condition is met that the final fit of the static model at the fixed set of dynamic values produces 
rfit values in Training, Validation and Testing sets that are very close together to minimize over-
fitting and maximum long-term stability as discussed above.  
After finding the dynamic parameters, the next step in the procedure is to obtain the static 
parameters under Eq. 10. With the dynamic parameters fixed, this becomes a linear regression 
problem which has a global minimum as the solution. However, since we have a validation set, 
we observe its rfit performance under an iterative approach to the global minimum using an 
iterative optimization process. We have found that most of the time, the global minimum is the 
optimal solution but sometimes we find a slightly better solution based on the validation set that 
is not too far away from the global minimum.  
The final process in the proposed procedure is the elimination of inputs that adversely 
affect the final model when fitting the combined set of inputs under the static model. Each input 
is removed from the model with all the other inputs kept in the model. If rfit increases when an 
input is removed, this input is taken out of the final model. After completing this process for all 
the inputs, the inputs that passed this test are used to obtain the fit of the final model under the 
static model. It should be noted that in most cases all the activity inputs were retained in the 
model and if any were eliminated this number was only a few. Rollins et al. obtained this set 
97 
 
from an extensive study in type 2 modeling involving all 22 of the armband inputs. Given that 
most of the inputs were retained in this work for each subject, this set appears to be quite 
acceptable. Also, note that the final set of inputs for a given model is not of concern in this work 
since we have no use for the models beyond model building to evaluate this approach.   
 
The Study 
Subjects in this study followed a two week free-living outpatient protocol in which no 
constraints or conditions were placed on their daily diet or lifestyle. The subjects in this study 
were all healthy young adults from the ages of 18 to 25 with type 1 diabetes and on insulin pump 
therapy with a body mass index (BMI) from 20.8 to 27.6.  To obtain a sufficiently fast sampling 
rate necessary for discrete-time (DT) dynamic glucose modeling, the iProTM Continuous Glucose 
Monitor (CGM) (Medtronic MiniMed, Inc., Northridge, California) was used to provide glucose 
measurements.  Use of the CGM requires the insertion of a short flexible sensor (by needle) into 
the subcutaneous tissue of the abdominal/supra-iliac area (i.e., between the umbilicus and the 
hip).  The sensor samples the surrounding interstitial glucose, which is then used to infer an 
individual’s blood glucose levels with a reporting frequency of every five minutes. Following 
FDA recommendations the sensors were replaced every three days.  A period of one to two hours 
of missing measurements resulted during initialization of the new sensor after each insertion. To 
maximize sensor reading accuracy the sensor must be calibrated with at least four finger-stick 
measurements daily from the subject’s personal blood glucose lancet meter.   
Activity information was collected using the SenseWear® Pro3 Body Monitoring System 
(BodyMedia Inc., Pittsburgh, Pennsylvania) shown in Fig. 2, which is wore on the triceps of the 
subject’s arm. The SenseWear® armband utilizes pattern detection algorithms [30,31] that 
employ physiologic signals from a unique combination of sensors to generate values for twenty 
98 
 
activity variables. The armband collects data using a two-axis accelerometer and four sensors 
that are used to determine heat flux, skin temperature, near body temperature, and galvanic skin 
response (GSR).  The two-axis accelerometer provides information about body position and 
tracks upper arm movement.  The heat flux sensor calculates the amount of heat being dissipated 
from the body by measuring the amount of heat lost along a thermally conductive path between 
the skin and a vent on the side of the armband.  Skin temperature and near-body temperature are 
measured by sensitive thermistors and GSR is measured via the conductivity of the subject’s skin 
as it varies due to physical and emotional stimuli [31].  The SenseWear® armband samples at a 
rate of once per minute, however, measurements at five minute intervals were used to match the 
sampling rate of the CGM used in this study.  The armband was typically only removed once a 
day while the subject was showering. Finally, to represent circadian rhythm (i.e. the body’s 
internal clock) we used a variable that we called the time of day (TOD) which is simply 24 hour 
clock time.  
 
Figure 2. BodyMedia, Inc. SenseWear® Pro3 Body Monitoring System 
 
 
Food information was collected using food logs. For Subjects 1-6, and 11 detailed food 
logs were kept on the actual food consumed and for Subjects 7-10 meals were logged based on 
the size of the meal with small = 1, medium = 2 and large = 3. As part of the detailed protocol, 
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subjects recorded the approximate serving size and the time they started eating, for all of the 
food they consumed, into a PDA, which used Weightmania® Pro software (Edward A. 
Greenwood, Inc., Cambridge, Massachusetts) to determine the carbohydrate, fat, and protein 
content of their meals. In addition, the subjects’ insulin pumps were downloaded on biweekly 
basis to retrieve their daily bolus and basal insulin infusion rate data. The thirteen variable input 
set for this study is given in Table 1. 
     Table 1. Input variables. 
 
 
 
 
 
Based on results in Rollins et al. [27] for a Type 2 subject and in Beverlin et al. [32] for 
20 non-insulin dependent Type 2 diabetics, a goal was set for rfit to be greater than 0.40 with a 
value greater than 0.60 considered excellent. Note that this goal of rfit may not seem very high. 
However, one must recognize that this is an application in FF model development for inputs only 
and not a model prediction application requiring high model accuracy. Our objective function, 
Eq. 11, is defined in terms of usefulness, which essentially means any model that has the 
potential to significantly tighten BGC for a given subject. For a given subject, it is not likely 
necessary for ρy y, $  to be too high to achieve usefulness when input model causation is strong. 
However, ultimately, the only way to truly evaluate the effectiveness of a given model is its use 
Food   Activity   Circadian Rhythm  Insulin 
 
1. Carbohydrates  4. Transverse accel – peaks  11. Time of Day (TOD) 12. Bolus 
2. Fats 5. Heat flux – average     13. Basal 
3. Proteins 6. Longitudinal accel – average 
 7.    Near Body Temperature 
 8. Transverse Accel – MAD 
 9. GSR – average 
 10. Energy Expenditure 
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in FFC. Models with strong input-causation fitting can actually do better than models with 
weaker input-causation and higher rfit results. 
The first half of this study involved splitting the data into a week of training data and a 
week of validation data. The second half of the study split the data into a week of training data, 
four days of validation data, and three days of test data.   
 While correlation is the premier performance statistic as mentioned above, three other 
statistics were determined that are affected by model bias. Since bias can be neutralized as shown 
in Eq. 1, these statistics are irrelevant as FF model performance measures, but are included to 
give an indication of how well rfit holds its level in Validation and Testing data under conditions 
when model bias can be significant. These additional statistics are the average deviation (AD), 
the average absolute deviation (AAD) and mean relative absolute deviation (MRAD).  The AD is 
simply the average of the residuals and is an estimate of model bias, B, as shown below: 
 ( )∑
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1ˆ                                                   (13) 
where n is the number of observed blood glucose measurements in the statistic being calculated.  
A check that the aforementioned convergence criterion is met is the AD value equaling 0.0 
mg/dL.  A model with a significantly large absolute value of AD or model bias will tend to raise 
AAD values.  The equation for AAD is similar to AD except AAD takes the absolute value of 
the residuals before finding the average.  
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The spread in BCG can vary widely among T1Ds and AAD will tend to be large when 
the BGC spread is large. Therefore, MRAD, a relative ADD value, is defined as follows:    
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Results 
 Tables 2 and 3 contain results for 15 subject-specific models and Tables 4 and 5 for 11 
subject-specific models. The data for Subjects 1-11 were collected by an experienced graduate 
student that left the project after completing the first phase of the study. The other ones (Subjects 
12-15) were collected by a new, less experienced, graduate student in the second phase of the 
study. This lack of experienced is revealed in the tables by the number of days of modeling data. 
Although data collection for each subject was about 2 weeks, the amount of useful modeling data 
was much less for Subjects 12-15 because of missing BGC data that the CGMS did not give. 
Thus, for a given subject, the data in Tables 2 and 3 had a split of ½ for Training and ½ for 
Validation and in Tables 4 and 5 the split was ½ Training, 2/7th Validation, and 3/14th Testing.  
 As mentioned, Tables 2 and 3 equally splits the data into Training and Validation sets. In 
Table 2 all the inputs are included in the models and in Table 3 the armband inputs are not 
included. Thus, a comparison of these tables indicates the modeling improvement from use of the 
armband inputs. The average rfit with and without the armband for Validation are 0.62 and 0.52, 
respectively, indicating a very significant improvement from use of the armband. The Training 
and Validation rfit values are in general quite close together and thus, supporting the 
effectiveness of the proposed modeling approach to obtain similar values to guard against over-
fitting. Note that the mean Training and Validation values are 0.60 and 0.62, respectively, and 
0.50 and 0.52, respectively, for Tables 2 and 3, respectively. While the three biased indicating 
statistics are quite larger for the Validation results in several cases, rfit is quite consistent given 
that it is an estimate of fitted correlation with significant standard error. Thus, the approach 
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appears to be maintaining its level of fit quite well from Training to Validation results. The fit of 
model for Subject 11 is given in Fig. 3. As shown, the input-only model tracks the observed 
BGC quite well in terms of correlation. The systematic bias of the Validation fit is quite evident 
as well as the apparent shift in the average BGC level from Training to Validation data. 
  
Table 2. Model results for one week (or 7/14th) of training and one week (or 7/14th) of validation 
with all inputs included. AE and AAE values are in mg/dL. 
 
 The mean Validation rfit for the detailed food logged cases, 1-6, and 11-15 is 0.63. The mean Validation rfit for the 
non-detailed food logged cases, 7-10 is 0.59.  
 
Tables 4 and 5 include test data. In Table 4 all the inputs are included in the models and 
in Table 5 the armband inputs are not included. The average rfit with and without the armband for 
Testing are 0.59 and 0.51, respectively. These results are very similar to the previous ones in 
Tables 2 and 3 and support a significant improvement from use of the armband. The Training, 
Validation, and Testing rfit values are in general quite close together and thus, supporting the 
AD AAD MRAD rfit AD AAD MRAD rfit
1 14.0 0.00 44.8 0.44 0.61 20.4 50.5 0.33 0.68
2 13.0 0.00 72.1 0.62 0.49 -18.0 68.5 0.72 0.51
3 13.9 0.00 48.0 0.37 0.68 -0.1 49.3 0.33 0.66
4 10.7 0.00 31.6 0.38 0.53 33.4 48.4 0.39 0.55
5 14.0 0.00 62.6 0.47 0.56 15.1 73.6 0.53 0.55
6 13.9 0.00 50.1 0.31 0.67 24.9 45.6 0.23 0.68
7 14.0 0.00 46.7 0.43 0.69 37.1 56.5 0.36 0.64
8 14.0 0.00 32.7 0.36 0.45 10.8 43.2 0.42 0.43
9 13.9 0.00 51.8 0.37 0.63 -35.2 64.2 0.62 0.56
10 16.8 0.00 47.4 0.30 0.57 14.0 46.8 0.30 0.73
11 15.1 0.00 33.7 0.23 0.72 -24.3 47.2 0.43 0.79
12 8.9 0.00 56.3 0.25 0.63 -33.0 83.0 0.57 0.72
13 8.2 0.30 55.4 0.47 0.54 52.5 76.9 0.41 0.58
14 7.9 -0.10 48.2 0.39 0.56 -30.1 48.6 0.59 0.61
15 13.6 0.00 23.1 0.21 0.56 20.7 45.2 0.35 0.56
Validation
0.0 47.412.8
Subject
Mean
Days
Training
0.37 0.60 7.1 56.5 0.44 0.62
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effectiveness of the proposed modeling approach to obtain similar values to guard against over-
fitting. Note that the mean Training, Validation, and Testing values are 0.58, 0.59 and 0.59, 
respectively, and 0.50, 0.54, and 0.51, respectively, for Tables 4 and 5, respectively. The AAD 
and MRAD values in these tables are similar to the ones in Tables 2 and 3 and the analysis of 
model bias is the same as before. That is, while they are larger for the Validation and Testing 
results in several cases, rfit is quite consistent, Thus, the approach appears to be maintaining its 
level of rfit quite well from Training to Validation to Testing results.  
 
Table 3. Model results for one week (or 7/14th) of training and one week (or 7/14th) of validation 
without armband inputs included. AE and AAE values are in mg/dL. 
 
 The mean Validation rfit for the detailed food logged cases, 1-6, and 11-15 is 0.52. The mean Validation rfit for the 
non-detailed food logged cases, 7-10 is 0.50. 
 
 In comparing rfit results of detailed food log cases (Subjects 1-6, 11-15) versus meal size 
(non-detailed) food log cases (Subjects 7-10), it is not conclusive how much the detailed food 
logs improve the fit, if at all. Averaged rfit Validation results in Tables 2 and 3 for detailed and 
AD AAD MRAD rfit AD AAD MRAD rfit
1 14.0 0.0 49.2 0.47 0.52 26.9 56.8 0.36 0.57
2 13.0 0.0 65.4 0.55 0.58 -13.1 64.4 0.64 0.56
3 13.9 0.0 61.0 0.48 0.46 18.2 56.6 0.35 0.42
4 10.7 0.0 32.2 0.38 0.48 32.6 32.6 0.38 0.49
5 14.0 0.0 66.1 0.51 0.50 11.3 81.7 0.62 0.44
6 13.9 0.0 62.8 0.40 0.39 13.9 50.8 0.26 0.35
7 14.0 0.0 58.3 0.55 0.52 21.3 51.5 0.34 0.57
8 14.0 0.0 35.8 0.41 0.25 15.1 46.6 0.46 0.34
9 13.9 0.0 59.3 0.43 0.52 -21.8 64.4 0.63 0.43
10 16.8 0.0 48.8 0.31 0.55 13.3 49.8 0.32 0.67
11 15.1 0.0 33.5 0.23 0.70 -23.5 48.3 0.43 0.77
12 8.9 0.2 58.4 0.26 0.61 -37.6 87.7 0.61 0.61
13 8.2 0.0 61.5 0.53 0.40 54.9 82.0 0.45 0.45
14 7.9 -0.1 48.2 0.39 0.56 -30.1 48.6 0.59 0.61
15 13.6 0.0 25.2 0.24 0.50 26.4 48.5 0.37 0.50
0.520.41 0.50 7.2 58.0 0.45Mean 0.012.8
Subject Days
Training Validation
51.1
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non-detailed cases are 0.63 versus 0.59 and 0.52 versus 0.50, respectively.  In Tables 4 and 5, 
averaged rfit Testing results for detailed and non-detailed cases are 0.62 versus 0.53 and 0.50 
versus 0.55, respectively.  If Subject 8 is removed in Table 4, the averaged rfit, for the 3 
remaining subjects, increases from 0.53 to 0.60, and it is very close to the detailed result of 0.62. 
Thus, it seems that if detailed food log are improving the fit, it does not appear to be very 
significant. 
   
Table 4. Model results for one week (or 7/14th) of training, 4 days (or 4/14th) of validation, and 3 
days (or 3/14th) of testing with all inputs included. AD and AAD values are in mg/dL. 
 
The mean Testing rfit for the detailed food logged cases, 1-6, and 11 is 0.62. The mean Testing  rfit for the non-detailed food 
logged cases, 7-10 is 0.53. 
 
AD AAD MRAD rfit AD AAD MRAD rfit AD AAD MRAD rfit
1 14.0 0.00 45.0 0.45 0.60 20.1 52.9 0.36 0.66 16.7 46.9 0.30 0.66
2 13.0 0.00 67.2 0.55 0.57 -33.3 62.6 0.74 0.67 2.9 64.8 0.47 0.54
3 13.9 0.00 50.9 0.39 0.64 -12.9 60.7 0.37 0.53 -21.3 53.0 0.37 0.68
4 10.7 0.00 31.9 0.38 0.53 31.1 52.5 0.45 0.52 35.4 40.5 0.29 0.57
5 14.0 0.00 63.3 0.48 0.55 31.4 87.3 0.63 0.54 -15.0 55.9 0.44 0.67
6 13.9 0.00 52.8 0.33 0.65 37.9 59.8 0.29 0.60 -0.1 34.0 0.20 0.60
7 14.0 0.00 56.4 0.53 0.56 25.6 52.6 0.32 0.58 -1.7 58.7 0.48 0.56
8 14.0 0.00 36.5 0.41 0.21 26.7 46.1 0.38 0.28 -0.1 48.7 0.59 0.30
9 13.9 0.00 53.2 0.38 0.61 -19.4 51.8 0.41 0.65 -54.9 75.8 0.90 0.55
10 16.8 0.00 44.9 0.29 0.62 15.0 43.6 0.25 0.68 0.8 50.9 0.37 0.70
11 15.1 0.00 30.4 0.21 0.79 -22.3 41.8 0.36 0.81 -25.3 60.8 0.56 0.63
3 Days Testing
0.40 0.58 9.1 55.6 0.41 0.59
7 Days Training 4 Days Validation
-5.7 53.6 0.45 0.59Mean 13.9 0.0 48.4
Subject Days
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Table 5. Model results for one week (or 7/14th) of training, 4 days (or 4/14th) of validation, and 3 
days (or 3/14th) of testing without armband inputs. AD and AAD values are in mg/dL. 
 
The mean Testing rfit for the detailed food logged cases, 1-6, and 11 is 0.50. The mean Testing  rfit for the non-detailed food 
logged cases, 7-10 is 0.55. 
 
 
Figure. 3. Fitted and observed BGC versus time for Subject 11 in Table 2.   
AD AAD MRAD rfit AD AAD MRAD rfit AD AAD MRAD rfit
1 14.0 0.00 49.2 0.47 0.52 22.1 56.5 0.39 0.56 31.5 57.1 0.33 0.58
2 13.0 0.00 68.0 0.58 0.56 -28.2 65.1 0.79 0.55 6.5 71.7 0.52 0.48
3 13.9 0.00 60.6 0.48 0.47 13.3 51.7 0.30 0.47 25.1 64.2 0.42 0.36
4 10.7 0.00 32.1 0.38 0.49 31.7 52.4 0.44 0.49 34.2 40.6 0.29 0.52
5 14.0 0.00 66.0 0.51 0.49 27.3 92.5 0.71 0.48 -12.4 65.3 0.51 0.45
6 13.9 0.00 63.5 0.40 0.38 23.7 62.8 0.32 0.27 -3.4 37.1 0.21 0.52
7 14.0 0.00 60.7 0.58 0.47 22.6 47.8 0.29 0.60 -2.9 55.1 0.44 0.54
8 14.0 0.00 33.6 0.38 0.39 23.8 42.9 0.36 0.47 -4.6 45.5 0.54 0.48
9 13.9 0.00 63.8 0.48 0.44 -6.0 62.6 0.44 0.47 -44.1 69.0 0.85 0.49
10 16.8 0.00 48.3 0.31 0.56 15.2 42.7 0.25 0.70 11.8 54.1 0.37 0.67
11 15.1 0.00 31.5 0.22 0.77 -20.6 38.7 0.33 0.83 -14.5 59.0 0.51 0.58
0.4552.5 0.44 0.50 11.4 56.0 0.42 0.54 2.5 56.2
Subject Days
7 Days Training 4 Days Validation
Mean 13.9 0.0 0.51
3 Days Testing
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 The FF model can be obtained by application of Eq. 1. Note that from Eq. 10 at the initial 
steady state when 0== tt vx  and ,
ˆˆ BYy set += then .ˆˆ BYa seto +=  For simplicity, we use only 
two inputs, one for say, carbohydrates, for example, x1, and one for insulin infusion, say x2. Thus, 
Eq. 1 in continuous time is: 
0)(ˆˆ)(ˆˆ 2211 =+ tvatva                                                          (16) 
 
In the Laplace domain Eq. 16 becomes 
 
0)(ˆ)(ˆ)(ˆ)(ˆ)(ˆˆ)(ˆˆ 2221112211 =−=+ sGsXasGsXasVasVa                                    (17) 
 
By taking ,0ˆ =iθ  for simplicity, in the s-domain, Eq. 2 becomes 
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                                                   (18) 
Substituting Eq. 18 into Eq. 17, rearranging and writing as a differential equation, one gets the 
following form for the proposed FF controller: 
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As shown by Eq. 19, the FF control law contains the numerator and denominator dynamics of 
both the load variable and the manipulated variable, the insulin infusion rate. This equation can 
be solved numerically using a technique such as Euler’s method to give the insulin infusion rate 
at each time instant to satisfy Eq. 1. 
 For an ARMAX model, the FF controller would be (the derivation is not shown for space 
considerations) 
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Note that this controller only has numerator dynamics for the inputs. Since inputs in this context 
will have very different denominator dynamics (e.g., very different residence times of 
carbohydrates and fats), it is not reasonable to use a model with this restriction when it is 
unnecessary. Thus, ARMAX and its related structures such as ARX are not considered based on 
the goals of this research work. 
  
Concluding Remarks 
 This work proposed an input-only, multiple-input, outpatient free-living, modeling 
methodology for T1D subjects for FFC. We have not found any input-only models for real T1D 
subjects in the literature and thus, none that meet the requirements for FF controller development 
under Eq. 1, our scope. The proposed methodology extends the one developed by Rollins et al. 
[27] for Type 2 diabetic subjects to include insulin infusion. It decomposes the static and 
dynamic parameter estimation problems and then decomposed the dynamic parameter estimation 
problem into a separate one for each input. This strategy seeks to guard against over-fitting and 
to strengthen long-term stability by producing Training, Validation and Testing fitted 
correlations (rfit) that are similar as evidence of achieving these goals. The activity inputs 
provided by the armband were shown to be quite valuable in improving model fit.  For several 
subjects, the fits were excellent (rfit ≥  0.6) even though they were developed from free-living 
data and totally from non-invasive inputs. This work makes a major step towards the goal of the 
development of a long-term automatic insulin delivery system for T1Ds. 
 The goal of a FF controller is to determine the insulin infusion rate that will cancel the 
effects of measured input changes on BGC. Thus, the FF model used to build the FFC system 
can have large model bias and be quite effective as long as it is able to accuracy determine the 
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insulin infusion rate to cancel out changes of measured and modelled inputs. Consequently, a FF 
model can be quite biased and still very effective in this application.  
Given that of model bias does not matter in this application, the premier performance 
measure is rfit  as it is not affected by model bias and gives an indication of model fit. However, 
high correlation does not necessarily mean high causation. Moreover, under free-living data 
collection, and this context of modeling real subjects, input model causation cannot be 
determined and can only, ultimately, be evaluated under real subject FFC. Nonetheless, our 
approach has attempted to strengthen input causation in model building by using highly structure 
nonlinear models with physically interpretable dynamic parameters and a model identification 
strategy to minimize over fitting. We sought to accomplish the latter by a cross-validation 
strategy that used sequential data for training, validation, and testing sets and obtains similar 
values of rfit for all the data sets. In addition, by using a sequential cross-validation approach as 
opposed to a k-fold approach, ones is able to evaluate how rfit maintains it level under a model 
with changing bias due to changes in unmeasured disturbances and this is more realistic in terms 
of practice since the model will be used in practice on data that is collected after the model is 
built.  
 In the future, we will continue to improve the accuracy of the method and evaluate its 
suitability for FF control in real data studies. While the Wiener structure has unique strengths, it 
is still limited. Consequently, we will continue to look for other types of structures that have 
better phenomenological attributes, especially for the incorporation of unmeasured blood insulin. 
We feel this accomplishment has the potential for a significant advancement in model-based FFC 
applications as it should provide the insulin infusion rate to compensate for multiple and 
simultaneous input changes in a dynamic fashion.     
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Appendix 
The purpose of this appendix is to provide a mathematical proof that rfit, under the simple 
linear regression, i.e., Eq. 27 with one input. Let
tiit vaa ,0 ˆˆˆˆ +=η , in this context, rfit is 
mathematically given by 
  
( )( )
( ) ( )
( )( )
( ) ( )
( )( )
( ) ( )
tit
tt
vy
i
i
n
j
iti
n
j
ji
n
j
itiji
n
j
iitii
n
j
j
n
j
iitiij
n
j
j
n
j
j
n
j
jj
yfit
r
a
a
vvyya
vvyya
vaavaayy
vaavaayy
yy
yy
rr
,ˆ,
1
2
,
1
22
1
,
1
2
0,0
1
2
1
0,0
1
2
1
2
1
ˆ,
|ˆ|
ˆ
ˆˆˆ
ˆˆ
ˆˆˆˆˆˆ
ˆˆˆˆˆˆ
ˆ
ˆˆ
=
−⋅−
−−
=
−−+⋅−
−−+−
=
−⋅−
−−
==
∑∑
∑
∑∑
∑
∑∑
∑
==
=
==
=
==
=
r
ηη
ηη
η
                               (21) 
Thus, with iaˆ  > 0, 
tit vyfit
rr
,ˆ,
= and for iaˆ < 0, .
,ˆ, tit vyfit
rr −=  This result means that if the correlation 
of measured blood glucose concentration (BGC) and 
tiv ,ˆ is positive, iaˆ  can be set at any positive 
value and rfit, which will be > 0, will depend only of the behavior of tiv ,ˆ which is independently 
controlled by the values of the dynamic parameters associated with vi,t. Conversely, if the 
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correlation of BGC and 
tiv ,ˆ  is negative, iaˆ can be set at any negative value and rfit will be > 0 and 
independently controlled by the values of the dynamic parameters associated with vi,t. 
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Abstract 
The potential for successful automatic control of blood glucose concentration (BGC) has 
entered a new era due to recent technological advancements in insulin pumps and blood glucose 
sensors. However, a critical advancement necessary for full automation and long-term use is a 
control algorithm that can effectively maintain tight control of BGC under extreme variation of 
important disturbances such as activity, stress, and food consumption. Since feedforward control 
(FFC) models disturbances directly it has the potential to eliminate the effects of disturbances 
completely. A Wiener-type feedforward control law is limited to the inclusion of only input (i.e., 
modeled disturbances and the manipulated variable) dynamics. Using a semi-coupled modeling 
network that includes pseudo-blood insulin concentration, this work presents a more 
phenomenological FFC law that includes input dynamics, blood insulin and blood glucose 
dynamics and blood glucose levels. Modeling results on fifteen adults with type 1 diabetes 
mellitus for the proposed method are nearly identical to Wiener modeling results. 
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predictive modeling, model predictive control. 
Introduction 
 In a person without diabetes, several systems such as the metabolic, endocrine, 
cardiovascular, etc. function collectively to maintain homeostasis. However in a person with 
diabetes, their inherent glucose regulation mechanism is dysfunctional. Glucose levels are 
affected by the state of the metabolic-physiological-endocrine system (consisting of factors such 
as insulin, stress, physical activity, hormonal levels, fatigue, etc.) [1-5]. The effects of all these 
factors on blood glucose concentration (BGC) are highly complex and inter-related [6]. In 
addition, factors such as food intake can cause glucose levels to change greatly and make glucose 
regulation and health management more difficult.  
 Insulin therapy involves multiple daily doses of insulin before meals or after meals to 
correct high blood glucose, with the amount either pre-recommended by a physician or decided 
by the patient on the basis measured blood glucose concentration (BGC) and number of 
carbohydrates to be ingested at the time of the meal. This protocol is not only inconvenient but 
also unreliable; often resulting in hypoglycemic and hyperglycemic episodes, both of which can 
be life-limiting and life-threatening [7]. Consequently, what is needed is automatic delivery of 
insulin that results in minimal variability around the desired glucose target.  
 The potential for successful automatic insulin delivery has entered a new era due to 
recent technological advancements of insulin pumps and blood glucose sensors. However, for 
full automation and control twenty four hours a day/seven days a week (24/7) the control 
algorithm must be capable of tight control for major disturbances such as meals, various from of 
activity and stress. Theoretically, the superiority of feedforward control (FFC) over all other 
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control systems is that corrective action can be taken to cancel the effects of disturbances on the 
control variable (i.e., BGC) [8]. While Feedback Control (FBC) [9, 10, 11] and some model-
based algorithms [12-15] have shown promise and progress in real studies, there does not appear 
to be FFC clinic studies on real subjects in the literature. Actually, even from a search in the 
process control literature the success implementation of FFC on real systems appears to be quite 
limited as we were only able to find a few articles [16, 17]. We believe that this is due to the 
difficulty of developing accurate causative relationship of inputs on the control variable for real 
processes because of the existence of unmeasured disturbances and pairwise correlation of the 
inputs. Therefore, the objective of this work is the development a subject-specific FFC modeling 
methodology for maintaining tight BGC under free-living data collection (i.e., without any 
restrictions on the subject’s eating or activity) to effectively compensate for changes in meals, 
activity, and stress. 
The general FFC law used in this work is determined as follows. Let =tyˆ  estimated 
value of the output (i.e., BGC) at time t and given as 
 ( ) tcttxt yBfy ηˆˆˆ;ˆ =+== θX                                               (1) 
with ( ) 000 ˆˆ;ˆ η=+== setx YBfy θX                                              (2) 
where ( )θX ˆ;txf  is a fitted function of input variables only (more specifically, no outputs); tX is a 
matrix of measured input variables; θˆ is the vector of estimated parameters; B is the model bias; 
setY is the target value of the controlled variable (i.e., the set point); B, is determined by
( ) ,ˆ;0 setx YfB −= θX ctyˆ is the bias corrected estimated BCG at t; and tηˆ is the estimate of the 
expected value of BGC at t. For the input variables that are measured, with a perfect model for 
this set of inputs, the FFC model determines the value of the manipulated variable, in this context 
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,,tIx the insulin infusion rate at t, to offset all these input changes at t. Mathematically, using 
Eqs. 1 and 2 a general FFC law is given as: 
( ) ( ) ( ) 0ˆˆˆ;ˆ;ˆˆ 00
,
=−=+−+=−=− setct
setc
txtxt YyYByBffyy
tI
θXθX
x
                (3) 
Thus, at each time instant, Eq. 3 determines the value of 
tIx , for ( )θX ˆ;txf  to remain at its initial 
value of ( )θX ˆ;0xf , the set point plus its systemic bias. The FFC law is stated via Eq. 3 because
( )θX ˆ;txf  is unrestricted. The common way the FFC law is given in process control textbook is 
for simple block diagrams [8]. However, in this work the block diagram is not simple but a semi-
coupled network. Using a highly nonlinear coupled network in a simulation study of a 
continuous stirred tank reactor (CSTR), the implementation of Eq. 3 as a control algorithm is 
illustrated in this work. 
 Note that ( )θX ˆ;txf  is a function of inputs only which is a necessity to satisfy Eq. 3 for 
FFC. Therefore, models that use outputs, such as k-steps-ahead models, cannot satisfy Eq. 3 for 
FFC. For example, for k-steps-ahead models, Eq. 3 becomes 
( ) ( ) ( ) ( )
( ) ( ) ( ) ( ) 0ˆ;ˆ;ˆ;ˆ;
0ˆ;ˆ;ˆ;ˆ;ˆˆ
*0
*00
,
,
≠−=−⇒
=−−+=−
ϕϕ
ϕϕ
tytyxtx
tyxtytxt
ffff
ffffyy
tI
tI
YYθXθX
YθXYθX
x
x
                     (4) 
where ( )ϕˆ;tyf Y  is the portion of fitted model dependent on the past outputs; tY is a vector of 
measured output variables; ϕˆ is a vector of estimated residual parameters; and t* is the earliest 
time t that model estimates the fitted value. Comparing the FFC law with Eq. 4, it is evident the 
use of outputs overcompensates by ( ) ( )ϕϕ ˆ;ˆ;* tyty ff YY − . Finally, it should be noted in Eq. 3 that 
the systematic bias, B, cancels and thus, does not adversely affect the determination of
tIx , . A 
modification of Eq. 3 for non-constant B will be given later in the article. 
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Subject-specific modeling of BGC involving inputs have been limited to short data 
collection periods [19-22] for model development, mostly one or two disturbances 
(carbohydrates and exercise) [23, 24], and heavy reliance on previously measured BGC [25-28].  
The only multiple-input subject-specific modeling of BGC meeting the requirements of Eq. 3 
known to us is the work of Kotz et al [18] where a Wiener modeling approach was taken. In this 
work the FFC law was given in terms of model parameters as a differential equation. The 
limitation of this equation is that it is only a function of the static and dynamic parameters of the 
inputs which is a limitation of the Wiener structure.  In this work, using a pseudo-variable (i.e., 
unmeasured variable) for blood insulin concentration (BIC) and a semi-coupled network for 
BGC and BIC is developed that leads to a FFC law that depends on static and dynamic input 
parameters, blood insulin and blood glucose dynamic parameters and the level of BGC. Thus, the 
proposed model is theoretically statically and dynamically superior to the Wiener model and 
thus, has the potential to provide a significant improvement in the FFC of BGC. A comparison 
study with the Wiener model on the 15 subjects [18] is given in this work.  
 
Modeling Methodology  
As mentioned above, the proposed semi-coupled modeling approach is an advancement 
over the Wiener modeling method (WMM) [18] in development of a FFC algorithm to address 
static and dynamic behavior better. While the WMM approach can produce feedforward (FF) 
controllers that contain input-specific numerator and denominator dynamics, its structural 
limitations impact its ability to maintain high accuracy over a broad range of BGC, especially at 
the extreme limits. The proposed method also allows for different input dynamics as in the 
Wiener approach but extends the ability to address other types of static and dynamic behavior via 
the use of a semi-coupled network that has an unmeasured pseudo-blood insulin concentration 
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(BIC) variable. The use of this variable allows modeling on the blood insulin directly and the 
inclusion of the interaction of glucose and insulin in the blood. The net result of this novelty is 
the ability to specify a FF controller that not only has input-specific numerator and denominator 
dynamics, but also blood glucose and pseudo-blood insulin dynamics as well as a dependence on 
the BGC level. This section gives a brief review of the WMM and then the proposed extension of 
the coupled network.   
     The Wiener Modeling Method 
In general, Wiener modeling follows a block-oriented model structure formed by a series 
and/or parallel arrangement of nonlinear static and linear dynamic blocks.  A block diagram with 
p inputs and one output is given in Fig. 1. 
 
 
Fig. 1. Block diagram for a general multiple-input, single-output Wiener network.  
 
The inputs, xi for i = 1, …, p, of the Wiener network are the measured noninvasive 
variables or disturbances (i.e., food, activity, and stress) and the output, y, is BGC.  Each input 
has its own linear dynamic block, Gi, and each dynamic block has an intermediate, unobservable 
output, vi, which represents the independent dynamic response of its corresponding input.  All 
the intermediate vi’s are collected and passed through an unrestricted static gain block,  f(V), to 
G1
G2
Gp
f (V)
x1
x2
xp
v2
v1
V y
vp
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produce the final output, y.  The linear dynamic blocks are essentially linear ordinary differential 
equations; a second-order-plus-lead-plus-dead-time (SOPLDT) form is shown in Eq. 5. 
 )(
)(
)(
)(
2
)(
2
2
2 tx
dt
tdx
tv
dt
tdv
dt
tvd
i
i
aii
i
ii
i
i +=++ τζττ  (5) 
where i = 1, . . ., p, p is the total number of inputs, τi is the time constant, ζi is the damping  
coefficient, τai is the lead parameter and θi is the dead time. Using a backward difference 
approximation applied to a sampling interval of Δt, an approximate discrete-time form of Eq. 5 
given below by Eq. 6 [29].:   
 
ttiittiittiittiiti xxvvv ∆∆∆∆ 2,2,,1,2,2,,1,, −−−− +++= ωωδδ                         (6) 
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                                                     (9) 
and 
1,2,1,2, 1 iiii ωδδω −−−=                                                     (10) 
 
to satisfy the constraint of unity gain, and xi,t is the value of the ith input at t. Two additional 
physical constraints are 0>iτ and .,0 ii ∀>ζ  
The substitution of Eqs. 7-10 into Eq. 6 provide an advantage in modeling the 
independent input effects when using free-living outpatient data over the use of the linear form 
of Eq. 6 which would estimate the directly δ’s and ω’s directly [29]. More specifically, for each 
vi,t, the parameters (i.e., δ1,i, δ2,i, ω1,i, ω2,i)  in Eq. 6 are determined from highly non-linear 
functions of the continuous-time dynamic parameters, τai, τi, and ζi, via Eqs. 7-10. After 
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obtaining Eq. 6 for each i, the modeled glucose value is determined by substituting these results 
into the specific static function, f (V), such as a second-order regression form shown below:  
tptppptt
tppttpptt
vvcvvc
vbvbvavaaf
,,1,1,2,12,1
2
,
2
,11,,110)(
−−
+++
+++++==
L
LLVη
                   (11) 
where ai, bi, and ci,j, denote the linear, quadratic and interaction parameters for i = 1, . . ., p-1 and 
j = 2,…, p.  Note that Eq. 11 depends only on inputs as required by Eq. 3. The measurement 
model that corresponds to Eq. 11 is    
 ttty εη +=  (12) 
where yt is the modeled BGC at time instant t, tε is the error term under the assumptions of 
independence, normality and constant variance (i.e., ).),,0(~ 2 tNt ∀σε Under these assumptions 
the WMM estimator for BGC is given as [29]: 
tptppptt
tppttppttt
vvcvvc
vbvbvavaay
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2
,
2
,11,,110
ˆˆˆˆˆˆ
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−−
+++
+++++==
L
LLη
                            (13) 
 
     The Proposed Approach 
While the Wiener network is an excellent choice for the input transfer function model, in 
the response space, it is limited in representing the interaction of insulin and glucose in the 
blood. This drawback limits the ability to develop an accurate fit for insulin infusion rate, which 
is critical to controller performance. However, to model blood insulin and glucose interaction, 
one needs BIC at the sampling rate of BGC (i.e., every five minutes with the glucose sensor used 
in our studies). There is no such sensor in existence currently. To circumvent this need, we 
developed a semi-coupled network for BIC and BGC that was inspired by the compartment 
modeling work of Topps et al. [30] as illustrated by the following two equations for this work: 
                    (14) [ ] )()()()()( 00 tGtIStEtR
dt
tdG
IG +−=
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        (15) 
 
where G is the BGC; I is the blood insulin concentration (BIC); R0 is the net rate of production at 
zero glucose; EG0 is the total glucose effectiveness at zero insulin; SI is the total insulin 
sensitivity; (beta) is the mass of pancreatic beta cells (measured in mg);(alpha)  is a coefficient in 
the Hill function that describes a sigmoid ranging from 0 to 1; and k is the clearance constant 
representing the combined insulin uptake at the liver, kidneys, etc.  
 BIC is not a measured variable in the proposed approached. As a result, the proposed 
approach uses a “pseudo” or “latent” BIC variable that may or may not even be observable in the 
body; hence, the use of the description “pseudo” insulin. This variable is allowing the use of a 
modeling structure that is hypothesized to provide characteristics for BGC that are more 
physiologically correct than a Wiener modeling approach. To our knowledge, this is the first use 
of such a variable in this context of subject-specific clinical modeling of BGC consisting only of 
inputs in free-living data collection. As this work will show, this novel change made a substantial 
advancement in obtaining a better phenomenological model and in providing a dynamic 
relationship between insulin infusion rate, consumed nutrients, and BGC. Our proposed 
Wiener/Semi-Coupled network is shown in Fig. 2.  
As shown in Fig. 2, all of the inputs, xi, pass through a linear dynamic block to produce 
the unobservable dynamic output variables vi as in the WMM. Note that, i = A1, . . ., Ap, for the p 
activity inputs, C for carbohydrates, F for fats, P for proteins, and I for insulin. A dynamic mass 
balance on GFI block in Fig. 2, which represents the BGC due to food and insulin only, gives 
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Fig. 2. Block diagram for the proposed semi-coupled modeling approach. 
  
 
where aC, aF, aP, and aFI, are estimable model parameters; I(t) is the unmeasured BIC at time t; 
and VFI(t) is the BGC due to food and insulin changes only. Similarly, a dynamic mass balance 
on the GBI block, which represents BIC, gives
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tIatva
dt
tdI
BIII −=
                                                        (17) 
 
where aI and aBI, are estimable model parameters. Note the similarities of Eqs. 16 and 17 with 
Eqs. 14 and 15, respectively.  
 The function f(V) is called “the static function.” This function can theoretically be of 
any form. For effectiveness under mild extrapolation, in modeling real BGC data we will use a 
first-order linear regression structure, given in discrete form as: 
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where tε is the error term assumed to be independently normally distributed with mean 0 and 
variance σ2 for all t, and a0 , aAi’s are static estimable model parameters. The modeling approach 
with the network defined by Fig. 2, i.e., the proposed method, will be called the “coupled 
modeling method” (CMM) in this article, although strictly speaking, Fig. 2 is a semi-coupled 
network.  
     Model Identification Procedure 
The use of free-living data presents the challenge of not over-fitting the data to behavior 
that is correlated with the BGC, the response. The common way to address this challenge is to 
use cross-validation, which splits the data into three sets: Training, Validation, and Testing. The 
model parameters are estimated using the Training data, which is usually the largest set. The 
Validation set is used to guard against over-fitting, as the final set of parameters must maximize 
the fit in this set. Since these two sets influence the parameter estimation process, the Testing set 
is used as a final check on model fit, as the data in this set has no influence on the values of the 
estimated parameters (called “process or system identification”). To achieve the best fit possible, 
this work follows the cross validation process of the WMM [18] which seeks to maximize fit in 
the training data set and obtain comparable (i.e., similar) fit in the other two sets. Following the 
cross validation strategy of the WMM [18], this work developed a novel procedure to estimate 
the model parameters in the CMM under the least squares criterion that decomposes the problem 
as follows. First, all the coupled parameters, i.e., the ones in Eqs. 14-15, are estimated under a 
fixed set of dynamic parameters for the nutrient variables obtained from Eq. 6 and Eq. 16 with 
aA1 to aAp set to zero (i.e., without activity variables). Next, the dynamic parameters for each 
activity variable are estimated individually under Eqs. 6 and 16 with VFI set to 0. After obtaining 
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the dynamic parameters for each activity variable, the static model coefficients of Eq. 16 are 
estimated. 
The Studies 
 There are two fundamental contributions of this work towards the goal of the 
development of an effective artificial pancreas. The first one is the semi-coupled modeling 
approach as represented in Fig. 2 with the nonlinear parameterized approach as given by Eqs. 5-
10. The first study in this section will evaluate the proposed approach based on its ability to 
develop an improved FFC model. These models will be developed from data of real people with 
type 1 diabetes. The second study will evaluate the control algorithm based on the FFC law 
given by Eq. 3 to directly implement a highly nonlinear model structure of a complex network 
such as Fig. 2 without using a linear approximation. Since controller data does not exist for this 
control approach, this study will be given using simulated data from a continuous stirred tank 
reactor (CSTR). This study consists of three inputs and will model one measured state variable 
(the controlled variable) and one unmeasured state variable in a coupled network. The fitted 
model is highly nonlinear in time dependent process variables and in the dynamic and static 
model parameters. In this study feedback control (FBC) will be compared with feedback-
feedforward control (FBFFC) to assess the strengths of the proposed control algorithm. 
     Modeling Real Subjects with Type 1 Diabetes 
      The Data Sets 
The data sets for evaluating the coupled modeling method (CMM) of Fig. 2 are taken 
from Kotz et al. [18], where the WMM was evaluated on 15 data sets consisting of two weeks of 
data each. (Note that for Subjects 1−6, and 11, detailed food logs were kept on the actual food 
consumed and for Subjects 7−10 only meal size (small, medium and large) was logged.) In this 
126 
 
section, the CMM will be compared directly with the WMM [18]. Given that the modeling 
objective is the determination of the insulin infusion rate to offset changes in measured input 
variables on BGC, i.e., the development of FFC models, a model is useful when it achieves this 
objective to any significant degree. Thus, in this context model usefulness is not determined by 
prediction accuracy but by the ability of the model to explain output behavior strictly from 
measured input changes. The effectiveness of a FF controller for any modeled disturbance will 
depend on the accuracy of its causative modeled relationship on BGC and its contribution to the 
variability of BGC for the given subject. Therefore, for a given set of inputs: 1. their combined 
contribution to the variability of BGC is at a particular level; 2. this level represents the limit of 
the FF controller on the reduction of variability for the subject modeled, and; 3. the actual or 
effective reduction of variability will depend on how well the model has obtain the causative 
input relationships on BGC. Given the consistency between the Training, Validation, and Testing 
results of the WMM on these 15 data sets, it appears that the fitted models in this work captured 
quite adequately the variability of BGC for the set of inputs modeled. Thus, the CMM is not 
expected to significantly improve the fit over the WMM and the similar fit is an indication that it 
was also able to capture quite adequately the amount of variation in BGC due to set of modeled 
inputs. 
 
       Performance Statistic 
A FF controller will be useful when it can significantly reduce the variation of BGC. A 
FF controller will be useful when it is able to effectively manipulate insulin infusion rate to 
compensate for the variables that are in its input set. Since its effectiveness is based on its ability 
to model the relationship of the measured inputs on BGC and model bias can be neutralized, the 
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premier performance statistic is the correlation between the fitted input-only model and the 
measured BGC, rfit. This work also reports AD, the average of the difference between the fitted 
and measured BGC and AAD, the average of the absolute difference between the fitted and 
measured BGC. It is recognized that correlation does not imply causation. The only way to truly 
evaluate model accuracy under causation is to independently manipulate the inputs and 
determine the fit of the model. This is not possible using free living data which is inherently 
cross correlated. However, after presenting the rfit results for this study, we will interrogate the 
modeling approaches for physical soundness and potential for success in FFC applications.  
            Inputs 
The 13 variable input set is given in Table 1 and consists of three (3) food nutrients, 
seven (7) activity variables including one to measure stress, 24-hour clock time for circadian 
rhythm, and two (2) for insulin infusion. Modeling 13 inputs is quite a large set in this context 
and we know of no work beyond these data sets that has modeled nearly this many variables in 
clinical data collection. Note that for any particular case, the final form of the reduced model is 
irrelevant to our objective since we have no use for the fitted models beyond determining their rfit 
values in this study.  
The activity variables were collected using the SenseWear® Pro3 Body Monitoring 
System (BodyMedia Inc., Pittsburgh, Pennsylvania) shown in Fig. 3, which is worn on the 
triceps of the subject’s arm. The SenseWear® armband utilizes pattern detection algorithms [31, 
32] that employ physiologic signals from a unique combination of sensors to generate values for 
twenty activity variables. The armband collects data using a two-axis accelerometer and four 
sensors that are used to determine heat flux, skin temperature, near body temperature, and 
galvanic skin response (GSR).  The two-axis accelerometer provides information about body 
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position and tracks upper arm movement.  The heat flux sensor calculates the amount of heat 
being dissipated from the body by measuring the amount of heat lost along a thermally-
conductive path between the skin and a vent on the side of the armband.  Skin temperature and 
near-body temperature are measured by sensitive thermistors, and GSR is measured via the 
conductivity of the subject’s skin as it varies due to physical and emotional stimuli [32].  The 
SenseWear® armband samples at a rate of once per minute, however, measurements at five 
minute intervals are used to match the sampling rate of the Medtronic continuous glucose 
monitor system (CGMS). 
Results 
 Modeling results for the WMM and the CMM are given in Tables 2-7 for the 15 subject-
specific models. Results are given for three different sets of data. The “Training” data set is used 
to estimate model parameters. The “Validation” data set is used to stop the convergence process 
of the estimation procedure on the Training data and to guard against over-fitting the model. The 
goal is to stop the estimation process when the highest rfit is obtained on the Validation data 
given that its value was close to the Training value. The “Testing” data set represents data not 
used in any way to influence the fitting of the model.  
 
 
Fig. 3. BodyMedia, Inc. SenseWear® Pro3 Body Monitoring System 
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     Table 1. Input variables. 
 
The data collection was done in two parts. Part 1 consisted of Subjects 1-11 and was done 
in the first year of the study and run by an experienced graduate student. The data collection was 
not completed in the first year because we were not able to fully recruit all the needed subjects. 
This student graduated and new, inexperienced students were used the second year in Part 2 for 
Subjects 12-15.  
 Our performance goal for the CMM was an rfit similar to or better than the WMM. This 
goal was reached as shown by the results in Tables 2-7. In addition, our modeling procedure 
guarded well against over-fitting as rfit values for Training and Validation are very similar. Table 
2 contains results for Part 1 using all the inputs with one week of training and one week of 
validation. Table 3 represents the same conditions as Table 2 except for excluding the armband 
inputs. As one can see, the armband appears to contribute significantly in improving the fit; from 
an average rfit of 0.54 to 0.64 for the CMM. Tables 4 and 5 are for Subjects 1-11 with one week 
for Training, 4 days for Validation and 3 days for Testing. The averaged rfit values vary only 
slightly for the three data sets in both tables and for the WMM and the CMM. Again, the 
Food   Activity   Circadian Rhythm  Insulin 
 
1. Carbohydrates  4. Transverse accel – peaks  11. Time of Day (TOD) 12. Bolus 
2. Fats 5. Heat flux – average     13. Basal 
3. Proteins 6. Longitudinal accel – average 
 7.    Near Body Temperature 
 8. Transverse Accel – MAD 
 9. GSR – average 
 10. Energy Expenditure 
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armband appears to significantly help as the averaged rfit for the Testing data sets go from 0.53 to 
0.61. The results for Part 2, i.e., Subjects 11-15, are very similar to the ones in Part 1. The only 
observation worth mentioning is that for the CMM, the armband did not help quite as much with 
rfit, going from an average value of 0.60 to 0.64. However, there is less confidence in this size of 
improvement due to the significantly smaller number of cases.  
 From the form of Eq. 13, its fundamental limitation is revealed as an inadequate structure 
in determining a dynamic food to insulin infusion relationship to achieve a target value of BGC. 
This limitation is due to the separate additive nature of Eq. 13 for food consumption and insulin 
infusion. While its use can be effective in estimating BGC under a particular correlation 
relationship among all the inputs, it is not capable of providing a food consumption/insulin 
infusion coupling relationship for BGC. A simple test of inadequacy is to set all food inputs to 
zero with non-zero insulin infusion and vice versa. With all food inputs set to zero (under an 
assumption that BGC only changes for food consumption) tyˆ should drop to zero over time. And 
with insulin infusion set to zero, tyˆ should continue to increase over time. Figure 4 illustrates this 
inadequacy on one of the fitted cases, Subject 11. The top plot gives the fit with all the variables 
included. As shown, the fit is quite good given that it was produced using only input variables.  
The bottom left plot shows what happens when all the food coefficients in Eq. 13 are set to zero. 
As shown, its discrepancy with the measured BGC increases, but it is stable and not decreasing 
as it should be doing. Similarly, the bottom right plot shows what happens when the insulin 
coefficient in Eq. 13 is set to zero. As before, its discrepancy increases, but its level is stable and 
not increasing as it should be doing. Thus, while the WMM is capable of providing accuracy for 
fitting BGC, its structure is not adequate to give a correct physiological coupled relationship 
between food intake and insulin infusion on BGC. 
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 Results to evaluate the CMM for inadequacy are shown in Fig. 5 for Subject 11. The top 
plot gives the fit with all the variables included. As shown, the fit is quite good and similar to the 
WMM shown in Fig. 4. The bottom left plot in Fig. 5 shows what happens when all the food 
coefficients in Eq. 10 are set to zero. As shown, the fitted BGC drops steadily towards zero as it 
should. The response is oscillatory and does not drop to a fixed value of zero because, as seen by 
Eq. 18, the activity variables have a Wiener-type structure and are thus, additive with respect to 
VFI and also contribute to BGC. Similarly, the bottom right plot shows what happens when the 
insulin infusion coefficient in Eq. 15 is set to zero. Here, as it should be, BGC rises steadily over 
time. Thus, not only can the CMM provide a good fit, but it also overcomes the WMM 
deficiencies in regards to zero insulin and zero food intake scenarios.  Another critical advantage 
of the CMM worth noting is the use of BIC even though this output variable is unmeasured, 
which is another novel improvement.   
While it is only possible to truly evaluate the cause-and-effect ability of our fitted models 
under real FFC for the subject modeled, we found, however, a way to evaluate the soundness of 
our CCM in its ability to provide realistic insulin infusion rates. We did this by obtaining the 
steady state relationships between carbohydrates (xC), BGC ( )GVy FI == , and insulin infusion 
rates (xI) (see Fig. 2) as follows. Note that in practice this experiment could not be done as it 
would not be practical or safe, but having a model allows this virtual evaluation. Using a 
backwards difference finite derivative, in discrete form, Eq. 16 becomes 
tFItFItPPtFFtCC
ttFItFI
VIavavava
t
VV
,,,,
,,
−++=
∆
− ∆−
                                (19) 
and solving for VFI,t gives 
( )
tIa
Vtvavava
V
tFI
ttFItPPtFFtCC
tFI ∆+
+∆++
=
∆−
1
,,,,
,
                                       (20) 
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Setting a0 = aF = aP = aA1 = …= aAp = 0, Eq. 20 becomes 
tIa
Gtva
VG
tFI
tttCC
tFIt ∆+
+∆
==
∆−
1
,
,
                                                  (21) 
 
 
 
 
Table 2. WMM and CMM Part 1 Study results with all the inputs under one week of training 
and one week of validation. The units for AD and AAD are mg/dL. 
 
 
 
 
Training
AD AAD r fit AD AAD r fit
1 WMM 14.0 0.0 44.8 0.61 20.4 50.5 0.68
2 WMM 13.0 0.0 72.1 0.49 -18.0 68.5 0.51
3 WMM 13.9 0.0 48.0 0.68 -0.1 49.3 0.66
4 WMM 10.7 0.0 31.6 0.53 33.4 48.4 0.55
5 WMM 14.0 0.0 62.6 0.56 15.1 73.6 0.55
6 WMM 13.9 0.0 50.1 0.67 24.9 45.6 0.68
7 WMM 14.0 0.0 46.7 0.69 37.1 56.5 0.64
8 WMM 14.0 0.0 32.7 0.45 10.8 43.2 0.43
9 WMM 13.9 0.0 51.8 0.63 -35.2 64.2 0.56
10 WMM 16.8 0.0 47.4 0.57 14.0 46.8 0.73
11 WMM 15.1 0.0 33.7 0.72 -24.3 47.2 0.79
1 CMM 14.0 1.1 43.5 0.65 32.2 57.4 0.64
2 CMM 13.0 -0.4 57.8 0.73 -44.6 66.4 0.71
3 CMM 13.9 -0.1 51.7 0.62 -40.6 58.8 0.62
4 CMM 10.7 -0.1 29.9 0.62 59.8 63.8 0.56
5 CMM 14.0 0.3 63.3 0.60 24.7 70.8 0.58
6 CMM 13.9 -0.5 49.9 0.67 31.7 49.0 0.67
7 CMM 14.0 0.3 44.8 0.71 -53.8 69.5 0.63
8 CMM 14.0 0.9 32.8 0.42 12.6 43.3 0.48
9 CMM 13.9 6.3 54.3 0.60 -9.2 52.5 0.59
10 CMM 16.8 0.0 43.5 0.68 15.9 48.3 0.68
11 CMM 15.1 0.2 29.8 0.82 -37.1 60.4 0.85
CMM
13.9
13.9 0.64
0.60 21.2 54.0 0.62
0.9 45.4 0.65 32.9 58.2
Validation
0.0 47.4
Subject Method
Avg of Absolute Value WMM
Days
Avg of Absolute Value
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Table 3. WMM and CMM Part 1 Study results without armband inputs under one week of 
training and one week of validation. The units for AD and AAD are mg/dL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AD AAD r fit AD AAD r fit
1 WMM 14.0 0.0 49.2 0.52 26.9 56.8 0.57
2 WMM 13.0 0.0 65.4 0.58 -13.1 64.4 0.56
3 WMM 13.9 0.0 61.0 0.46 18.2 56.6 0.42
4 WMM 10.7 0.0 32.2 0.48 32.6 32.6 0.49
5 WMM 14.0 0.0 66.1 0.50 11.3 81.7 0.44
6 WMM 13.9 0.0 62.8 0.39 13.9 50.8 0.35
7 WMM 14.0 0.0 58.3 0.52 21.3 51.5 0.57
8 WMM 14.0 0.0 35.8 0.25 15.1 46.6 0.34
9 WMM 13.9 0.0 59.3 0.52 -21.8 64.4 0.43
10 WMM 16.8 0.0 48.8 0.55 13.3 49.8 0.67
11 WMM 15.1 0.0 33.5 0.70 -23.5 48.3 0.77
1 CMM 14.0 4.0 49.4 0.55 26.8 66.4 0.51
2 CMM 13.0 13.8 60.2 0.68 -31.6 64.1 0.66
3 CMM 13.9 1.5 60.3 0.44 -5.0 55.9 0.41
4 CMM 10.7 -2.3 31.5 0.58 65.9 68.7 0.52
5 CMM 14.0 0.2 68.4 0.50 0.1 75.9 0.53
6 CMM 13.9 -0.1 58.9 0.51 20.9 49.3 0.51
7 CMM 14.0 3.8 54.2 0.59 -53.2 69.4 0.58
8 CMM 14.0 -0.1 34.9 0.35 14.5 46.3 0.30
9 CMM 13.9 1.1 62.7 0.50 -53.4 78.0 0.48
10 CMM 16.8 0.0 45.0 0.65 23.6 52.2 0.64
11 CMM 15.1 1.1 29.7 0.81 -30.4 58.2 0.81
Subject Method Days
Training Validation
52.0 0.51
Avg of Absolute Value CMM 2.6 50.5 0.56 29.6 62.2 0.54
0.50 19.2 54.9Avg of Absolute Value WMM 0.013.9
13.9
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Table 4. WMM and CMM Part 1 Study results with all the inputs under one week of training, 
four days of validation, and 3 days of testing. The units for AD and AAD are mg/dL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AD AAD r fit AD AAD r fit AD AAD r fit
1 WMM 14.0 0.0 45.0 0.60 20.1 52.9 0.66 16.7 46.9 0.66
2 WMM 13.0 0.0 67.2 0.57 -33.3 62.6 0.67 2.9 64.8 0.54
3 WMM 13.9 0.0 50.9 0.64 -12.9 60.7 0.53 -21.3 53.0 0.68
4 WMM 10.7 0.0 31.9 0.53 31.1 52.5 0.52 35.4 40.5 0.57
5 WMM 14.0 0.0 63.3 0.55 31.4 87.3 0.54 -15.0 55.9 0.67
6 WMM 13.9 0.0 52.8 0.65 37.9 59.8 0.60 -0.1 34.0 0.60
7 WMM 14.0 0.0 56.4 0.56 25.6 52.6 0.58 -1.7 58.7 0.56
8 WMM 14.0 0.0 36.5 0.21 26.7 46.1 0.28 -0.1 48.7 0.30
9 WMM 13.9 0.0 53.2 0.61 -19.4 51.8 0.65 -54.9 75.8 0.55
10 WMM 16.8 0.0 44.9 0.62 15.0 43.6 0.68 0.8 50.9 0.70
11 WMM 15.1 0.0 30.4 0.79 -22.3 41.8 0.81 -25.3 60.8 0.63
1 CMM 14.0 18.2 45.9 0.71 35.7 45.9 0.78 51.5 64.8 0.71
2 CMM 13.0 2.3 57.7 0.73 -51.9 65.8 0.74 -28.8 58.4 0.70
3 CMM 13.9 -4.9 52.0 0.63 -29.8 66.8 0.54 5.0 51.9 0.51
4 CMM 10.7 0.7 30.2 0.62 58.3 64.6 0.52 64.6 65.3 0.47
5 CMM 14.0 1.0 51.9 0.71 19.7 74.3 0.60 -54.8 76.8 0.61
6 CMM 13.9 0.8 58.0 0.53 -9.8 56.5 0.61 -11.3 37.4 0.55
7 CMM 14.0 0.6 47.4 0.68 -24.5 54.8 0.58 -75.4 82.6 0.76
8 CMM 14.0 0.4 33.3 0.44 15.2 41.0 0.46 -17.6 47.9 0.56
9 CMM 13.9 3.4 55.3 0.61 -15.0 59.2 0.53 -80.8 99.1 0.49
10 CMM 16.8 0.4 45.2 0.63 21.1 42.3 0.75 21.1 52.4 0.65
11 CMM 15.1 -0.1 30.9 0.79 -70.2 73.4 0.83 -100.1 108.6 0.63
Subject Method Days
15.8 53.6 0.59
Avg of Absolute Value CMM 13.9 3.0 46.2 0.64 31.9 58.6 0.63 46.5 67.7 0.61
Avg of Absolute Value WMM 13.9 0.0 48.4 0.58 25.1 55.6 0.59
7 Day Training 4 Day Validation 3 Day Testing
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Table 5. WMM and CMM Part 1 Study results without the armband inputs under one week of 
training, four days of validation, and 3 days of testing. The units for AD and AAD are mg/dL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AD AAD r fit AD AAD r fit AD AAD r fit
1 WMM 14.0 0.0 49.2 0.52 22.1 56.5 0.56 31.5 57.1 0.58
2 WMM 13.0 0.0 68.0 0.56 -28.2 65.1 0.55 6.5 71.7 0.48
3 WMM 13.9 0.0 60.6 0.47 13.3 51.7 0.47 25.1 64.2 0.36
4 WMM 10.7 0.0 32.1 0.49 31.7 52.4 0.49 34.2 40.6 0.52
5 WMM 14.0 0.0 66.0 0.49 27.3 92.5 0.48 -12.4 65.3 0.45
6 WMM 13.9 0.0 63.5 0.38 23.7 62.8 0.27 -3.4 37.1 0.52
7 WMM 14.0 0.0 60.7 0.47 22.6 47.8 0.60 -2.9 55.1 0.54
8 WMM 14.0 0.0 35.8 0.25 26.6 45.6 0.33 -0.1 47.7 0.35
9 WMM 13.9 0.0 63.8 0.44 -6.0 62.6 0.47 -44.1 69.0 0.49
10 WMM 16.8 0.0 48.3 0.56 15.2 42.7 0.70 11.8 54.1 0.67
11 WMM 15.1 0.0 31.5 0.77 -20.6 38.7 0.83 -14.5 59.0 0.58
1 CMM 14.0 37.5 65.2 0.63 53.4 78.8 0.54 83.8 105.3 0.64
2 CMM 13.0 -3.6 65.7 0.69 -70.6 88.4 0.65 -48.1 70.2 0.70
3 CMM 13.9 0.9 60.3 0.44 -8.9 53.4 0.53 0.0 59.7 0.18
4 CMM 10.7 0.7 30.2 0.62 58.3 64.6 0.52 64.6 65.3 0.47
5 CMM 14.0 0.4 63.3 0.57 6.5 87.8 0.39 -85.3 97.9 0.49
6 CMM 13.9 0.8 58.0 0.53 -9.8 56.5 0.61 -11.3 37.4 0.55
7 CMM 14.0 -0.1 55.5 0.57 -16.6 49.9 0.54 -69.9 77.7 0.75
8 CMM 14.0 -1.2 35.9 0.36 17.1 42.4 0.36 -13.9 51.6 0.35
9 CMM 13.9 -0.1 61.5 0.45 -21.5 63.9 0.46 -103.7 118.9 0.47
10 CMM 16.8 0.7 47.4 0.60 20.5 42.6 0.75 27.4 58.1 0.60
11 CMM 15.1 0.1 32.1 0.73 -46.6 53.8 0.80 -1.0 56.4 0.58
0.50
3 Day Testing
Subject Method Days
7 Day Training 4 Day Validation
Avg of Absolute Value WMM 13.9
Avg of Absolute Value CMM 52.3 0.56
0.0 56.4
0.56 46.3 72.6 0.534.2 30.0 62.013.9
52.7 0.49 21.6 56.2 0.52 17.0
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Table 6. WMM and CMM Part 2 Study results with all the inputs under one week of training 
and one week of validation. The units for AD and AAD are mg/dL. 
 
 
 
 
 
Table 7. WMM and CMM Part 2 Study results without armband inputs under one week of 
training and one week of validation. The units for AD and AAD are mg/dL. 
 
 
 
 
 
 
 
 
 
 
Training
AD AAD r fit AD AAD r fit
12 WMM 8.9 0.0 56.3 0.63 -33.0 83.0 0.72
13 WMM 8.2 0.3 55.4 0.54 52.5 76.9 0.58
14 WMM 7.9 -0.1 48.2 0.56 -30.1 48.6 0.61
15 WMM 13.6 0.0 23.1 0.56 20.7 45.2 0.56
12 CMM 8.9 1.3 55.6 0.66 -39.8 72.8 0.76
13 CMM 8.2 0.0 49.4 0.67 48.5 74.3 0.61
14 CMM 7.9 -0.2 45.3 0.60 -5.4 41.9 0.61
15 CMM 13.6 2.3 23.4 0.56 21.2 46.0 0.57
Avg of Absolute Value CMM 9.7 0.9 43.4 0.62 28.7 58.7 0.64
Subject Method Days
Validation
Avg of Absolute Value WMM 9.7 0.1 45.8 0.57 34.1 63.4 0.62
Training
AD AAD r fit AD AAD r fit
12 WMM 8.9 0.2 58.4 0.61 -37.6 87.7 0.61
13 WMM 8.2 0.0 61.5 0.40 54.9 82.0 0.45
14 WMM 7.9 -0.1 48.2 0.56 -30.1 48.6 0.61
15 WMM 13.6 0.0 25.2 0.50 26.4 45.5 0.50
12 CMM 8.9 0.0 56.9 0.65 -52.5 81.4 0.71
13 CMM 8.2 0.0 59.0 0.47 68.0 87.5 0.56
14 CMM 7.9 -0.2 45.3 0.60 -5.4 41.9 0.61
15 CMM 13.6 -2.6 24.6 0.54 10.9 45.8 0.50
Avg of Absolute Value CMM 9.7 0.7 46.4 0.57 34.2 64.1 0.60
Subject Method Days
Validation
Avg of Absolute Value WMM 9.7 0.1 48.3 0.52 37.3 66.0 0.54
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Fig. 4. Representative WMM fitted response plots for Subject 11 with one week of training and 
one week of validation. The graph on the top has all the inputs. The graph on the bottom left has 
no food consumption. The graph on the bottom right has no insulin infusion. 
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Fig. 5. Representative CMM fitted response plots for Subject 11 with one week of training and 
one week of validation. The graph on the top has all the inputs. The graph on the bottom left has 
no food consumption. The graph on the bottom right has no insulin infusion. 
 
  
Again by using a backwards difference finite derivative, in discrete form, Eq. 17 becomes 
ta
Itva
I
BI
tttII
t ∆+
+∆
=
∆−
1
,
                                                         (22) 
At steady state, VC,t = XC,t = XC, VI,t = XI,t = XI, Gt = Gt-t = . . . = ,G  and It = It-t = . . . = I , and 
Eq. 22 becomes 
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ta
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II
∆+
+∆
=
1
                                                          (23) 
and then from simplifying Eq. 23, 
I
BI
I x
a
a
I =                                                              (24) 
Similarly, at steady state, Eq. 21 becomes 
tIa
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G
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+∆
=
1
                                                     (25) 
Solving for Gand substituting in Eq. 24, Eq. 25 becomes 
IIFI
CBIC
FI
CC
FI
CC
xaa
xaa
Ia
xa
tIa
txa
G ==
∆
∆
=                                        (26) 
Now from Eq. 26  
C
FII
BIC
I x
Gaa
aa
x =                                                         (27) 
 Soundness can be seen from a close examination of Eq. 27. First, xI is correctly 
proportional to xC. Secondly, xI is correctly inversely proportional to .G  Since this effect cannot 
be demonstrated using real people, this relationship may not be immediately intuitive; but it 
implies that for a constant consumption rate of carbohydrates, the insulin infusion rate to 
maintain a constant BGC level (i.e., G), decreases as G increases. For example, a higher 
infusion rate is needed to maintain a BGC level of 100 mg/dL than to maintain a level of 300 
mg/dL. This makes intuitive sense because additional insulin is needed to drop the level from 
300 to 100 mg/dL. By substituting the estimated coefficients for a subject into Eq. 27, an 
evaluation of this subject can be made on the basis of the “realistic” results. This was done for 
Subject 11 and the results are plotted in Fig. 6. As shown, at xC = 60 gm, xI ranges from 2.4 units 
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to 7.3 units of insulin for Gequal to 300 mg/dL to 100 mg/dL, respectively. These values are 
very practical and thus, Eq. 27 produces values that are quite realistic for this subject. Note that 
when the model is actually implemented in a real control setting, the dynamic form will be 
manipulating insulin levels for some target value of BGC and thus, this ratio will vary 
dynamically based on a number of conditions at each time instant and be specific to the subject’s 
personal model. The analysis presented is a very practical check on the soundness of a modeling 
approach and, perhaps equally as important, on the soundness of a specific subject’s model. 
Thus, an important contribution of this work is this practical evaluation and we recommend it for 
evaluation of FFC models.  
If the modeling bias is not constant, i.e., B = Bt, which is likely the case, then Eq. 3 
becomes 
( ) ( )( ) ( ) ( ) 0ˆ;ˆ;ˆ;ˆ; 0000
,,
=−+−=−−− tx
x
txxt
x
tx BBffBfBf
tItI
θXθXθXθX          (28) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. The steady state relationship in the CMM for insulin infusion (xI) and food consumption 
(xC) at constant BGC (G).  
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If the model is causative for the inputs on BGC, for any subject, one can evaluate the 
impact of that particular FFC model to reduce variability from a target BGC upon its 
implementation into FFC. This will be illustrated for Subject 11 and its fit given in Table 4 using 
all the data. As shown by AAD, model bias varies considerably between the data sets. The initial 
time, t = 0, was selected the first night when the measured glucose was fairly stable and the 
subject was resting. At the selected time, y0 = Yset = 140 mg/dL. Thus, ,140ˆˆ 00 −= yB  where “^” 
is used to represent estimate. For Bt a very simple algorithm was used to estimate its value. More 
specifically, .ˆˆ ttttt yyB ∆∆ −− −=  With tFFCy , and tNACy , as the observed BGC with FFC and the 
observed BBC with no automatic control, respectively, then 
)ˆ()ˆ()ˆˆ(
ˆˆ)ˆˆ(
,0,00,
00,,
ttNACttNACttNAC
tttNACtFFC
yyyyyyy
BByyyy
∆∆ −− −−−+−−=
−+−−=
                 (29) 
Note that )ˆˆ( 0yyt − is the amount that the model “compensates” by insulin infusion when the 
bias is constant (see Eq. 3). The results of applying Eq. 29 to Subject 11 are shown in Fig. 7 for 
the full two weeks of data. The plot on the left is
tNACy ,  and the one on the right is .,tFFCy  As 
shown, the variability is substantially reduced, with the standard deviations of
tNACy , ( )NACσ  and 
tFFCy , ( )FFCσ  equal to 73.9 mg/dL and 8.7 mg/dL, respectively, that is a decrease of 88.3%. 
Thus, this level of the fitted model has the potential to greatly tighten BGC in an automatic FFC 
system. Also note how stable the response is in maintaining variation about the target of Yset = 
140 mg/dL. This stability supports the adaptive effectiveness of the algorithm to estimate model 
bias at each time instant over long periods of time.  
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     Simulation Study of the Control Law 
 The Process 
The process to for this part is a mathematical model for a CSTR from Smith and Corripio 
[34] and shown in Fig. 8. A dynamic model of the process was developed using first principles 
on the mass, species and energy balances of the process for the generating artificial data. 
Conditions included the following: constant densities and heat capacities of the tank and jacket 
contents; constant volumes in the tank and jacket; perfect mixing in the tank; negligible thermal 
capacitance of the tank wall and jacket wall; for this liquid system constant volume heat 
capacities (cv, cvc) and constant pressure heat capacities at (cp, cpc) are approximately equal and 
constant for both the reactor and jacket contents, respectively; and the energy due to flow 
streams is adequately described by the enthalpy. A list of variables and initial values are given in 
Table 8.  
 
 
Fig. 7. The potential reduction in BGC variability from use of the proposed approach. The plot 
of the left represents the two weeks of BGC data for Subject 11 and plots
tNACy , versus time in 
this analysis. The plot on the right is
tFFCy , versus time in this analysis for the fitted model in 
Table 4 for Subject 11.   
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The Coupled Network 
 
For this study, this process has two loads (F and CAi), three state variables (T, Tj, and CA), 
where T, the controlled variable, is measured, Tj is not measured but estimated (i.e., identified), 
and CA is not measured or estimated. We chose to identify Tj in the model as it is coupled with T 
and is directly affected by the manipulated variable just as BIC directly affects BGC and is 
directly affected by the manipulated variable in this process, i.e., M. The coupled network for 
this system that we developed to model this process is given in Fig. 9. Note that, since this 
network is coupled, it is more complex that the semi-coupled network of Fig. 2.  
 
 
Fig. 8. A flow diagram for the CSTR process. 
 
The CSTR process is described mathematically by Eqs. 30-34 below:   
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Table 8. Definition of variables and initial steady-state values for the CSTR process. 
Variable Definition SS value (units) 
A Heat transfer area 5.40 (m2) 
α Control valve rangeability parameter 50 (none) 
CA Concentration of species A in reactor 1.0302 (kgmol/m3) 
CAi Concentration of species A in inlet stream 2.88 (kgmol/m3) 
cp Heat capacity of feed and product streams 1.815x105 (J/kgmol-°C) 
cpc Heat capacity of coolant 4184 (J/kg-°C) 
∆HR Heat of reaction -9.86x107 (J/kgmol) 
E Activation energy 1.182x107 (J/kgmol) 
F Feed flow rate 0.45 (m3/s) 
FC Coolant flow rate 0.44 (m3/s) 
FCmax Maximum flow rate of coolant through control valve 1.2 (m3/s) 
K Reaction rate constant 0.09 (m3/s-kgmol) 
ko Arrhenius frequency parameter 0.0744 (m3/s-kgmol) 
M Input signal to the valve  0.26 (none) 
R Gas law constant 8314.39 (J/kgmol-K) 
ρ Density of reactor contents 19.2 (kgmol/m3) 
ρc Density of coolant 1000 (kg/m3) 
Tc Coolant temperature in the jacket 50.48 (°C) 
TCi Coolant inlet temperature 27 (°C) 
T Reactor temperature 88 (°C) 
Tm Measured reactor temperature 88 (°C) 
U Overall heat transfer coefficient 2.13x105 (J/s-m2-°C) 
VC Cooling jacket volume 1.82 (m3) 
V CSTR volume 7.08 (m3) 
From Fig. 9, we get: 
( ) tCAiCAitFFtTjTjtt vavavafT ,,,,11 ++== V                                       (35) 
( ) tTTtMMtt vavafTj ,,,22 +== V                                                (36) 
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 The Fitted Model 
For the three inputs, M, F and CAi, the training data were generated using sequential step 
tests from a Box-Behnken design with one center point. This gave a total of 13 sequential step 
tests (100 seconds each). This input sequence is shown in Fig. 10, along the measured response 
of reactor temperature. Measurement noise was added to the true reactor temperature, T, 
according to Eq. 12 with 20.0=σ oC, which is quite substantial as revealed in Fig. 10.   
 
Fig. 9. Block diagram of the coupled network of the model for CSTR. 
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Fig. 10. The input training sequences plotted on the left and the fitted and measured tank 
temperature responses plotted on the right.  
 
 During the fitting process, the dynamics of the T and Tj were found to be negligible 
allowing the fitted equations of Eqs. 35 and 36 to be expressed as 
tCAiCAitFFtTjt vavajTaT ,, ˆˆˆˆ
ˆˆˆ ++=                                             (37) 
ttTtMMt TbvbjT ∆−+= ˆ
ˆˆˆˆ
,                                                     (38) 
Extending Eq. 37 to a second order regression structure to address the nonlinear static 
behavior of this process and from substitution of Eq. 38 into Eq. 37 gives: 
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              (39) 
Second order dynamics, based on Eq. 5, was modeled for the transfer functions for F and CAi, 
and M was modeled using first order dynamics leading to the discrete-time derivation of 
tMv ,ˆ as 
shown below: 
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To fit Eq. 39 the dynamic parameters (using Eqs. 5-10 and 40) and the static parameters (using 
Eq. 39) were estimated simultaneously using the method of nonlinear regression [33]. The fitted 
correlation coefficient for mT  and Tˆ (i.e., rfit) is 0.999. This excellent fit is also shown in Fig. 10. 
 Cross validation is unnecessary in this simulation study because there were no 
unmeasured disturbances and a statistical experimental design was used insuring causative 
modeling of the inputs (due to their orthogonality) on the output behavior. Nonetheless, a 
different test sequence was generated to evaluate the fit of the model to verify its testing ability. 
This sequence along with the fitted response plot is shown in Fig. 11.  As expected, the fit is 
excellent. The estimated values of the model parameters are given in Table 9. 
 
Table 9.  Fitted parameters for Coupled CSTR model.   
Parameter  Estimate Parameter  Estimate 
a0 -0.008 aCAiCAi 0.164 
aF 2.009 bM 3.815 
aTj 0.654 bT 1.406 
aCAi 1.347 τF 6.996 
aMF -2.440 ζF 1.022 
aMCAi 0.639 τaF -3.907 
aFCAi 0.957 τCAi 6.004 
aMM 2.171 ζCAi 1.363 
aFF -4.868 τM 13.339 
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Fig. 11. The input testing sequences plotted on the left and the fitted and measured tank 
temperature responses plotted on the right.  
 
 The temperature of the jacket contents, Tj, is not measured and used in the model and 
thus, the model is not fitting Tj. However, one of the purposes of this simulation study was to 
determine the importance of accurate predictions for the unmeasured state variable on the 
accuracy of the modeled stated variable that is measured. For the training and testing sets, the 
model predictions and the true values of Tj are shown in Fig. 12. As shown, the predictions are 
not close to the true values quite often, especially for the training data. However, given the high 
degree of fit of the measured variable as shown in Figs. 10 and 11, the poor predictions of jacket 
temperature are not translating into poor fit of tank temperature. In relating this to the proposed 
BGC model, this suggests that for whatever the pseudo-BIC is physically representing, its 
accuracy can be poor and the fit of BGC can still be quite acceptable.  Moreover, pseudo-BIC is 
playing a role to provide a structure and its accurate determination does not appear to be crucial. 
 The Feedback Controller (FBC) 
 
A typical proportional-integral (PI) controller was implemented to control the reactor 
temperature. The manipulated variable chosen to maintain the reactor temperature is the coolant 
flow rate through the jacket of the CSTR vessel and is varied by changing the controller signal 
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sent to the valve, i.e., M. It was tuned to give the best possible response to the sequence of the 
two load changes in Fig. 11.  For this controller Kc = 1.40,τI = 11.0 and M = Mfb, where Mfb is the 
signal from the PI controller to the valve. The response of the PI controller is shown in Fig. 13. 
 
 
Fig. 12. The true and predicted responses of Tj for the training data (left graph) and the testing 
data (right graph).  
 
 
Fig. 13. Controller results; The FB controller response is on the left and the FBFF controller 
response is on the right. The addition of FF control of the proposed approach reduced the 
standard deviation of the controlled variable from set point by nearly 75%.  
 
 
      The FBFF Controller 
The coupled model was implemented into the FBFF controller in conjunction with the FB 
PI controller. Since Tˆ is a quadratic function as shown by Eq. 39, by application of the FFC law 
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given by Eq. 3, the roots were found at each time t using the quadratic equation. The correct root 
at each time instant was 
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Therefore, for this FBFF controller, M = Mfb + Mff. The response of the FBFF controller to the 
same input sequence as the FB controller is also given in Fig. 13. As shown, the addition of this 
FFC system greatly reduced the deviations of the controlled variable, Tm, from its set point 
temperature of 88 oC. For the FB and FBFF controllers, the standard deviations of Tm from its set 
point were 0.509 oC and 0.128 oC, respectively, or a reduction of 74.9%. Thus, the proposed 
coupled model FFC approach appears to be very promising.  
 
 
Concluding Remarks 
 This work proposed a modeling methodology that extends the WMM [18] approach for 
multiple-input modeling of BGC in free-living, subject-specific, outpatient data collection. The 
performance objective of each model is to obtain the best cause-and-effect fit possible from the 
given set of inputs since they are being obtained for FFC. To meet this objective, a semi-coupled 
modeling network was developed that uses an unmeasured pseudo-blood insulin concentration 
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(i.e., latent) variable to allow the inclusion of the product BGC and BIC in the dynamic glucose 
balance. 
 In real data sets such as these where the model horizon covers a long time period, 
unmeasured disturbances are likely to be significantly correlated with measured inputs. In 
addition, this type correlation can change significantly from one period to the next. This 
characteristic challenges the ability to obtain accurate causative input modeling and can lead to 
significant over-fitting. To guard against the latter, we use the cross-validation procedure 
developed for the WMM [18] that decomposes dynamic and static modeling in a novel technique 
that results in similar fits between Training, Validation, and Testing data sets, as demonstrated 
by the results on the 15 case studies in that work. In this work the proposed approach was 
evaluated on the same data sets and maintained similarity in fit for all three data sets with a slight 
improvement over the WMM. Thus, we feel that the proposed CMM captured a large percent of 
the information on glucose behavior from the given measured input data sets. In this work, this 
translated into an rfit value that averaged from 0.60 to 0.65 with a high for Validation of 0.85 and 
a high for testing of 0.77. This level of fit has the potential to greatly nullify measured inputs and 
thereby, significantly reduce BGC as demonstrated on Subject 11 were the potential decrease is 
almost 90%.  
The only way to truly know how effective a model developed under correlated inputs can 
be for FF control is to test it in actual control studies. The only way to do this at this stage of this 
work is in inpatient clinical studies under hospital observation and care. However, in this work 
we included an analysis to evaluate the physical soundness of the CMM results. This was first 
done by showing expected behavior with carbohydrate consumption without insulin infusion, 
and without carbohydrate consumption and with insulin infusion, which showed (in Fig. 5) 
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continual increase in BGC and continual drop in BGC to the zero level, respectively. In contrast, 
the WMM did not show this expected behavior (in Fig. 4). Another evaluation in this work 
consisted of examining the steady state relationship for the amount of insulin infusion at a given 
level of carbohydrate consumption, as given in Eq. 25 and shown in Fig. 6 for one of the 
subjects. These numbers are quite reasonable, and the relationships between BGC, insulin 
infusion and carbohydrate consumption are sound. Thus, when proposing modeling methods for 
use in FFC, it is our recommendation that these types of preliminary analyses be done to evaluate 
model soundness as a prior step to actually using them to build a FF controller. 
To evaluate the coupled approach with an unmeasured state variable and its 
implementation into FFC via the control law given by Eq. 3, a simulation study was given using 
a mathematical CSTR. It was demonstrated that a complex network with a highly nonlinear 
model meeting the requirement of Eq. 3 can be effectively implemented in the time domain 
without linearization of the model. In addition, it appears that the estimates of the unmeasured 
pseudo-state variable do not have to be very accurate to estimate the controlled variable 
accurately. This means that accuracy of pseudo-BIC is not a concern. It is playing a role that 
allows a physiologically sound structure and the addition of pseudo-BIC did not cause a 
reduction in accuracy in controlled variable as compared to the WMM results. Finally, the 
simulation study demonstrated the effectiveness of the FFC approach by a 75% reduction in the 
standard deviation from the set point for the FBFF controller as compared to FB controller.   
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Abstract 
 
Block-oriented modeling (BOM) is a multiple-input, multiple-output modeling approach 
for nonlinear dynamic processes. Current implementation of BOM into feedforward control 
(FFC) results in linearization of the model and decomposition into separate components for each 
input. This work presents a multiple-input BOM FFC approach that does not linearize and 
decompose the BOM into separate components for each input. This implementation uses a new 
FFC law that uses the complete BOM in the time domain. The approach is demonstrated with a 
Wiener model for a simulated continuous stirred tank reactor (CSTR) with four (4) measured 
inputs. The Wiener model is nonlinear in the physically-based dynamic parameters of the 
transfer functions and linear in the static parameters of the static gain function. The static gain 
function has a second order linear regression form with interaction and quadratic terms.  The 
Wiener model is built under open-loop conditions using a Box-Behnken statistical experimental 
design consisting of 27 sequential step tests. Under a sequence of multiple input changes, the 
addition of this feedforward controller to the feedback controller reduced the standard deviation 
of the controlled variable from its set point by 70% in comparison to the response with only 
feedback control. 
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Key words: feedforward control, model-based control, Wiener modeling, block-oriented 
modeling, nonlinear modeling, nonlinear regression. 
Introduction 
There are basically two types of control approaches – feedback control (FBC) and 
feedforward control (FFC). FBC is any control approach that determines the settings for the 
manipulated variable based on the deviation of the controlled variable from its target or set point 
(Yset). This deviation can be at the current time instant, as in common FBC or a more 
sophisticated one like a Smith Predictor, or it can be a predicted deviation at some future time as 
in model predictive control (MPC). FFC differs from FBC in that it changes the manipulated 
variable based on the values of input variables and not the deviation from set point. More 
specifically, the FFC control objective is to maintain the output of the FFC model, which 
consists of measured inputs only, at a constant value by changing the manipulated variable to 
“compensate” for changes in the measured inputs. Thus, to implement FFC effectively on the 
measured set of inputs, the model must be capable of accurate determination of the manipulated 
variable to “offset” the measured input changes while in an automatic control scheme. 
Approximations of the model to incorporate it into the control algorithm can also adversely 
affect control performance. 
Some models for nonlinear gain behavior have been proposed for model-based 
controllers including radial basis functions (RBF) [4,5], genetic algorithms (GA) [6], Nonlinear 
Auto Regressive Models And eXogenous inputs (NARMAX) models [7-9], and block-oriented 
models (BOMs) [10-15]. An important advantage of NARMAX and BOMs is that they can use 
transfer functions, i.e., linear dynamic equations with physically interpretable parameters. 
However, a limitation of the NARMAX structure is that all of its transfer functions have the 
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same characteristic equation or denominator dynamics [2]. BOMs use the outputs from blocks of 
dynamic (transfer) functions that are linear (L) differential equations as inputs to functions that 
can be nonlinear (N) with respect to static gain parameters. The simplest of the BOMs is the 
Hammerstein network (NL), which has an N block followed by an L block and the Wiener 
network (LN), which reverses the order of these two blocks. More complicated block-oriented 
structures include sandwich models such as an LNL network, which has linear dynamic blocks, 
followed by a nonlinear static block, followed by a second linear dynamic block. When the 
inputs can have different dynamic behavior, the Wiener network is the preferred choice over 
Hammerstein and is superior to NARMAX because the inputs can have completely different 
dynamic structures [2] as shown by its block diagram in Fig. 1. 
A number of researchers have studied the identification of model parameters for the 
Hammerstein and Wiener networks, including Greblicki [12,16], Eskinat et al. [17], Shi and Sun 
[18], and Al-Duwaish and Naeem [6]. Perhaps, due to its complexity, the LNL network has not 
gotten as much attention, but some have proposed methods for its parameter identification [19]. 
There has been much progress over the last decade in the identification of BOMs [19-25] and 
recently, by taking a nonlinear parametrized approach [26] for estimation of the dynamic 
parameters, Rollins et al. [2] demonstrated accurate Wiener modeling using nine (9) inputs on a 
real distillation process with large variation due to unmeasured disturbances and with highly 
pairwise cross-correlation of the inputs. While there has been progress in the use of BOMs in 
model based control [27-29], progress of FFC using BOMs appears to have been limited to single 
input models [30-31].  
To implement a p-input nonlinear model structure the current FFC approach would 
linearize the structure, transfer it to the Laplace domain and decompose it into p FFC blocks. 
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Additional approximations would be required for FFC blocks that are physically unrealizable to 
make them physically realizable. A numerical procedure (which is another approximation) such 
as Euler’s method would be needed to obtain the output from each FFC block at each time 
instant. For the approach proposed in this work, a FFC law and methodology is presented that 
eliminates all these approximations. More specifically, the value of the manipulated variable to 
“offset” input changes at each time instant is obtained directly from the FFC model in the time 
domain in a root solving procedure and passing this solution through the inverse of the process 
transfer function. Since this procedure is done completely in the time domain the inverse of the 
process transfer function uses backward difference approximations for derivatives. Thus, an 
approximation to achieve a physically realizable transfer function is not needed for the proposed 
approach.    
Thus, the objective of this work is the development of a general FFC framework for 
multiple-input BOMs in FFC with nonlinear static gain behavior. The BOM structure and 
identification will be demonstrated using a nonlinear parametrized Wiener model [1,2,26] with a 
second-order static gain structure on a simulated CSTR. The Wiener model is built under open-
loop conditions using a Box-Behnken statistical experimental design consisting of 27 runs or 
sequential step tests. The FFC model will be implemented using the proposed FFC approach 
discussed above. Under a sequence of multiple input changes, the addition of this feedforward 
controller to the feedback controller reduced the standard deviation of the controlled variable 
from its set point by 70% in comparison to the response with only feedback control. 
 
Methodology 
This section gives the methods used to develop and evaluate the BOM FFC approach 
with specific application to a CSTR. The general BOM FFC law is presented first and then its 
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form specific to the Wiener modeling approach used in this work. This includes specification of 
the Wiener model (WM), its FFC law, and the parameter estimation approach. Lastly details of 
the CSTR are given in this section.  
 
Fig. 1. Block diagram for the Wiener network with p inputs and one output. Each input, xi, is 
passed through their own unity gain linear dynamic block, Gi, after which these unobservable 
intermediate outputs are collected and passed through a single unrestricted static gain function, 
f(V), to produce the output, y.  
 
     General FFC Law 
The concept of FFC appears to have been applied as early as 1925 to level control 
systems for boiler drums [32].  It allows for theoretically perfect control of a process system 
because it corrects for input disturbances before the process outputs deviate from their desired 
values.  However, this requires timely and efficient measurement of all possible process 
disturbances, which is not likely in most applications, so it is commonly used in conjunction with 
FBC. The addition of FBC compensates for any deviation of the process output from its set 
point, regardless of the cause of the deviation. For each input, its FFC law is typically found 
independently of the other inputs from a function in the Laplace domain that uses an 
approximation to meet the requirement of physically reliability when necessary [32].  The joint 
FFC law for all the inputs is a sum of the individual ones, i.e., is linear and additive [33]. 
G1
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f (V)
x1
x2
xp
v2
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V y
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The FFC law that this work proposes for BOM is derived by modeling all inputs 
simultaneously without restrictions on linearity and additivity; it is also not necessary to work in 
the Laplace domain or to incorporate an approximation to meet the requirement of being 
physically realizable. The proposed FFC law is given as follows. Let xi,t = the ith measured input 
at time t, i = 1, . . ., p and vi,t = the output from the ith transfer function in Fig. 1 with Xt = [x1,t . . . 
xp,t]T and Vt = [v1,t . . . vp,t]T with the manipulated variable as xp,t. With the process initially at 
steady state and at Yset, and with no model bias, a general BOM FFC law, when the first block is 
N (e.g., Hammerstein model), is given as 
( ) 0ˆ;
,
=−
set
x
t Yf
tp
θX                                                    (1) 
where ( )θX ˆ;tf  is an unrestricted function of input variables only (more specifically, no outputs) 
for the first N block and θˆ is the vector of estimated parameters. Note that “^” is used for estimate 
throughout this article. Thus, at each time instant, Eq. 1 determines the value of 
tpx , (i.e., the 
output from the FFC system) for ( )θX ˆ;tf  to remain at Yset. Similarly, with the process initially at 
steady state and at Yset, and with no model bias, a general BOM FFC law, when the first block is 
L (e.g., a Wiener network), is given as 
( ) 0ˆ;ˆ
,
=−
set
v
t Yf
tp
θV                                                    (2) 
such that 
( )
tpptp vGx ,
1
,
ˆ−=                                                       (3) 
 
Thus, at each time instant, Eq. 2 determines the value of 
tpv ,ˆ for ( )θV ˆ;ˆtf  to remain at Yset and 
then determines the output from the FFC system,
tpx , , from Eq. 3. Note that this FFC law does 
not require linearization of ( )θV ˆ;ˆtf  or its transformation to the Laplace domain and back to the 
time domain to obtain .ˆ ,tpv  Furthermore, for discrete-time approximation with a sampling time 
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of ,t∆
tpx , can be obtained from Eq. 3 by inverting the discrete time approximation function of the 
differential equation and using backward difference approximations for derivatives. For example, 
if Gp is a first order process, then 
tp
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For a simple process with two inputs and linear gains (K1 and K2) such as the ones 
commonly appearing in process control textbooks [32], Eq. 2 can be shown to be in agreement 
with these textbooks as follows:  
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              (5) 
As shown, Eq. 5 agrees with Eq. 15-21 in Seborg et al. [32] since G2(s) is a product of the load 
transmitter, valve and process transfer functions and gains of G1(s) and G2(s) are one here. A 
general BOM feedback feedforward (FBFF) block diagram representing this approach is given 
Fig. 2. 
     The Wiener Model FFC Law 
 
This article applies and evaluates the discrete-time Wiener modeling approach of Rollins 
et al. [26] that was evaluated modeling the blood glucose levels of real subjects with type 2 
[26,34] and type 1 [1,3] diabetes and the top tray temperature of a real pilot distillation column 
[2]. This Wiener model (WM) structure for Gi in Fig. 1 is a second-order-plus-lead-plus-dead 
time (SOPLPDT) form that estimates the physically-based dynamic parameters of the vi’s 
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directly with a highly non-linear structure including physical constraints. The form of this 
differential equation (dead-time is excluded for simplicity) is 
)(
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)(
2
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2
2
2 tx
dt
tdx
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ii
i
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Fig. 2. A general BOM FBFF block diagram shown with m loads and p FFC variables. If the first 
block is N, Eq. 1 is applicable, the output of the BOM block is xp and GFFC = 1.  If the first 
blocks are L, Eq. 2 is applicable, the output of the BOM block is vp and GFFC = Gp-1.   
 
where i = 1, . . ., p, p is the total number of inputs (xi’s), iτ is the time constant, iζ is the damping 
coefficient, and aiτ is the lead parameter. Dead time is not shown in Eq. 6 since the process 
simulation in this work has no dead time. In a parameter estimation problem such as this one, a 
discrete-time approach has the advantage over a continuous-time approach of the not needing to 
change form as the dampening coefficient changes during parameter search process [26]. 
Furthermore, even after obtaining the set of parameters, implementation of a continuous-time 
function will be difficult because inputs change at each sampling instant that will result in a very 
complex input sequence that will require truncation after some time in the past and thus, will also 
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be an approximation. Thus, unless a continuous-time method can be justified on the basis of 
significantly better accuracy, a discrete-time method is preferred in this application. 
 Using a backward difference approximation 





∆
−
≈
∆−
t
vv
dt
tdv ttitii ,,)( e.g., , the following 
approximate discrete-time form of Eq. 6 is obtained [4]:  
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1,2,1,2, 1 iiii ωδδω −−−=                                                     (11) 
 
to satisfy the constraint of unity gain. Two additional physical constraints are 0>iτ and
.,0 ii ∀>ζ  Note that Eq. 7 is linear in the sδ ′ and .sω ′  Thus, Eq. 7 represents a linear regression 
form with the sδ ′ and sω ′ estimated directly. Notwithstanding, the nonlinear regression form is 
obtained by the substitution of Eqs. 8-11 into Eq. 7 and estimating the ,sτ ′ ,sζ ′  and sa 'τ (i.e., the 
physically-based dynamic parameters) directly with
tiv , given as a highly nonlinear function of 
the estimated parameters. Physical constraints also strengthen estimation by adding more true 
structure. Notably, these are: Eq. 6, 0>iτ and ii ∀> ,0ζ . Another advantage from using 
physically-based dynamic parameters is the ability to give sensible starting values for estimates.  
The general discrete-time, “white noise,” WM is given as  
t
set
tttt
set
t YfyYy εηε +−=+=′=− )(V                                    (12) 
where  
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( ) ttlyindependenNt ∀2,0~ σε                                           (13) 
 
the common assumption with least squares estimation and yt is the measured output at time t. 
Note that the expected response at time t is ],[ tt yE=η  since .0][ =tE ε  While f(Vt) can be any 
function, in the work it is a second order linear regression function of p variables as shown 
below:     
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where vp,t = vff,t. With ( ) ( ) settt Yff += VθV ˆˆ;ˆ and Eqs. 12-14, Eq. 2 becomes 
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where ,ˆ ppaa = tppptp vavab ,11,11 ˆˆˆˆ −−++= L and LL +++++= −− tttppt vvavavaac ,2,112,11,110 ˆˆˆˆˆˆˆˆ . For 
the CSTR in this work, a first order transfer function is used giving, with the solution to Eq. 15, 
the FFC system output as: 
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Note that for estimation of 
pτ a backwards differences approximation is used and in this case Eq. 
16 is written as 
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Thus, in estimating the model parameters, Eq. 17 is used and in determining the output of the 
FFC system, Eq. 16 is used. The FBFF block diagram specific to this WM approach is shown in 
Fig. 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. A Wiener FBFF block diagram based on Fig. 2 with m loads and p FFC variables; e = 
estimate, e.g., .ˆˆ ,, tfftpp
e
p vvv ==   
 
     The Mathematical Model for the CSTR  
The process to evaluate the WM FFC method is a simulated CSTR from Smith and 
Corripio [35] and shown in Fig. 4. A dynamic model of the process was developed using first 
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principles on the mass, species and energy balances of the process for the simulation.  The 
assumptions made included the following: constant densities and heat capacities of the tank and 
jacket contents; constant volumes in the tank and jacket; perfect mixing in the tank; negligible 
thermal capacitance of the tank wall and jacket wall; for this liquid system constant volume heat 
capacities (cv, cvc) and constant pressure heat capacities at (cp, cpc) are approximately equal and 
constant for both the reactor and jacket contents, respectively; and the energy due to flow 
streams is adequately described by the enthalpy. A list of variables and initial values is given in 
Table 1.  
The CSTR process is described mathematically in Eqs. 18-22 below:   
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Fig. 4. The simulated CSTR process used for this study. 
Table 1. Definition of variables and initial steady-state values for the CSTR process. 
Variable Definition SS value (units) 
A Heat transfer area 5.40 (m2) 
α Control valve rangeability parameter 50 (none) 
CA Concentration of species A in reactor 1.0302 (kgmol/m3) 
CAi Concentration of species A in inlet stream 2.88 (kgmol/m3) 
cp Heat capacity of feed and product streams 1.815x105 (J/kgmol-°C) 
cpc Heat capacity of coolant 4184 (J/kg-°C) 
∆HR Heat of reaction -9.86x107 (J/kgmol) 
E Activation energy 1.182x107 (J/kgmol) 
F Feed flow rate 0.45 (m3/s) 
FC Coolant flow rate 0.44 (m3/s) 
FCmax Maximum flow rate of coolant through control valve 1.2 (m3/s) 
K Reaction rate constant 0.09 (m3/s-kgmol) 
ko Arrhenius frequency parameter 0.0744 (m3/s-kgmol) 
M Input signal to the valve  0.26 (none) 
R Gas law constant 8314.39 (J/kgmol-K) 
ρ Density of reactor contents 19.2 (kgmol/m3) 
ρc Density of coolant 1000 (kg/m3) 
Tj Coolant temperature in the jacket 50.48 (°C) 
TCi Coolant inlet temperature 27 (°C) 
T Reactor temperature 88 (°C) 
Tm Measured reactor temperature 88 (°C) 
U Overall heat transfer coefficient 2.13x105 (J/s-m2-°C) 
VC Cooling jacket volume 1.82 (m3) 
V CSTR volume 7.08 (m3) 
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Results 
     Wiener Modeling Results 
This study consisted of the following four inputs: F (x1), TCI (x2), CAi (x3), and M (xff). 
The training data were generated using sequential step tests from a Box-Behnken design with 
three center points and four inputs. This gave a total of 27 sequential step tests (100 s each) or 
times that input changes occurred. This input sequence is shown in Fig. 5, and the response of 
reactor temperature to this series of input changes is given in Fig. 6. Measurement noise was 
added to the true reactor temperature, T, according to Eq. 13 with 03.0=σ oC. 
 
                                      (a)                                                                          (b)   
 
Fig. 5. The input training sequences (a) and the fitted and measured tank temperature response 
(b).   
 
The final form of the reduced fitted model is given by Eq. 23 below. 
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To fit Eq. 23 the dynamic parameters (using Eqs. 6-11 and 17) and the static parameters (using 
Eq. 23) were estimated simultaneously using the method of nonlinear regression [36]. For a static 
model parameter to be retained, its individual P-value had to be less than 0.05. Two parameters 
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did not meet this criterion, a23 and a22, as shown by comparing Eq. 15 with Eq. 23. R2, which 
measures the amount of “explained variation,” is 99.9% for the static model. All the retained 
parameter estimates are given in Table 2. The fitted correlation coefficient for mT  and mTˆ (i.e., rfit) 
for Eq. 23 is 0.998. This excellent fit is shown in Fig. 5. 
The input sequences for the test set are given in Fig. 6 along with a fit of the model. As 
shown, the fit is also excellent to this test sequence.  
     The FB Controller 
A typical proportional-integral (PI) controller was implemented to control the reactor 
temperature. The manipulated variable chosen to maintain the reactor temperature is the coolant 
flow rate through the jacket of the CSTR vessel and is varied by changing the controller signal 
sent to the valve, i.e., M. It was tuned to give the best possible response to the sequence of the 
three load changes in Fig. 6.  For this controller Kc = 1.40,τI = 11.0 and M = Mfb, where Mfb is the 
signal from the PI controller to the valve. The response of the PI controller is shown in Fig. 7. 
 
Table 2.  Fitted parameters for the WM using the input sequence in Fig. 5.   
Parameter  Estimate Parameter  Estimate 
a0 0.005 a33 0.678 
a1 26.027 a44 26.758 
a2 0.337 τ1 7.1 
a3 16.287 ζ1 1.054 
a4 30.507 τa1 -5.02 
a1,2 -0.506 τ2 5.0 
a1,3 7.816 ζ2 1.384 
a1,4 -33.405 τ3 7.2 
a2,4 -0.338 ζ3 1.096 
a34 8.276 τ4 14.5 
a11 -64.756 
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(a)                                                                         (b)  
 
Fig. 6. The input testing sequences (a) and the fitted and measured tank temperature responses 
(b).  
 
     The FBFF Controller 
 
The WM was implemented into the FBFF controller in conjunction with the FB PI 
controller. Since f(Vt) is a quadratic function as shown by Eq. 15, the roots were found at each 
time t using the quadratic equation. The correct root at each time instant was 
 
a
acbb
v tff
2
4
ˆ
2
,
−+−
=                (24) 
Using the result from Eq. 24, Mff was obtained from Eq. 16. Therefore, for this FBFF controller, 
M = Mfb + Mff. The response of the WM FBFF controller to the same input sequence as the FB 
controller is also given in Fig. 7. As shown, the addition of this FFC system greatly reduced the 
deviations of the controlled variable, Tm, from its set point temperature of 88 oC. For the FB and 
FBFF controllers, the standard deviations of Tm from its set point were 0.523 oC and 0.158 oC, 
respectively, or a reduction of 69.8%. Thus, the proposed WM FFC approach appears to have 
great promise as an effective FFC approach.  
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(a)                                                                        (b) 
 
Fig. 7. Controller results; The FB controller response (a) and the FBFF controller response (b). 
The addition of FF control of the proposed approach reduced the standard deviation of the 
controlled variable from set point by nearly 70%.  
 
 
 As discussed above the inverse of the model for Eq. 16 is not physically realizable. 
Consequently, we also evaluated this approach using the following approximation (where τav is a 
small number relative to τp) which is physically realizable.   
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tdx
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ff
ff
avff
ff
p +=+ ττ                                     (25) 
We evaluated Eq. 25 using Euler’s method to solve for xff,t at each time instant with τav = 0.09. 
The standard deviation of Tm from its set point with this approach was found to be 0.244 oC or a 
reduction of 52.3% from the FBC system, which is significantly smaller than the result using Eq. 
16 of 69.8%.  
Concluding remarks 
In this work, we have proposed a new approach for BOM FFC. This approach is 
represented graphically in a block diagram (Fig. 2) and mathematically by Eqs. 1-3. To 
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determine the FF controller output signal, all the inputs are used simultaneously in the complete 
nonlinear structure of the FFC model, linearization of the model is not necessary or 
transformation into the Laplace domain, as in the current approach with multiple inputs32. 
Moreover, the FFC law of this approach is rather general and should be applicable to FFC 
models of any type not just BOM.  
The primary objective was proposal of the new BOM FFC approach, a secondary 
objective was its demonstration using the nonlinear parameterized Wiener modeling approach of 
Rollins et al.26 on a simulated CSTR. A FBFF block diagram specific to a Wiener network was 
derived from the general one in Fig. 2 and given in Fig. 3. As Fig. 3 shows, the WM produces an 
estimate of vff and another step is needed to determine xff. In this work solving the discrete-time 
equation for the process transfer function for xff in terms of vff resulted in a greater reduction 
(69.8%) in the standard deviation from set point relative to the FB controller than an approach to 
approximate this transfer function to meet the physically realizable criterion (52.3%). More work 
will be needed to verify the superiority of this approach over the common practice of adding 
terms in the denominator to meet the physical realizable criterion. Nonetheless, for this example 
this FFC approach reduced the variation from set point substantially and appears to be a viable 
contribution to model-based control methodologies.  
When model bias can change over time, its value will need be approximated at each time 
instant. Modeling real data using this WM approach has shown that the level of model bias is 
likely to persists for several times periods [1,2,26] due to shifts in unmeasured disturbances. 
When this is the case, model bias at each time t should be approximated well by .ˆ tttt yy ∆∆ −− −  
Future work would also consist of applying the proposed BOM FFC approach to real 
processes. Our plan in the near future is to apply this work to the distillation process in Rollins et 
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al. [2] and in development of FFC for disturbances that affect the blood glucose levels of people 
that rely on externally infused insulin for control of their blood sugar [1].  
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Abstract 
 Feedforward control (FFC) is the only theoretically perfect control scheme. Potentially, it 
has the ability for tight control in real applications. However, when the dead time of the 
manipulated variable is greater than a modeled load disturbance (i.e., measured input), the result 
is a FFC algorithm that is physically unrealizable since it requires future information of the input. 
Notwithstanding, when future behavior of these types of inputs is available, FFC is possible 
without approximations to achieve a physically unrealizable controller. This work presents a 
multiple-input FFC framework with this capability. The motivation for this framework is the 
development of an automatic insulin delivery device for the control of blood glucose 
concentration (BGC) for people with type 1 diabetes. In this application, the manipulated 
variable, the exogenous insulin feed rate, has a large dead time that is likely to be greater than 
that of any measured variable that is a candidate for FFC. This novel approach is demonstrated 
using a multiple-input mathematically simulated continuous-stirred-tank-reactor (CSTR). 
Key words: feedforward control, time delay, in silico, closed-loop control, artificial pancreas, 
CSTR 
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Introduction 
 There is great need of tight control in Blood Glucose Concentration (BGC) for people 
with diabetes. The artificial pancreas (AP) is a tool that was created to help insulin-dependent 
people with diabetes to automatically control their BGC. The AP has the following control 
components: continuous glucose sensor, insulin pump, and control algorithm. The control 
algorithm takes input information such as measured BGC, processes it through an algorithm that 
manipulates the insulin feed rate (IFR) with the control object to minimize deviation from the 
BGC target called the “set point”. For the AP to achieve the tight control necessary for long 
term, i.e., 24 hour a day control, the control algorithm must significantly advance.  
Current AP algorithms include traditional feedback control (FBC) [1] , model predictive 
control (MPC) [2-11] , fuzzy logic control (FLC) [12,13] , and Feedforward control (FFC) [14-
16]. Although researchers have made considerable advancements in inpatients/outpatients BGC 
closed-loop control, daytime automatic control has only marginally improved over manual 
subject control. As sensor technology continues to improve for disturbances that affect BGC, 
with effective mapping of these disturbances to BGC behavior (i.e., modeling), the potential to 
greatly tighten BGC using model-based control algorithms increases. The potentially most 
powerful control algorithm is FFC due to its proactive theoretically perfect property. However, 
to develop an effective FFC system in this application, at least four major challenges need to be 
overcome. The first one is the development of an effective multiple-input modeling method with 
strong cause and effect input relationships to the output, BGC. While improvements are still 
needed, our research team has made considerable progress in recent years [17,23]. The second 
one is the development of an effective multiple-input FFC algorithm. We feel that we have 
addressed this challenge adequately in Rollins et al [18]. The third one is the advancement of 
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sensor technology for measuring the critical inputs such as meals, activity and stress. Sensor 
technology has been rapidly improving in the last decade and many of these sensors currently 
exists or will likely to be invented in a few years [23,24]. The last one is a control algorithm that 
overcomes the physically unrealizable limitation of FFC models in this context without making 
approximations to the model [11, 13]. Overcoming these challenges will improve the model in 
cancelling out disturbances more effectively. Therefore, the purpose of this work is to propose a 
new FFC approach that addresses the physically unrealizable property due to dead time. In this 
approach, a predictive model is used to make current changes in the manipulated variable to 
effectively cancel future effects of input variables. We have termed this approach feedforward 
predictive control (FFPC). We demonstrate its effectiveness using the CSTR in  Rollins et al 
[18]. While there are diabetes simulators that we could use in this study, they are all limited to 
just one input variable – meal size, as well as other limitations. Using the CSTR for this study 
allows the demonstration of FFPC algorithm in a multiple-input process study. In later work, we 
plan to evaluate our proposed FFPC approach using an FDA approved diabetes simulator. 
Methodology 
     Simulated CSTR 
A CSTR process is used in this initial development and evaluation of FFPC for the 
following reasons: 1. the currently available FDA approved UVA-padova simulator in type 1 
diabetes does not support a multiple-disturbance control approach [20,21]; 2. it is easy to 
implement relatively long time delays for this process and; 3. the dynamics of a CSTR are well 
understood theoretically as the process model is developed completely from conservation laws of 
material and energy balances. Thus, the model can be used with confidence that it represents true 
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dynamic behavior of a chemical process. This CSTR process [18] is illustrated in Fig. 1 and 
described by the following equations: 
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The definitions and values of the variables are shown in Table 1. 
In this study, three input variables are used: input signal to valve, M (x1), temperature of 
entering coolant, Tci (x2), and concentration of component A in inlet, CAi (x3). The one output for 
this study is the measured tank temperature, Tm. The CSTR is altered to have relatively long dead 
times ( )iθ in Tci, CAi, and the input signal to valve (M), specified as ,tkii ∆=θ where ik is a positive 
integer, i = 1, 2, or 3, for M, Tci, and CAi, respectively. The dead time for M is the largest. 
     Modeling Methodology 
The Wiener network from [22] is used for modeling the CSTR process. This Multiple-
Input, Single-Output (MISO) network is shown in Fig. 2. Each input (xi) has its own linear 
dynamic block, Gi, and each dynamic block has an intermediate unobservable, output vi, which 
represents the independent dynamic response of its corresponding input. All the intermediate vi’s 
are collected and passed through a nonlinear static gain block, f(V), to produce the final 
measured output, y.   
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Fig. 1. Simulated CSTR process for this study. 
The dynamic blocks are linear ordinary differential equations. M has first-order-plus-
dead-time dynamics given by Eq. 6 below: 
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Table 1. Definitions of variables and initial steady-state values for the CSTR process. 
Variable Definition SS value (units) 
A Heat transfer area 5.40 (m2) 
α Control valve rangeability parameter 50 (none) 
CA Concentration of species A in reactor 1.0302 (kgmol/m3) 
CAi Concentration of species A in inlet stream 2.88 (kgmol/m3) 
cp Heat capacity of feed and product streams 1.815x105 (J/kgmol-°C) 
cpc Heat capacity of coolant 4184 (J/kg-°C) 
∆HR Heat of reaction -9.86x107 (J/kgmol) 
E Activation energy 1.182x107 (J/kgmol) 
F Feed flow rate 0.45 (m3/s) 
FC Coolant flow rate 0.44 (m3/s) 
FCmax Maximum flow rate of coolant through control valve 1.2 (m3/s) 
K Reaction rate constant 0.09 (m3/s-kgmol) 
ko Arrhenius frequency parameter 0.0744 (m3/s-kgmol) 
M Input signal to the valve  0.26 (none) 
R Gas law constant 8314.39 (J/kgmol-K) 
ρ Density of reactor contents 19.2 (kgmol/m3) 
ρc Density of coolant 1000 (kg/m3) 
Tj Coolant temperature in the jacket 50.48 (°C) 
TCi Coolant inlet temperature 27 (°C) 
T Reactor temperature 88 (°C) 
Tm Measured reactor temperature 88 (°C) 
U Overall heat transfer coefficient 2.13x105 (J/s-m2-°C) 
VC Cooling jacket volume 1.82 (m3) 
V CSTR volume 7.08 (m3) 
 
 
Fig. 2. Block diagram for a general Wiener Network with p inputs and one (1) output.Each input, 
xi, is passed through their own unity gain linear dynamic block, Gi, after which these 
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unobservable intermediate outputs are collected and passed through a single unrestricted static 
gain function, f(V), to produce the output, y.  
 
Similarly, Tci and CAi have a second-order-plus-dead-time-plus-lead (SOPDTPL) form as 
shown in Eq. 9 below: 
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where i = 2, 3, τi is the time constant, ζi is the damping coefficient, τai is the lead parameter and θi 
is the dead time. Using a backward difference approximation to a sampling interval of Δt, an 
approximate discrete-time form of Eq. 9 is: 
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After obtaining 
tiv , for each input i, the modeled output value is determined by substituting these 
results into f (Vt).  
The general discrete-time, “white noise,” Wiener model (WM) is given as [18]: 
t
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the common assumption with least squares estimation and yt is the measured output at time t. 
Note that the expected response at time t is ],[ tt yE=η  since .0][ =tE ε  While f(Vt) can be any 
function, in the work it is a second order linear regression function of three (3) variables as 
shown below:     
( ) tttttttttsett vvcvvcvbvbvavaafY ,3,23,2,2,12,12,332,11,33,110 +++++++++==− LLLVη    (16) 
where ai, bi, and cj,k, denote the linear, quadratic and interaction parameters for i = 1, 2, 3,  j = 1, 
2 and k = j+1, . . ., 3. 
     FFPC Law 
The FFPC objective is to keep tη on the set point, Yset, by changing .,1 tx  More specifically, 
from Eq. 16, setting the predicted tank temperature 1k time steps in the future to the set point 
gives  
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For 1k time steps in the future, Eq. 7 becomes 
( ) ttktitkt xvv ,11,1)1(,1,1,1 111 δδ −+= ∆−+∆+                                            (20) 
where ai, bi, and cj,k, denote the linear, quadratic and interaction parameters for i = 1, 2, 3,  j = 1, 
2 and k = j+1, . . ., 3.  Thus, from Eqs. 8 and 20, 
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Results 
    Fit of the WM 
 For this study ,1 tk ∆ tk ∆2 and tk ∆3 are 10 seconds, 5 seconds, and 0 seconds, respectively, 
with t∆ = 0.1 seconds. The training input sequences for x1 - x3 are shown in Fig. 3. The fit for 
this training data is shown in Fig. 4. As shown, the fit is nearly perfect. A similar testing 
sequence resulted in a fit that was very similar.  
    Closed-loop Control 
With the model parameters identified, the effects of FFPC, in this case, which are the 
effects of input variables announcements will be examined. The goal in this study is to minimize 
the variation of tank temperature around its set point (88 °C) by manipulating input signal to 
valve, M. This study was divided into two parts. First part has only one disturbance Tci. In the 
second part, results for both disturbances Tci and Cai are given.  
 
Fig. 3. Input sequences for input signal to valve, M (x1), Temperature of inlet coolant flow, Tci 
(x2), and Concentration of component A in inlet flow, CAi (x3). 
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Fig. 4. Fitted measured tank temperature Tm. Grey line denotes observed measured tank 
temperature, and black solid line denotes fit of the model. 
A proportional-integral (PI) feedback controller (FBC) was implemented in conjunction 
with the FFC (no announcement of disturbances) and FFPC (announcement of the future 
behavior of disturbances) systems. For FBC, KC = 1.40, Iτ = 11.0 and Mfb is the signal from the 
FBC system to the valve. The combined signal is given as  
tfftfbt MMM ,, +=                                                       (22) 
In Fig. 5, Tci is the only disturbance. In this figure, the top plot shows the tank 
temperature response for FBC, the bottom left plot for FBC with FFC and the bottom right plot 
for FBC with FFPC. As shown in Fig. 5, the variation of Tm around its set point (e.g., its standard 
deviation) is reduced with FFC even without Tci announcement, from 0.1891°C to 0.1494°C, or 
about 21%. However, with FFPC, it is much greater, from 0.1891°C to 0.0686°C, a 63.7% 
reduction. 
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In Fig. 6, Tci and CAi are disturbances. In this figure, the top plot shows the tank 
temperature response for FBC, the bottom left plot for FBC with FFC for CAi (no announcement) 
and FFPC for Tci (announcement) and the bottom right plot for FBC with FFPC (announcement 
for both disturbances). As shown in Fig. 6, the variation of Tm around its set point (given by its 
standard deviation) is only slightly reduced without announcement for both disturbances from 
0.4352°C to 0.4003°C, or about 8%. However, with full FFPC, the reduction is from 0.4352°C to 
0.1131°C, a 74% reduction with both Tci and Cai announcements. 
 
 
 
Fig. 5. The controller response plots with Tci as the only disturbance; FBC (top plot), FBC with 
FFC (bottom left plot), and FBC with FFPC (bottom right plot).   
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Fig. 6. The controller response plots with Tci and CAi as disturbances; FBC (top plot), FBC with 
announcement for Tci only (bottom left plot), and FBC with full FFPC (bottom right plot).   
 
 
Concluding Remarks 
This article proposed a novel feedforward predictive control approach when the 
manipulated variable has significant dead time as in the case for exogenous insulin infusion.  It 
extends the work in [17, 18]. As demonstrated, the use of this approach has the potential to 
greatly impact control application that can benefit from FFPC such as control of BGC for people 
that depend on insulin. Thus, future work will focus on evaluating the methodology on an FDA 
approved diabetes simulator.  
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Abstract 
The development of an automatic insulin delivery system (i.e., the so called, “artificial 
pancreas (AP)”) is a very active area of research. The challenge has been to develop a control 
system that can substantially tighten blood glucose concentration (BGC) around the clock and 
under normal changes of measured and unmeasured disturbances. The unmeasured disturbances 
have a large effect on the variation of BGC. This effect, along with the large time delay of the 
manipulated variable, insulin feed rate (IFR), and the requirement for an accurate model of IFR, 
are three of the most significant challenges to overcome to achieve the goal of tight control of 
BGC. Model predictive control (MPC), a feedback control approach, is the most widely accepted 
control algorithm in AP research. In this work, a promising predictive modeling and control 
methodology is proposed that addresses the aforementioned challenges and thus, has 
considerable promise as an effective AP. Unlike MPC, for the proposed approach, a model for 
manipulated variable is not required. The proposed predictive modeling approach has a novel 
way of addressing time delay in the manipulated variable that does not use an approximation for 
the physically unrealizable attribute. It addition, it uses a novel noise structure to accurately 
predict future BGC in the presence of unmeasured disturbances. These strengths of the proposed 
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method are demonstrated on a mathematical continuous-stirred tank reactor (CSTR) in a 
comparative study with MPC.  
Key words: Artificial pancreas, model predictive control, feedback control, feedforward control, 
dynamic modeling. 
Introduction 
There is great need of tight control in blood glucose concentration (BGC) for people with 
diabetes. The artificial pancreas (AP) is the tool that was created to help insulin-dependent 
people with diabetes to automatically control their BGC. The AP has the following control 
components: continuous glucose sensor, insulin pump, and control algorithm. The control 
algorithm takes input information such as measured BGC, processes it through an algorithm that 
manipulates the insulin feed rate (IFR) with the control object to minimize deviation from the 
BGC target called the “set point.” For the AP to achieve the tight control necessary for long term 
24 hour a day control, the effectiveness of AP control algorithm must significantly be improved.  
Current AP algorithms include traditional feedback control (FBC) [1], model predictive 
control (MPC) [2-11], fuzzy logic control (FLC) [12, 13], and Feedforward control (FFC) [14-
16]. Although considerable achievements have been made for inpatients/outpatients BGC closed-
loop control, daytime automatic control has only marginally improved over manual subject 
control. As sensor technology continues to improve for disturbances that affect BGC, with 
effective mapping of these disturbances to BGC behavior (i.e., modeling), the potential to greatly 
tighten BGC using model-based control algorithms increases.  
There are two basic components of a predictive model-based control strategy – the model 
and the control algorithm. More specifically, the model must be capable of accurate predictions 
of the controlled when the future predictions are most needed. For the AP this is the time distant 
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into the future when insulin will start to affect BGC after a change in IFR, i.e., the dead time ( )θ
for this variable. In addition, the model must be capable of accurate predictions this distance into 
the future in the presence of disturbances that significantly change BGC, and maintain high 
accuracy during close-loop control. A multiple-input modeling method that has strong cause-
and-effect mapping of the inputs to the response space inclusive of phenomenologically sound 
input relationships, is also required. We believe that the modeling approach developed in [17, 
23] strongly meets this criterion. The proposed control method presented in this article builds on 
these modeling strengths.  
Model predictive control (MPC) [19] and feedforward predictive control (FFPC) [24,25] 
are control approaches that require accurate models for the manipulated variable in addition to 
accurate predictions θ time into future. It is very difficult to obtain an accurate model of the 
manipulated variable using any current modeling method for real BGC data. The approach that 
we are proposing in this work does not require a model of the manipulated variable, which is a 
critical advantage over MPC and FFPC. The proposed method uses a model to predict the value 
for the controlled variableθ time into the future, uses this value to determine the “feedback 
error” and then uses a classical feedback control (FFC) algorithm to change the IFR at the 
current time. Thus, we call this approach “feedback predictive control (FBPC).” As long as 
sufficiently accurate predictions are obtainable θ time into future under automatic control and 
with good tuning parameters, FBPC can be quite effective. In this work we evaluate FBPC 
against MPC using a simulated CSTR in the presence of very large unmeasured disturbance 
behavior. A CSTR is used because we can have large unmeasured disturbances as well as 
multiple-input modeling. Excluding the manipulated variable, no FDA approved diabetes 
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simulator has more than one input (meals) and the variation due to unmeasured disturbances is 
very small [24], if not, negligible.   
 
Methodologies 
     Simulated CSTR 
The CSTR process is used in this initial development and evaluation of the FBPC 
algorithm for the following reasons: 1. the currently available FDA approved UVA-padova 
simulator in type 1 diabetes does not support a multiple-disturbance control approach [20, 21]; 2. 
it is easy to implement the desired time delays for this process; 3. the dynamics of a CSTR are 
well understood theoretically as the process model is developed completely from conservation 
laws of material and energy balances and; 4. unmeasured disturbances can be implemented as 
desired. Thus, the model can be used with confidence that it represents true dynamic behavior of 
a chemical process and includes critical attributes of real BGC data. The CSTR process [18, 25] 
is illustrated in Fig. 1 and described by the following equations: 
2
AAAi
A kC)C(C
V
F
dt
dC
−−=                                                  (1) 
)T(T
VC
UA
kC
C
H
)T(T
V
F
dt
dT
CT
p
A
p
R
TT
T
−−
∆
−−=
ρρ
2                            (2)  
)T(T
V
F
)T(T
CρV
UA
dt
dT
CiC
C
CT
pCCC
C
−−−=                                      (3) 






+
−
=
)16.273(
exp0
TTR
E
kk                                               (4) 
( )M
FF CC
−×= αmax                                                     (5) 
The definitions and values of the variables are shown in Table. 1. 
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In this study, three input variables are used in the model. They are the input signal to 
valve, M (x1), temperature of entering coolant, Tci (x2), and concentration of component A in 
inlet, CAi (x3). There is one unmeasured disturbance, the feed flow rate (F). There is one output 
for this study, the measured tank temperature, Tm. The CSTR is altered to include dead time ( )iθ
in Tci, CAi, and the input signal to valve (M), specified as ,tkii ∆=θ where ik is a positive integer, i 
= 1, 2, or 3, for M, Tci, and CAi, respectively. The dead time for M is the largest. 
 
Fig. 1. Simulated CSTR process. 
     Modeling Methodology 
For FBPC to be successful the model must give accurate predictions in closed-loop 
control k1 time steps into the future, that is, when the current change in the manipulated variable 
affects the controlled variable. In practice, this is difficult because models are developed with 
one correlation structure (e.g., open loop) and used with another one (closed-loop). In addition, 
the models must have cause-and-effect input mapping to the outputs, maintain accuracy as 
unmeasured disturbances change, have low measure bias, and have physically sound 
phenomenological properties. 
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The Wiener network from [22] is used for modeling the CSTR process. This Multiple-
Input, Single-Output (MISO) network is shown in Fig. 2. Each input (xi) has its own linear 
dynamic block, Gi, and each dynamic block has an intermediate unobservable, output vi, which 
represents the independent dynamic response of its corresponding input. All the intermediate vi’s 
are collected and passed through a nonlinear static gain block, f(V), to produce the final 
measured output, y.   
 
Table 1. Definitions of CSTR process parameters 
Variable Definition SS value (units) 
A Heat transfer area 5.40 (m2) 
α Control valve rangeability parameter 50 (none) 
CA Concentration of species A in reactor 1.0302 (kgmol/m3) 
CAi Concentration of species A in inlet stream 2.88 (kgmol/m3) 
cp Heat capacity of feed and product streams 1.815x105 (J/kgmol-°C) 
cpc Heat capacity of coolant 4184 (J/kg-°C) 
∆HR Heat of reaction -9.86x107 (J/kgmol) 
E Activation energy 1.182x107 (J/kgmol) 
F Feed flow rate 0.45 (m3/s) 
FC Coolant flow rate 0.44 (m3/s) 
FCmax Maximum flow rate of coolant through control valve 1.2 (m3/s) 
K Reaction rate constant 0.09 (m3/s-kgmol) 
ko Arrhenius frequency parameter 0.0744 (m3/s-kgmol) 
M Input signal to the valve  0.26 (none) 
R Gas law constant 8314.39 (J/kgmol-K) 
ρ Density of reactor contents 19.2 (kgmol/m3) 
ρc Density of coolant 1000 (kg/m3) 
Tj Coolant temperature in the jacket 50.48 (°C) 
TCi Coolant inlet temperature 27 (°C) 
T Reactor temperature 88 (°C) 
Tm Measured reactor temperature 88 (°C) 
U Overall heat transfer coefficient 2.13x105 (J/s-m2-°C) 
VC Cooling jacket volume 1.82 (m3) 
V CSTR volume 7.08 (m3) 
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Fig. 2. Block diagram for a general Wiener Network with p inputs and one (1) output. 
 
Mathematical Model 
The dynamic blocks are linear ordinary differential equations. The manipulated variable 
(M) has first-order-plus-dead-time dynamics given by Eq. 6 below: 
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Similarly, Tci and CAi have second-order-plus-dead-time-plus-lead (SOPDTPL) form as shown in 
Eq. 9 below: 
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where i = 2, 3, τi is the time constant, ζi is the damping coefficient, τai is the lead parameter and θi 
is the dead time. Using a backward difference approximation applied to a sampling interval of 
Δt, an approximate discrete-time form of Eq. 9 is: 
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After obtaining 
tiv , for each input i, the modeled output value is determined by substituting these 
results into f (Vt).  
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Modification of Eq. 14 for predicting k1 time steps into the future with p = 3 gives 
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where ai, bi, and ci,j, denote the linear, quadratic and interaction parameters for i = 1, 2, 3 and j = 
2 and 3, 
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To model unmeasured disturbances and bias, we use the noise model structure in [26] and 
apply it to Eq. 14 as follows:  
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yt is the measured tank temperature, Tm, at t and .ttt xxB ∆−= γ
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Modification of Eq. 22 for predicting k1 time steps into the future gives 
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where “^” is used for estimate. Our identification of Eq. 23 (i.e., estimation of the unknown 
parameters) follows [26].  
     Control Algorithms 
The MPC and FFPC control algorithms we use in this study are given in detail in [25]. 
For these details, we refer the reader to this work. However, the FBPC approach will be 
described in detail here.  
The classical PID controller equation is given by Eq. 24 below.  
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)(tM fb is the FBC signal to the insulin pump at time t, sety is the set point for the tank 
temperature,
tkty ∆+ 1ˆ is the predicted tank temperature k1 time steps into the future, with tk ∆1 as the 
dead time for manipulated variable, )(te is the “feedback error” at t and;  Kp, Ki, and Kd are the 
proportional, integral, and derivative tuning parameters, respectively, for the proportional, 
integral, and derivative (PID) controller in this work. FBPC applies the network of the FBC 
algorithm with modifications, to use the predicted Tm ( )tkty ∆+ˆ in the feedback error shown by Eq. 
25 and Fig. 3.  
 
Fig. 3. Illustration of FBPC scheme 
Results 
     Fit of the WM 
 The training input sequences for x1-x3 are shown in Fig. 4. The fits for this training data 
are shown in Fig. 5. First one can see inverse response behavior for the feed rate in the response 
plots of Tm. There are two fits in Fig. 5. The first one is the model that fits the inputs and the 
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serial correlation structure of the noise, the unmeasured disturbances and the model bias as given 
by Eq. 19. As shown, this fit is excellent. This is the model that we used in the control 
algorithms. The fit on the right is a fit of the inputs on only. Thus, it does not fit the unmeasured 
disturbance, and as a result this fit is very poor given the large changes in the feed rate. Note that 
plot on the right reveals the large impact from the unmeasured disturbances, feed rate. 
      
 
Fig. 4. Input sequences for input signal to valve, M (x1), Temperature of inlet coolant flow, Tci 
(x2), and Concentration of component A in inlet flow, CAi (x3). 
 
 
 
Fig. 5. Fitted measured tank temperature Tm. The blue dotted line denotes observed measured 
tank temperature, and black solid line denotes fit of the model. The plot on the left is for a serial 
correlated noise structure (i.e. Nt is given by Eq. 19) and the plot on the right is for a “white” 
noise structure (i.e. Nt = at as given by Eq. 20). 
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Closed-loop Control 
For this study ,1 tk ∆ tk ∆2 and tk ∆3 are 10 seconds, 5 seconds, and 0 seconds with t∆ = 0.1 
seconds. Thus, the predictions for each control method is at least 100 time steps into the future. 
The control objective is to minimize the variation around the set point (i.e. the standard deviation 
in the control run about its mean (Stdev), the set point (88 °C)) by manipulating the input signal 
to valve, M. This study examined five different cases for the control run as shown in Table 2: No 
control, FFPC, MPC with FFPC (for J =10 and J = 15, where J is the MPC tuning parameter and 
represents the time steps beyond k1 time steps in the future), and FBPC with FFPC. As indicated 
by Table 2, the FBPC case significantly outperformed the MPC cases which have Stdev values 
35.3 and 37.7% higher for J equals 10 and 15, respectively. Note that the Stdev for MPC 
decreases as J decreases. However, the aggressiveness of the manipulated variable increases as J 
decreases and for these values of J, M is significantly more aggressive and FBPC is still much 
better than MPC. 
 
Table 2. Stdev Control Run Results 
 
 
No Control 0 3.68 0.0 429.4
FFPC 100 1.69 53.9 143.9
MPC/FFPC 110 0.94 74.4 35.3
MPC/FFPC 115 0.96 74.0 37.7
FBPC/FFPC 100 0.69 81.1 0.0
Control 
Method
Prediction 
Horizon (s)
Stdev 
(
o
C)
% decrease from 
No Control
% Increase from 
FBPC/FFPC
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Fig. 6. The control run without any control system manipulating the coolant flow rate. 
 
Fig. 7. The control runs for FBPC and MPC. 
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Fig. 8. Responses for the manipulated variable (M) for FBPC versus MPC for J = 10 (left plot) 
and J = 15 (right plot). As expected, the variability of M increases as J decreases. At these values 
of J the MPC is significant more variable that FBPC.  
 
 
Concluding Remarks 
 
FBPC appears to have a lot of promise as an AP control scheme when future predictions 
are accurate. Since it uses a classical FBC system to determine with the predicted feedback error, 
it can provide tight control without the need for a model of the manipulated variable like MPC 
and FFC. This is a critical advantage in BGC application because it is difficult to obtain accurate 
models for the manipulated variable when modeling real data. With a model that can accurately 
predict BGC k1 time steps in the future under unmeasured disturbances, FBPC should do quite 
well in terms of control performance. While for a PID FBPC, determining three turning 
parameters may appear to be a disadvantage in comparison to MPC that only has one, it is 
actually an advantage due to having more degrees of freedom or ways to optimize feedback 
control. Therefore, as demonstrated in this work, the use of this approach has the potential to 
greatly impact control application that can benefit from FBPC such as control of BGC for people 
that depend on insulin. Thus, future work will focus on evaluating the methodology on an FDA 
approved Diabetes simulator.  
 
207 
 
Literature Cited 
[1] Ly, T. T., A. Roy, B. Grosman, et al. “Day and night closed-loop control using the integrated 
medtronic hybrid closed-loop system in type 1 diabetes at diabetes camp”, Diabetes Care, 2015, 
DOI: 10.2337/dc14-3073. 
[2] Tauschmann, M., J. M. Allen, M. E. Wilinska, et al, “Day and night hybrid closed-loop 
insulin delivery in adolescents with type 1 diabetes: a free-living, randomized clinical trial”, 
DOI: 10.2337/dc15-2078.  
[3] Del Favero, S., D. Bruttomesso, F. Di Palma, et al, “First use of model predictive control in 
outpatient wearable artificial pancreas”, Diabetes Care, Vol 37, 1212-1215, May 2014.  
[4] EI-Khatib, F. H., S. J. Russell, D. M. Nathan, et al, “Bi-hormonal closed-loop blood glucose 
control for type 1 diabetes”, Sci Transl Med, 2(27), April 14, 2010.  
[5] Thabit, H., M. Tauschmann, J. M. Allen, et al, “Home use of an artificial beta cell in type 1 
diabetes”, N EnglJ Med, 373:21 29-40, 2015. 
[6] Hovarka, R., D. Elleri, H. Thabit, J. M. Allen, L, Leelarathna, R. El-Khairi, K. 
Kumareswaran, K. Caldwell, P. Calhoun, C. Kollman, H. R. Murphy, C. Acerini, M. E. 
Wilinska, M. Nodale, D. B. Dunger, “Overnight closed-loop insulin delivery in young people 
with type 1 diabetes: A free-living, randomized clinical trial”, Diabetes Care, 37:1204-1211, 
2014.  
[7] Kudva, Y. C., R. E. Carter, C. Cobelli, R. Basu, and A. Basu. “Closed-loop artificial pancreas 
systems: physiological input to enhance next-generation devices”. Diabetes Care, doi: 
10.2337/dc13-2066.  
[8] Jacobs, P. G., J. E. Youssef, J. Castle, et al. “Automatic control of an adaptive bihormonal, 
dual-sensor artificial pancreas and evaluation during inpatient studies”, IEEE Transaction on 
Biomedical Engineering, Vol. 61, No. 10, Oct, 2014.  
[9] Feng, J., K. Turksoy, A. Cinar, “Performance assessment of model-based artificial pancreas 
control systems”, DOI: 10.1007/978-3-319-25913-0 13.  
[10] Turksoy, K., L. T. Quinn, E. Littlejohn, A. Cinar, “An integrated multivariable artificial 
pancreas control system”, DOI: 10.1177/1932296814524862F  
[11] Ellingsen, C., E. Dassau, H. Zisser, et al, “Safety constraints in an artificial pancreatic beta 
cell: an implementation of model predictive control with insulin on board”, Journal of Diabetes 
Science and Technology, Vol 3(3), May 2009. 
[12] Mauseth, R., Y. Wang, E. Dassau, et al, “Proposed clinical application for tuning fuzzy 
logic controller of artificial pancreas utilizing a personalization factor”, Journal of Diabetes 
Science and Technology, Vol 4(4), July, 2010.  
[13] Nimri, R., I. Muller, E. Atlas, et al, “MD-Logic overnight control for 6 weeks of home use 
in patients with type 1 diabetes: randomized crossover trial”, DOI: 10.2337/dc14-0835.  
208 
 
[14] Marchetti, G., M. Barolo, L. Jovanovic, ˇ H. Zisser, D.E. Seborg, “An improved PID 
switching control strategy for type 1 diabetes”, IEEE Transactions on Biomedical Engineering 
55 (3) 857–865,2008.  
[15] Marchetti, G., M. Barolo, L. Jovanovic, ˇ H. Zisser, D.E. Seborg, “A feedforward-feedback 
glucose control strategy for type 1 diabetes mellitus”, Journal of Process Control 18 (2) 149–162, 
2008.  
[16] Abu-Rmileh, A., & W. Garcia-Gabin, “Feedforward–feedback multiple predictive 
controllers for glucose regulation in type 1 diabetes”, Computer Methods and Programs in 
Biomedicine, 99 (1), 113-123, 2010. 
[17] Rollins, D. K., C. E. Goeddel, S. Matthews, Y. Mei, et al, “An extended static and dynamic 
feedback/feedforward control algorithm for insulin delivery in the control of blood glucose 
level”, DOI: 10.1021/ie505035r . 
[18] Rollins, D. K., Y. Mei, S. D. Loveland, and N. Bhardari, “Block oriented feedforward 
control with demonstration to nonlinear parametrized wiener modeling”, Chemical Engineering 
Research and Design, May, 2016. 
[19] Seborg, D. E., T. F. Edgar, D. A. Mellichamp, Process Dynamics and Control, 2nd edition, 
Wiley 2004. 
[20] Magni, L., D. M. Raimondo, L. Bossi, C. D. Man, G. De Nicolao, B. Kovatchev and C. 
Cobelli, “model predictive control of type 1 diabetes: An in silico trial”, Journal of diabetes 
science and technology, vol.1(6), Nov 2007. 
[21] Kovatchev, B., M. Breton, C. D. Man, C. Cobelli, “in silico preclinical trials: a proof of 
concept in closed-loop control of type q diabetes”, Journal of diabetes science and technology, 
vol.3(1), Jan 2009. 
[22] Rollins, D. K., N. Bhandari, J. Kleinedler, K. Kotz, A. Strohbehn, L. Boland, M. Murphy, 
D.Andre, N. Vyas, G.Welk and W. Franke, "Free-living inferential modeling of blood glucose 
level using only noninvasive inputs", Journal of Process Control , 20 95-107 , 2010. 
[23] Rollins, D. K., A. Roggendorf, Y. Khor, Y. Mei, P. Lee, S. Loveland, “Dynamic modeling 
with correlated inputs: theory, method and experimental demonstration”, Industrial & 
Engineering Chemistry Research, Feb, 2015. 
[24] Mei, Y., D. K. Rollins, “An in-silico study of feedforward predictive control in blood 
glucose concentration for people with type 1 diabetes”, manuscript for Journal of diabetes 
science and technology, 2017. 
[25] Rollins, D. K., Y. Mei, “A feedforward control approach when the time delay of the 
manipulated variable is greater than the input variable”, Manuscript to Industrial Eng. Chem. 
Res., 2017. 
[26] Rollins, D. K., N. Bhandari, S. Chin, T. M. Junge, and K. M. Roosa, "Optimal deterministic 
transfer function modeling in the presence of serially correlated noise," Chemical Engineering 
Research and Design, 84(A1), 9-21, 2006. 
209 
 
CHAPTER 10: AN IN-SILICO STUDY OF FEEDFORWARD PREDICTIVE CONTROL IN 
BLOOD GLUCOSE CONCENTRATION FOR PEOPLE WITH TYPE 1 DIABETES 
The paper to be submitted to Journal of Diabetes Science & Technology 
Yong Mei1* and Derrick K. Rollins, Sr. 1,2 
 
1Department of Chemical and Biological Engineering, Iowa State University, Ames, IA; 
2Department of Statistics, Iowa State University, Ames, IA 
 
*Corresponding Author 
Abstract 
Type 1 diabetes is the condition where the pancreas is unable to produce insulin. The so-
called “artificial pancreas” (automatic insulin delivery control system) that typically includes an 
insulin pump, a blood glucose sensor, and control algorithm, has the potential to help people with 
diabetes to tightly control their blood glucose concentration. This work applies and evaluates a 
feedforward predictive control (FFPC) algorithm using the first five subjects from a diabetes 
simulator.  For each of these five cases, control was as tight or tighter than the most widely used 
approach, model predictive control (MPC). 
Key words: Artificial pancreas, model predictive control, feedforward control, dynamic 
modeling 
 Introduction 
Tight control of blood glucose concentration (BGC) is critical for people with diabetes. 
For people without diabetes, their BGC typically varies between 70 – 180 mg/dL (fasting 
glucose is around 70-130 mg/dL, and postprandial glucose level is typically less than 180mg/dL) 
[1]. For people with Type 1 diabetes (T1D), their BGC can go far above 180mg/dL. High levels 
of BGC can cause nerve, kidney and eyesight damage, in addition to many other health 
problems. At the other extreme, low levels of BGC can cause insufficient energy supply to the 
brain and can be immediately life threatening. 
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To survive, people with T1D must use exogenous insulin. The timing and amount of 
insulin to compensate for meals and other changes that affect BGC (i.e., disturbances) 
determines how BGC varies over time. The control objective is the tight variation around the 
target BGC. Because of the dynamic and uniquely complex effects of the factors that cause BGC 
variation (i.e., the inputs), tight control of BGC is not likely to be achieved by the subject 
(manual control) and it highly challenges the automatic control systems. Perhaps the most critical 
factor is the large time delay associated with the use of exogenous insulin, the manipulated 
variable. While this time is subject-specific and variable, it can take as much as an hour for 
insulin to begin to lower BGC after injection [2]. This property of the manipulated variable is 
unique to this application and is not common in industrial process control. Because of this 
property, effective BGC can only be achieved by making insulin changes ahead of any 
disturbance with a smaller time delay so that their effects on BGC are synchronous. For example, 
if carbohydrates have a dead time of 30 minutes and exogenous insulin has a dead time of one 
hour, insulin should be infused 30 minutes before eating so that one hour after that time when 
BGC will rise from the meal, the insulin is there to counteract this rise.  Thus, optimal control 
also requires future knowledge for the times when these disturbances change (e.g., meal 
announcements) and the knowledge to predictively change insulin infusion rate to effectively 
cancel out the changes of disturbances (i.e., a control algorithm or model). The most popular 
approach that incorporates this type of optimality for automatically controlling BGC is model 
predictive control (MPC) [3-10]. Other approaches such as traditional feedback control is also 
being used in this application [11]. While MPC has seen success in automatic control of BGC, 
substantially more progress is needed in artificial pancreas research to achieve an acceptable and 
widespread control around the clock [12,13].  
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 Automatic control of BGC can possibly be enhanced by the addition of an effective 
feedforward predictive control (FFPC) strategy in concert with an effective predictive feedback 
control (FBC) approach, such as MPC. Thus, the objective of this work is to evaluate the FFPC 
approach in Rollins [14] using artificially generated data from an FDA approved UVA/Padova 
diabetes simulator [15]. The use of this simulator allows the independent evaluation of FFPC 
because we are able to achieve a nearly perfect fit of the model using its only inputs, 
carbohydrates and insulin infusion rate, which is also an indication that unmeasured disturbances 
have small effect on the variation of BGC. Thus, in this work we evaluate FFPC without the 
addition of FBC. This allows us to examine the correctness of the proposed FFPC algorithm in 
the application of controlling BGC. Because of its proactive nature and control objective to keep 
the model fixed, in this study, the FFPC algorithm has the potential of outperforming MPC, 
given the low amount of unexplained variation of by the model. Thus, if the proposed FFPC 
algorithm can be effective in this application, the expectation is that in this study it will perform 
as well and maybe even better than MPC.  
 This article is organized as follows. In the next section, we will present the modeling 
methodology for this application, introduce the FFPC approach, discuss MPC in the context of 
this work, and the manual bolus (MB) method we use in this study. Following this section, the 
next one gives the protocols for the virtual patients and discusses the conditions of the study. 
After this section, the next gives results of the control run on virtual patients. The final section 
gives concluding remarks and ideas for future work. 
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Modeling Methodology 
The model for BGC is the Wiener Model (WM) found in Kotz [16] and evaluated on real 
subject data. This approach is used due to its simplicity over the semi-coupled model [17] and 
because it is able to obtain excellent causative and physically correct fits to the subject data in 
the simulator.  
The WM used in this study features multiple parallel dynamic inputs and one output. 
Figure 1 illustrates its block diagram. As shown, the inputs are first passed through dynamic, 
nonlinear, blocks where they are transformed into unmeasurable intermediate variables, and then 
all the intermediate variables are collected are passed through a function representing the static 
gain block.    
 
Figure 1. Block diagram for a general wiener network with p inputs and one (1) output. 
In the context of diabetes, the inputs, xi for i = 1,…, p, of the Wiener network are the 
measured noninvasive variables (i.e., meal components, physical activity, and emotional stress) 
and the output, y, is BGC.  Each input has its own linear dynamic block, Gi, and each dynamic 
block has an intermediate unobservable, output vi, which represents the independent dynamic 
response of its corresponding input.  All the intermediate vi’s are collected and passed through a 
nonlinear static gain block, f(V), to produce the final measured output, y.  The linear dynamic 
G1
G2
Gp
f (V)
x1
x2
xp
v2
v1
V y
vp
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blocks are essentially linear ordinary differential equations; a second-order-plus-lead with dead 
time (SOPLDT) form [18,19] as shown in Eq. 1. 
 )(
)(
)(
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2
2
2
ii
ii
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ii
i
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dt
tdx
tv
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tdv
dt
tvd θθτζττ −+−=++          (1) 
where i = 1, . . ., p, p is the total number of inputs, τi is the time constant, ζi is the damping 
coefficient, τai is the lead parameter and θi is the dead time.  Using a backward difference 
approximation (e.g.,
()

≈
,	
,	∆	
∆
), applied to a sampling interval of Δt, Rollins [19] 
obtained an approximate discrete-time form of Eq. 2 as: 
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where iii ktk ,∆=θ is an integer, and to satisfy the unity gain constraint, , = 1 − , − , −
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After obtaining Eq. 2 for each input i, the modeled glucose value is determined by substituting 
these results into f (V) such as a second order regression form shown below:  
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where ai, bi, and ci,j, denote the linear, quadratic and interaction parameters for i = 1, . . ., p-1 and 
j = 2,…, p.  This study uses only linear terms in the v’s, as this is sufficient to give the best fit.  
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In this simulation study, there are only two inputs: 
tx ,1 is the grams of carbohydrate 
consumed at time t and
tx ,2  is the bolus injection/insulin infusion rate in unit of insulin unit per 
minute at t. Thus, in this study, 
ttt vavaaf ,22,110)( ++== Vη                                                      (7) 
The measurement model is   
,ttty εη +=         tNt ∀),,0(~ 2σε                                              (8)                                                                                              
where yt is the measured glucose concentration at t, εt is the error term under the assumptions of 
independence, normality and constant variance. Our identification of this model (i.e., estimation 
of the unknown parameters) follows Kotz [16]. In this study 1θ and 2θ are tm∆ and ,tn∆
respectively, with m and n as positive integers. 
To model unmeasured disturbances and bias, we use the noise model structure in [22] and 
apply it to Eq. 8 as follows:  
,ttt Ny +=η                                                              (9)    
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yt is the measured BGC at t and .ttt xxB ∆−= γ
γ  Then 
[ ] [ ] ttt aBBBBy +−−−=−−− KK 221221 11 ϕϕηϕϕ                       (12) 
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Modification of Eq. 13 for predicting n time steps into the future gives 
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where “^” is used for estimate.  Our identification of Eq. 14 (i.e., estimation of the unknown 
parameters) follows [22].  
 
Control Algorithms 
     FFPC 
FFPC is the proposed control strategy in this study. Its control objective is to keep tη on 
the set point, yset, by changing .,2 tx  More specifically, from Eq. 7, setting the predicted BGC tn ∆
time steps in the future to the set point gives  
tnttnttntset vavaay ∆+∆+∆+ ++== ,22,110η                                   (15) 
Rearranging Eq. 15 and using Eq. 2 gives 
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Solving for the current bolus insulin rate to satisfy Eq. 15 gives from Eq. 16 
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where 
tmnttmnttnttnttnt xxvvv ∆−−+∆−+∆−+∆−+∆+ +++= )1(,11,2)(,11,1)2(,21,2)1(,11,1,1 ωωδδ         (18) 
Given that negative values can occur from Eq. 17 and that it is possible that ,settnt y<∆+η the 
FFPC control law that we implemented is this study is as follows: 
 If ,settnt y<∆+η then set ,0,2 =tx  otherwise, 
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where β is a tuning parameter between 0 and 1 to assist in hypoglycemia levels of BGC. The 
application of feedforward control here is unique because changes in the manipulated variable 
does not have the ability to increase BGC as always the case in chemical process control. Thus, 
the proposed FFPC is written to address this limitation of the manipulated variable in this 
application. 
     MPC 
 The MPC algorithm that we used in this study is now given as adapted from Seborg [20]. 
It uses the same WM as FFPC. First, a unit step change response in BGC, denoted as Sj , with 
respect to one unit step change of bolus feed rate is approximated from the second order equation 
given by Eq. 1, where j denotes the tuning parameter that represents the number of steps the 
predicted model would take to reach the set point beyond tn ∆ time steps in the future.  
Then, with k representing current time instant, and n representing time delay for insulin, 
at j steps ahead, based on Eq.14, prediction of BGC without current or future control action is 
given by: 
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where p = 1, 2, representing the inputs of meal and insulin infusion rate. 
And the change of control action (manipulated variable) is given by, 
j
jnkset
k
S
yy
x
0
++−
=∆
)
                                                  (23) 
Therefore, the manipulated variable at time instant k (current time) will be, 
kkk xxx ∆+= −1                                                         (24) 
And j becomes the sole tuning parameter for MPC, which keeps it a simple form suited for 
subject specific tuning in the study. 
     MB 
The third control strategy tested in this study provides a baseline for closed loop BGC 
control. This manual bolus (MB) control method calculated insulin infusion rate base on 
carb/insulin ratio of the subject only at the time of meal. In the aspect of administration 
frequency, MB is equivalent to open loop insulin bolus injection. Difference is that insulin is 
administrated automatically. And it can provide the baseline for the performance of closed loop 
BGC control since it is already implemented into commercialized insulin pumps. 
The manipulated variables x(t) from FFPC, MPC and MB are constrained by the bound of 0 0 ≤
() ≤ 100 0. That is, whenever x falls below 0 from FFPC or MPC, it will be set to 0, and if 
values of x is beyond 100, it will be set to 100.  
Both the FFPC and MPC are applied on virtual patients from a diabetes simulator with 
WM used. Since in this article, the proposed WM structure is stable and does not drift in a five-
day control run, Time-varying version of MPC (e.g. MPC-LTV) [9] is not necessary for this 
study. Also, by pre-training the model before control runs and have the parameters in both FFPC 
and MPC fixed,  the computational cost in running the algorithm can be greatly reduced. 
218 
 
 
Training Performance Statistics 
Three measures of performance are used in this study for evaluating the fit of the model. 
The first one is the correlation coefficients between the fitted and measured BGC (rfit); 
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where nt is the number of pairs of values in the set, and iy and iyˆ  are the i
th measure and fitted 
values in the set, respectively. The closer this statistic is to 1.0 the better the model fits the 
measured response data without consideration of model bias. The second statistic, the “averaged 
error (AE),” gives a measure of model bias. As shown in the equation below, it is the average of 
deviation between for the differences of iy and iyˆ . 
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The final statistic is the “averaged absolute error (AAE),” is a measure of the average closeness 
of iy and iyˆ . Its formula is: 
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A common benchmark used in this area is the percent of values in a range, e.g. 70-180 
mg/dL suggested by American Diabetes Association [21], with values below 70mg/dL 
commonly considered as the hypoglycemic region and above 180mg/dL commonly considered 
as the hyperglycemic region.  
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Protocols of the In-Silico trials 
The simulation environment used in this study is the diabetes simulator developed by 
UVA/Padova, which is approved by FDA for substitution of animal trials. As in this pilot study, 
five (5) virtual subjects were used in this study. The virtual patient information is summarized 
below in Table 1. 
 
Table 1. Summary of patient information 
Subject Age Body Weight 
(kg) 
Fasting 
BGC 
(mg/dL) 
Basal 
(U/hr) 
1 16 36.16 115 0.61 
2 18 50.88 123 0.54 
3 19 54.49 127 0.87 
4 17 41.47 123 0.74 
5 19 59.34 118 0.53 
 
This study contains two phases: phase one is the Open Loop Phase (OLP) where 
individualized model parameters are identified based on two weeks of data with experimentally 
designed orthogonal inputs of meal and bolus injections in training period. Phase two is the 
Closed-Loop Phase (CLP) which is a five-day controlled run for each of the three control 
systems:  FFPC, MPC and MB. In CLP, three meals were provided each day; meal times were 
7am, 12pm and 8pm, respectively, and each meal contained 50 gm of carbohydrate. Meal 
announcements were provided 10 mins prior to a meal (i.e., m = 10 since the sampling frequency 
was every one (1) minute), and each meal lasted 15 minutes. Time delays associated with meal 
ingestion and insulin infusion rate were taken as 10 and 20 minutes ((i.e., n = 20), respectively. 
The values were determined during modeling the subjects. Under closed-loop, the control 
systems provided continuous insulin infusion at the changing frequency of every minute. The 
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virtual pumps supplied each subject with a pre-determined basal insulin (U/hr) according to 
patient information that kept BGC balanced during fasting. 
Results and Discussion 
In OLP, the experiment design for the input changes, which are orthogonal, for the nine 
(9) days of Training data, are given in Table 2. Table 3 gives the input changes to generate the 
two (2) days of Validation and three (3) days of Testing data.  
The modeling results for each subject is given in Table 4. As shown, rfit is excellent for 
all five subjects and for the full set of data with values of 0.99 or better. Similarly, the AE and 
AAE results are also excellent averaging 0.217 and 1.685 mg/dL, respectively on the Testing 
data. A graphical example of these excellent fits under CLP is given in Fig. 2 for Subject 4.  
Table 2. Input changes used to generate the Training data.  
Time (t) 
 hr 
Meal Size (x1,t)  
grams 
Insulin Bolus (x2,t) 
(U/hr) 
7 50 0 
31 100 0 
54 100 2 
79 0.01 1 
103 50 2 
127 100 1 
151 0.01 2 
175 0.01 0 
199 50 1 
 
Table 3. Input changes used to generate the Validation and Testing data. 
Time (t) 
 (hr) 
Meal Size (x1,t)  
(grams) 
Insulin Bolus 
(x2,t) 
(U/hr) 
Validation 223 70 0.5 
247 40 1.2 
Testing 271 100 0.0 
295 80 0.8 
319 50 1.0 
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Table 4. Model fitting results in mg/dL 
   
Subject 
rfit 
AE 
(mg/dL) 
AAE 
(mg/dL) 
Training Validation Testing Testing Testing 
1 0.999 0.999 0.999 0.275 1.694 
2 0.997 0.996 0.997 0.433 2.161 
3 0.999 0.999 0.999 0.219 1.218 
4 0.999 0.999 0.999 0.068 1.897 
5 1 0.999 0.999 0.088 1.454 
Mean 0.999 0.998 0.999 0.217 1.685 
 
 
 
Figure 2. Model fitness for subject 4 under CLP, where the orange line denotes BGC sensor 
measurements and blue line represents model prediction. 
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Figure 3. Panels (a) – (e) represent BGC measurements under different control algorithms for 
subject 1 – 5, respectively. Black lines denote BGC measurements under FFPC, blue dashed 
lines are for MPC, and red dotted lines are for MB. 
 
 
 
(a) 
(b) (c) 
(d)
d) 
(e) 
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Table 5. Results, in mg/dL, of control runs under FFPC, MPC and MB for all 5 subjects 
Subject Set 
Point 
FFPC MPC MB 
Mean 
(mg/dL) 
Stdev 
(mg/dL) 
70-180 
mg/dL 
Mean 
(mg/dL) 
Stdev 
(mg/dL) 
70-180 
mg/dL 
Mean 
(mg/dL) 
Stdev 
(mg/dL) 
70-180 
mg/dL 
1 115 119.7 41.0 86.6% 108.2 42.4 69.8% 149.6 45.8 66.4% 
2 123 113.3 32.0 93.6% 110.8 32.7 94.2% 153.3 36.7 74.9% 
3 127 116.3 23.1 100.0% 114.8 23.6 100.0% 139.1 25.9 99.3% 
4 123 129.5 40.6 85.0% 130.0 41.3 84.2% 149.9 42.6 64.3% 
5 118 101.8 20.7 100.0% 108.1 21.9 100.0% 117.8 21.6 100.0% 
Average 116.1 31.5 93.0% 114.4 32.4 89.7% 141.9 34.5 81.0% 
 
 
The CLP results for all three control algorithms are given graphically in Fig. 3 and 
numerically in Table 5. The tuning parameter j for MPC ranges from 250 to 700. The results for 
FFPC and MPC are very similar. The mean values for the MB results are consistently higher 
than FFPC and MPC. Since the mean levels for FFPC and MPC can be shifted by changing the 
set point, the most important result is the standard deviation about the mean level, given as Stdev 
in Table 5. In each of the five cases, FFPC is better than MPC. On the average, FFPC has a 
higher percent in the 70 to 180 mg/dL range, 93.0% versus 89.7% for MPC. Therefore, the 
proposed FFPC algorithm appears to be capable of contributing to better close-loop control of 
BGC for people with T1D.  
Concluding Remarks 
FFPC appears to have the potential to enhance automatic control of BGC. Although in 
this evaluation FFPC and MPC were treated as separate control systems, in practice they would 
operate in concert with each other as one control system. FFPC would use the predictive model 
to change insulin infusion to keep the model inputs at a fixed value proactively at the current 
time instant. A predictive FBC method such as MPC, at the next future sampling time, would 
change insulin fusion rate to correct any predicted deviations from set point which would largely 
be due to unmeasured disturbances. Thus, FFPC control would compensate earlier for the 
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modeled disturbances and the MPC would compensate for unmeasured disturbances. The 
algorithm for FFPC is fundamentally different than MPC or any other control algorithm. In 
general feedforward control is a powerful control approach because it is theoretically perfect 
control. In this application, FFPC does not have this theoretical capability because manipulated 
variable, insulin, can only lower BGC. To get the most out of FFPC, an effective and safe way 
must be found to raise and to lower BGC. Future work will involve the usage of glucagon and 
insulin infusion to evaluate the impact of even tighter control for the subjects in this simulator.  
In practice, any control system that relies on an accurately modeled relationship for the 
manipulated variable, e.g., FFPC and MPC, will suffer in performance considerably when the 
relationship is inaccurate. Currently, there is no modeling methodology, to our knowledge, that 
can develop this relationship accurately enough to implement an effective control system in 
practice over several days or weeks. Thus, given the current limitations in modeling accuracy for 
insulin infusion rate in real subject applications, an effective predictive control algorithm is 
needed to effectively change the insulin infusion rate without using an accurate model for 
manipulated variables. Our research group has developed such a predictive feedback modeling 
method that will be evaluated using this simulator and will compare its results with MPC. Our 
hypothesis is that this method will be significantly better than these methods and thus, is more 
likely to be effective in modeling real subjects.   
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Abstract 
Type 1 Diabetes (T1D) is a prevalent health disease. To better control blood glucose 
concentration and ease the burden for people with T1D, the closed-loop insulin-delivery system 
(i.e., artificial pancreas), which includes a glucose sensor, a control algorithm, and an insulin 
pump, appears to have much promise. In this work, a promising predictive modeling 
methodology is proposed. It uses a powerful modeling methodology to accurately predict BGC 
in the future that is equivalent to the dead time of exogenous insulin. At this future time, it 
determines the feedback error and uses this value in a feedback controller at the present time to 
achieve optimal distance in the future. This feedback predictive control (FBPC) algorithm is 
introduced and evaluated against model predictive control (MPC) and manual bolus (MB) using 
five subjects from a diabetes simulator. The reduction in BGC standard deviation around its 
mean significantly smaller than these three approaches.  
Key words: Artificial pancreas, model predictive control, feedforward control, feedback control, 
dynamic modeling 
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Introduction 
For people with type 1 diabetes (T1D), their pancreatic beta cells are destroyed and fail to 
produce insulin to maintain glycemic homeostasis. In that case, blood glucose concentration 
(BGC) cannot be balanced at a desired level. Their postprandial BGC can reach the 
hyperglycemia region (i.e. BGC > 180mg/dL), where untreated hyperglycemia status could cause 
irreversible damage to organs, eye sight, or limbs [1,2]. On the other hand, typical treatment for 
people with T1D is insulin therapy by injection or infusion via a pump. BGC could be brought to 
hypoglycemia region (BGC < 70mg/dL) if insulin delivery is too high. This status has immediate 
effects on people and since insufficient BGC supply will affect brain functionality, 
hypoglycemia can be immediately life-threatening [3]. Thus, tight control of BGC for people 
with T1D has become an important subject in diabetes research. An effective control algorithm 
can greatly impact the health for people with T1D. 
There is a long history in management of BGC for people with T1D. A typical approach 
is, as mentioned before, insulin injection. In typical manual (i.e., open-loop) control, a person 
measures their BGC, and based on the value and recorded/anticipated carbohydrate ingestion, for 
example, the amount of injected insulin is calculated and administrated. This method requires a 
restricted life style and its effectiveness greatly depends on the management skills of the patients. 
Recent research shows that, due to advances in continuous glucose sensors, insulin pumps, fast 
acting insulin, automatic (i.e., closed-loop) control has much promise in tightening BGC. As a 
result, artificial pancreas (AP) research is a highly active field [4-14].   
While automatic control is a highly effective and mature practice in industrial processes, 
its application to BGC control is relatively new. There are at least three critical reasons that 
automatic control of BGC is a unique and much more challenging application in automatic 
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control. The first one is the large dead time of exogenous insulin. In chemical processes, the 
manipulated variable, like the flow rate of coolant to the jacket around a reactor, is located close 
to the controlled variable, so its changes are observed relatively quickly. In contrast, when 
insulin is administered it can take as much as an hour [1] before the BGC begins to drop. The 
second one is that, unlike coolant flow rate to the jacket, for example, that is able to increase or 
decrease the controlled variable by its flow rate, changes in insulin flow rate is unidirectional, 
i.e., can only decrease BGC. The third one is that the input space for the generation of modeling 
data from humans is more restricted than the typical chemical process for not only safety reasons 
but also by personal limits and desires of the individual. In this article, the focus is the 
development of a control approach that overcomes the first challenge, large dead time in the 
manipulated variable.  
Model predictive control (MPC) [15] and feedforward predictive control (FFPC) [16] are 
control approaches that require accurate models for the manipulated variable in addition to 
accurate predictions of θ time into future, where θ is the dead time of the manipulated variable. 
It is very difficult to obtain an accurate model of the manipulated variable using any current 
modeling method for real BGC data. The approach that we are proposing in this work does not 
require a model of the manipulated variable, which is a critical advantage over MPC and FFPC. 
The proposed method uses a model to predict BGCθ time into future, using this value to 
determine the “feedback error” and then uses a classical feedback control (FBC) algorithm to 
change the insulin infusion rate at the current time. Thus, we call this approach feedback 
predictive control (FBPC). As long as sufficiently accurate BGC θ time into future under 
automatic control are obtained and with good tuning parameters, FBPC can be quite effective. In 
this work, we evaluate FBPC against MPC using the FDA approved UVA/Padova diabetes 
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simulator [17]. We are able to obtain a fairly accurate model of the manipulated variable using 
this simulator [16]. Even with this advantage, FBPC will significantly perform better. 
FBPC with FFPC was introduced in Rollins et al.[18] and compared MPC with FFPC in 
a simulation study using a continuous stirred tank reactor (CSTR). There are two critical 
advantages of that process over the diabetes simulator in this study – unmeasured disturbances 
and multiple inputs. In that study, FBPC was far superior to MPC. However, this study uses a 
diabetes simulator, which allows for a comparison with some of the unique challenges of BGC 
control mentioned above that cannot be mimicked in the CSTR simulation study.  
Methodology 
     Control Algorithms 
The MPC control algorithms we use in this study are given in detail in Seborg et al. and 
Mei and Rollins [15,16]. For these details, we refer the reader to these works. However, the 
FBPC approach will be described in detail here.  
The classical PID controller equation is given by Eq. 1 below.  
t
dt
tde
KdeKteKtx d
t
ip
)(
)()()(
0
++= ∫ ττ                                      (1) 
where 
tntset yyte ∆+−= ˆ)(                                                              (2) 
)(tx is the controller signal to the insulin pump at time t, sety is the set point for BGC, tnty ∆+ˆ is the 
predicted BGC n time steps into the future, with tn ∆ as the dead time for insulin feed rate, )(te is 
the “feedback error” at t and;  Kp, Ki, and Kd are the proportional, integral, and derivative, tuning 
parameters, respectively, for the proportional, integral, and derivative (PID) controller in this 
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work. FBPC applies the network of the FBC algorithm with modifications, to use the predicted 
BGC ( )tnty ∆+ˆ in the feedback error shown in by Eq. 2 and Fig. 1.  
 
Fig. 1. Illustration of FBPC scheme 
 
     Modeling Methodology 
For FBPC to be successful, the model must give accurate predictions in closed-loop 
control n time steps into the future, that is, when the current change in insulin infusion rate 
affects BGC. In practice, this is difficult because models are developed with one correlation 
structure (e.g., open loop) and used with another one. In addition, the models must have cause-
and-effect input mapping to the outputs, maintain accuracy as unmeasured disturbances change, 
have low measure bias, and have physically sound phenomenological properties. For the diabetes 
simulator in this work, the Wiener method (WM) used in Mei and Rollins [16] was shown that it 
met these conditions quite well and will also be used in this study.   
The WM used in this study features multiple parallel dynamic inputs and one output. 
Figure 2 illustrates its block diagram. As shown, the inputs are first passed through dynamic, 
nonlinear, blocks where they are transformed into unmeasurable intermediate variables, and then 
232 
 
all the intermediate variables are collected are passed through a function representing the static 
gain block.    
 
 
Fig. 2. Block diagram for a general Wiener Network with p inputs and one (1) output. 
 
 
In the context of diabetes, the inputs, xi for i = 1,…, p, of the Wiener network are the 
measured noninvasive variables (i.e., meal components, physical activity, and emotional stress) 
and the output, y, is BGC.  Each input has its own linear dynamic block, Gi, and each dynamic 
block has an intermediate unobservable, output vi, which represents the independent dynamic 
response of its corresponding input.  All the intermediate vi’s are collected and passed through a 
nonlinear static gain block, f(V), to produce the final measured output, y.  The linear dynamic 
blocks are essentially linear ordinary differential equations; a second-order-plus-lead with dead 
time (SOPLDT) form [19,20] as shown in Eq. 3. 
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where i = 1, . . ., p, p is the total number of inputs, τi is the time constant, ζi is the damping 
coefficient, τai is the lead parameter and θi is the dead time.  Using a backward difference 
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After obtaining Eq. 4 for each input i, the modeled glucose value is determined by substituting 
these results into f (V) such as a second order regression form shown below:  
tptppptttppttpptt vvcvvcvbvbvavaaf ,,1,1,2,12,1
2
,
2
,11,,110)( −−+++++++++== LLLVη       (8)             
where ai, bi, and ci,j, denote the linear, quadratic and interaction parameters for i = 1, . . ., p-1 and 
j = 2,…, p.  In this study, linear terms are sufficient for the modeling of BGC. 
In this simulation study, there are only two inputs: 
tx ,1 is the grams of carbohydrate 
consumed at time t and
tx ,2  is the bolus injection/insulin infusion rate in unit of insulin unit per 
minute at t. Thus, in this study, 
ttt vavaaf ,22,110)( ++== Vη                                                   (9) 
In this study, 1θ and 2θ are tm∆ and ,tn∆ respectively, with m and n as positive integers.  
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To model unmeasured disturbances and bias, we use the noise model structure in Rollins 
et at. [21] and apply it to Eq. 9 as follows:  
,ttt Ny +=η                                                              (10)    
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yt is the measured BGC at t and .ttt xxB ∆−= γ
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Modification of Eq. 14 for predicting n time steps into the future gives 
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where “^” is used for estimate.  Our identification of Eq. 15 (i.e., estimation of the unknown 
parameters) follows Rollins et at. [21].  
     Protocols of In-silico Study  
The diabetes simulator used in this study is developed by UVA/Padova, and is approved 
by FDA [17].17 It is a valid substitute for animal trials in the early stages for development of AP. 
In addition, it provides us a safe tool to test different BGC control algorithms before moving 
them onto real patient study. 
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Table 1. Summary of patient information 
Subject Age 
Body 
Weight 
(kg) 
Fasting 
BGC 
(mg/dL) 
Basal 
(U/hr) 
1 16 36.16 115 0.61 
2 18 50.88 123 0.54 
3 19 54.49 127 0.87 
4 17 41.47 123 0.74 
5 19 59.34 118 0.53 
 
The pool for this study contains 5 virtual patients from the simulator. Their characteristics 
are summarized in Table 1. To minimize the effect of measurement delay, both the virtual insulin 
pump and virtual BGC sensor were selected as intravenous (IV) type. As for the scenario tested 
in this study, three meals were served each day at 7am, 12pm and 8pm, and all the serving sizes 
contain 50 grams of carbohydrate. To examine the robustness of the proposed FBPC method, a 
longer than usual period of five-day closed loop control run was done. At the start of each trial, a 
two-day run-in period was implemented. In total, a seven-day trial was run for each virtual 
patient. A total of 3 different control algorithms were used in this in-silico study: 
• Feedback predictive control (FBPC). Insulin was administrated for one hour before meal 
time at every minute. 
• Model predictive control (MPC). As in Mei and Rollins [16] insulin was administrated at 
every minute. 
• Manual bolus (MB). Traditional bolus insulin that was determined by insulin/carb ratio as 
explained in Mei and Rollins [16]. 
 
All four control algorithms were supplemented by basal insulin infusion (at the rate of U/hr) that 
is customized to each subject as shown in Table 1. The set point for each subject was set to their 
fasting BGC before the start of the trial. In addition, to prevent hypoglycemia episode, a pump 
shut-off protocol was implemented as when the predicted BGC was below set point – that is, the 
insulin pump would be turned off. 
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     Evaluation Metrics 
The evaluation of the effectiveness of a BGC control algorithm is often in the forms of 
percentage of time spent within 70-180mg/dL. Additionally, there are other metrics that can 
describe the different aspects of the effects of the control algorithms. The standard deviation 
around mean indicates the spread. Also, low blood glucose index (LBGI) and high blood glucose 
index (HBGI) can be used to gauge the risks in hypo-/hyperglycemia for each subject. The 
higher values of LBGI or HBGI, the higher probability of hypo- or hyperglycemia. 
Table 2. Interpretations for values of LBGI and HBGI 
Risk LBGI HBGI 
minimal ≤ 1.1 < 5.0 
low 1.1 – 2.5 5.0 – 10.0 
medium 2.5 – 5.0 10.0 – 15.0 
high > 5.0 > 15.0 
 
     Training Performance Statistics 
Three measures of performance are used in this study for evaluating the fit of the model. 
The first one is the correlation coefficients between the fitted and measured BGC (rfit); 
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where nt is the number of pairs of values in the set, and iy and iyˆ  are the i
th measure and fitted 
values in the set, respectively. The closer this statistic is to 1.0, the better the model fits the 
measured response data without consideration of model bias. The second statistic, the “averaged 
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error (AE),” gives a measure of model bias. As shown in the equation below, it is the average of 
deviation between for the differences of iy and iyˆ . 
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The final statistic is the “averaged absolute error (AAE)”, which is a measure of the average 
closeness of iy and iyˆ . Its formula is: 
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A common benchmark used in this area is the percent of values in a range, e.g. 70-180 
mg/dL suggested by American Diabetes Association [22], with values below 70mg/dL 
commonly considered as the hypoglycemic region and above 180mg/dL commonly considered 
as the hyperglycemic region.  
Results and Discussion 
Training of the models follows the protocols describes in Rollins et al. [20]. The data set 
for identifying all parameters is the same as in Mei and Rollins [16]; specifically, 9 days of 
training, 2 days of validation and 3 days of testing. Modeling results are summarized in Table 3. 
The modeling results for each subject is given in Table 3. As shown, rfit is excellent for 
all five subjects and for the full set of data with values of 0.99 or better. Similarly, the AE and 
AAE results are also excellent averaging 0.22 and 1.7 mg/dL, respectively on the Testing data. 
To demonstrate the excellent ability of the model to fit well n time steps into the future under 
automatic control, an example of the fit for FBPC is shown in Fig. 3 for Subject 4. The rfit 
between n steps ahead predictor and measurements is 0.9855, AE is 1.1771, and AAE is 3.8764. 
 
238 
 
 
 
Table 3. Results of model fitting 
Subject 
rfit 
AE 
(mg/dL) 
AAE 
(mg/dL) 
Training Validation Testing Testing Testing 
1 0.999 0.999 0.999 0.275 1.694 
2 0.997 0.996 0.997 0.433 2.161 
3 0.999 0.999 0.999 0.219 1.218 
4 0.999 0.999 0.999 0.068 1.897 
5 1 0.999 0.999 0.088 1.454 
Mean 0.999 0.998 0.999 0.217 1.685 
 
 
Figure 3. Model predictions under FBPC for subject 4. The orange line represents BGC 
measurements under FBPC, and blue dotted line represents model prediction of 20 mins into the 
future. 
 
In this study, five subjects were used and their results are shown in Fig. 4(a)–(e). For 
each subject, the proposed FBPC approach outperforms the other ones, as the black lines for 
FBPC have smaller variation around mean than all other methods tested in this study. For more 
specific pairwise comparison, the results are summarized in the following Table 4.  
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Fig. 4. Panel (a)-(e) represent BGC measurements for subject 1-5. Black line represents results 
under proposed FBPC, blue dashed line denotes MPC, and yellow dotted line is for MB. 
 
 
(a) 
(b) (c) 
(d) (e) 
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Table 4. Summary results of control runs with different algorithms 
Subject Set 
Point 
FBPC MPC MB 
Mean 
(mg/dL) 
Stdev 
(mg/dL) 
70-180 
mg/dL 
Mean 
(mg/dL) 
Stdev 
(mg/dL) 
70-180 
mg/dL 
Mean 
(mg/dL) 
Stdev 
(mg/dL) 
70-180 
mg/dL 
1 115 114.4 36.6 92.9% 108.2 42.4 69.8% 149.6 45.8 66.4% 
2 123 124.0 26.4 94.9% 110.8 32.7 94.2% 153.3 36.7 74.9% 
3 127 122.1 20.7 100.0% 114.8 23.6 100.0% 139.1 25.9 99.3% 
4 123 124.0 34.1 98.8% 130.0 41.3 84.2% 149.9 42.6 64.3% 
5 118 116.9 13.6 100.0% 108.1 21.9 100.0% 117.8 21.6 100.0% 
Average 120.3 26.3 97.3% 114.4 32.4 89.7% 141.9 34.5 81.0% 
 
For pairwise comparison, standard deviation reduction with FBPC is 19% and 23%, 
compared to MPC and MB, respectively. Furthermore, the increase of time spent within 70 – 180 
mg/dL with FBPC against MB is 21%, and on average, 97.3% of time was spent within desired 
BGC region. 
For evaluation of risks for hypo-/hyperglycemia episode, the statistics of LBGI and 
HBGI are used. They serve as alerts and boundaries for control methods tested. The goal for 
LBGI and HBGI is to maintain both risks at minimal level according to Table. 2, whereas LBGI 
weighs more in our consideration since hypoglycemia has more immediate life-threatening 
effects on people with T1D. Results for LBGI and HBGI are demonstrated in Tables 5 and 6. For 
LBGI, all cases under FBPC have minimal risks for hypoglycemic episode, and 2 cases under 
MPC have risks that are greater than minimal. As for HBGI, all cases are under the values of 5, 
which indicates the concern for hyperglycemia is minimum for all control algorithms tested in 
this study. 
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Table 5. LBGI for different control algorithms 
Subject FBPC MPC MB 
1 1.07 3.54 0.08 
2 0.12 1.19 0 
3 0.12 0.76 0.02 
4 0.7 0.92 0.12 
5 0.1 0.94 0.32 
Mean 0.422 1.47 0.108 
 
Table 6. HBGI for different control algorithms 
Subject FBPC MPC MB 
1 2 1.29 4.68 
2 1.63 0.88 4.3 
3 1.77 0.68 2.49 
4 3.49 2.38 4.82 
5 1.78 0.35 0.68 
Mean 2.134 1.116 3.394 
. 
Concluding Remarks 
This article demonstrated the potential superiority of FBPC to tighten BGC control for 
people with T1D over current methods. In addition to this advantage, FBPC just requires a model 
that can predict accurately a time distant into the future equal to the dead time of the insulin 
infusion rate. This is a considerable advantage over model based methods, such as MPC and 
FFPC that require an accurate cause-and-effect model for the manipulated variable as the input to 
determine BGC. Modeling methods to implement FBPC should focus on multiple-input cause-
and-effect [19], phenomenologically sound structure [23], and high accuracy under automatic 
control conditions. The pre-whitening procedure we applied in this work will effectively handle 
unmeasured disturbances and model bias as demonstrated in Rollins and Mei [18] and in Kotz et 
al. [24] on real Type 1 diabetes data with rfits as high as 0.9 for several subjects. In practice, since 
it is a FBC method it would be combined with FFPC when accurate models for the manipulated 
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variable can be obtained. Since the method has shown it superiority over MPC here using a 
diabetes simulator and in Rollins and Mei [18], the next step is to evaluate it on real subjects.  
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CHAPTER 12: FUTURE WORKS                                                                              
The successful development and demonstration of the effectiveness of feedback 
predictive control (FBPC) algorithm, has paved the way for real subject clinical studies in the 
future. Additional work needs to be done to further polish this methodology. For example, 
physiologically sound semi-coupled structure should be implemented into FBPC to capture more 
cause-and-effect relationships between meals, insulin, and BGC. Plus, more measured 
disturbances such as variables that concern physical activities and emotional stress should be 
incorporated into the model. Last but not least, FBPC could work in concert with other control 
algorithms and potentially achieve tighter BGC control.  
 In addition, Further investigation will be conducted on model predictive control (MPC), 
feedforward predictive control (FFPC) and other modeled based control algorithms, with the 
development of sensing technology in blood glucose concentration (BGC) and plasma insulin, 
and the commercialization of other hormones such as glucagon. 
For people with type 2 diabetes, virtual BGC sensing algorithm can be incorporated into 
lifestyle management system residing on portable devices that can provide valuable information 
on how people should manage their diets and exercises. 
 
